Sentence,class,file
http://dx.doi.org/10   .1016/j.immuni.2012.11.00 3,OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10   .1093/infdis/jit00 2 Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T.W.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1016/S0140-6736(13)60177- 4 Torrado, E., J.J. Fountain, R.T. Robinson, C.A.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1371/journal.pone.006168 1 van der Plas, H., G. Meintjes, C. Schutz, R. Goliath, L. Myer, D. Baatjie,  R.J. Wilkinson, G. Maartens, and M. Mendelson.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10   .1371/journal.pone.005414 5 Villarino, A.V ., J.S.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.4049/   jimmunol.176.1.23 7 Villegas-Mendez, A., J.B. de Souza, S.-W. Lavelle, E. Gwyer Findlay,  T.N.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1371/journal.ppat.100329 3 Woodworth, J.S., Y .",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10   .4049/jimmunol.181.12.859 5 Woodworth, J.S., C.S.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.4049/jimmunol   .130028 3 Yang, W.B., Q.L.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1371/journal.pone.004045 0 Y oshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia,   A.C. W akeham, H. Nishina, J. Potter, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00206- 0Pearl, J.E., S.A. Khader, A. Solache, L. Gilmartin, N. Ghilardi, F. deSauvage,  and A.M. Cooper.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.4049/jimmunol.173.12.749 0 Pearl, J.E., E. T orrado, M. Tighe, J.J. Fountain, A. Solache, T. Strutt, S. Swain,   R. Appelberg, and A.M. Cooper.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1002/eji.20114215 8 Pflanz, S., J.C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L.  Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/   10.1016/S1074-7613(02)00324- 2 Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J.F .",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.4049/   jimmunol.172.4.222 5 Reiley, W.W., M.D.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/   10.1111/imr.1225 9 Sakai, S., K.D.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10   .4049/jimmunol.140001 9 Slight, S.R., J. Rangel-Moreno, R. Gopal, Y. Lin, B.A.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/   10.1172/JCI6572 8 Sodenkamp, J., J. Behrends, I. Förster, W. Müller, S. Ehlers, and C. Hölscher.",OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
"http://dx.doi.org/10.1038/ni.195 7 Tadokera, R., G. Meintjes, K.H.",Non-OADS,/arxiv_data1/oa_pdf/4a/9f/JEM_20141520.PMC4548054.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"Online supple ­ mental material is available at http://www.jem.org/cgi/content/full/jem   .20141555/DC 1.human tumor cells, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.2353/ajpath.2010.09062 2 Fidler, I.J.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/   10.1038/nrc109 8 Fischer, C., B. Jonckx, M. Mazzone, S. Zacchigna, S. Loges, L. Pattarini, E.  Chorianopoulos, L. Liesenborghs, M. Koch, M. De Mol, et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/   10.1016/j.cell.2007.08.03 8 Gil­Bernabé, A.M., S. Ferjancic, M. Tlalka, L. Zhao, P.D.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/   10.1182/blood­2011­08­37642 6 Grivennikov, S.I., F.R.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.cell   .2010.01.02 5 Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/   S1535­6108(02)00153­ 8 Hutchinson, J.N., and W.J.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10   .1038/sj.onc.120397 0 Jemal, A., R. Siegel, J. Xu, and E. Ward.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.3322/caac.2007 3 Joyce, J.A., and J.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/   nrc261 8 Kaplan, R.N., R.D.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/   nature0418 6 Kitamura, T., B.Z.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1084/jem.2014183 6 Labelle, M., and R.O.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/   10.1158/2159­8290.CD­12­032 9 Lin, E.Y., A.V.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1084/jem   .193.6.72 7 Lin, E.Y., J.G.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/S0002 ­  9440(10)63568­ 7 Lyden, D., K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn,  B. Heissig, W. Marks, L. Witte, et al.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
http://dx.doi.org/10.1016/j.coi.2010.01.00 9Research reported in this publication was supported by the National Cancer  Institute of the National Institutes of Health under award numbers R01CA131270  and PO1CA100324 and the Wellcome Trust (101067/Z/13/Z) to J.W.,Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/nature0524 9 Bais, C., X. Wu, J. Yao, S. Yang, Y. Crawford, K. McCutcheon, C. Tan, G.  Kolumam, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.cell.2010.01.03 3 Beck, H., S. Raab, E. Copanaki, M. Heil, A. Scholz, M. Shibuya, T.  Deller, M. Machein, and K.H.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1097/   NEN.0b013e3181c9c05 b Borowsky, A.D., R. Namba, L.J.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1007/s10585­005­2908­ 5 Byrne, P.V., L.J.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1083/jcb.91.3.84 8 Casanovas, O., D.J.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1016/j.ccr.2005.09.00 5 Chen, Q., X.H.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/   j.ccr.2011.08.02 5 Chitu, V., and E.R.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1016/j.coi.2005.11.00 6 Condeelis, J., and J.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.cell.2006.01.00 7 Coussens, L.M., and J.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1126/science.123222 7 Curry, J.M., T.D.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1371/journal.pone   .000340 5 Dawson, M.R., D.G.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1371/journal.pone.000652 5 Dawson, M.R., D.G.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1038/nature0825 4 De Palma, M., and C.E.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1016/j.ccr.2013.02.01 3 Deng, L., J.F.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.it.2011.12.00 1 Saeed, A.I., V .",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1093/jnci/86.2.12 0 Scholl, S.M., R. Lidereau, A. de la Rochefordière, C.C.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1007/BF0180615 5 Shibuya, M. 2006.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.ejca.2010.02.03 9 Smith, H.O., P.S.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/nature1008 5 Tichelaar, J.W., W. Lu, and J.A.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1074/jbc.275   .16.1185 8 T oy, E.P ., J.T.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1006/gyno.2000.607 0 Van Nguyen, A., and J.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10   .1006/dbio.2002.066 9 Wiktor­Jedrzejczak, W., A. Bartocci, A.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10   .1073/pnas.87.12.482 8 Wu, Y., Z. Zhong, J. Huber, R. Bassi, B. Finnerty, E. Corcoran, H. Li, E.  Navarro, P. Balderes, X. Jimenez, et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1158/   1078­0432.CCR­06­083 1 Wyckoff, J.B., Y .",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
http://dx.doi.org/10.1158/0008 ­5472.,Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/   nature0720 5 McDermott, R.S., L. Deneux, V. Mosseri, J. Védrenne, K. Clough, A.  Fourquet, J. Rodriguez, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1038/nature0379 9 Murakami, M., Y. Zheng, M. Hirashima, T. Suda, Y. Morita, J. Ooehara,  H. Ema, G.H.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"28:658– 664. http://dx.doi.org/10.1161/ATVBAHA.107.15043 3 Murdoch, C., A. Giannoudis, and C.E.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1182/   blood­2004­03­110 9 Neve, R.M., K. Chin, J. Fridlyand, J. Yeh, F.L.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/j.ccr.2006.10.00 8 Nielsen, B.S., L.R.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi   .org/10.1016/S0002­9440(10)64671­ 8 Olsson, A.K., A. Dimberg, J. Kreuger, and L. Claesson­Welsh.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/nrm191 1 Peinado, H., M. Ale čković, S. Lavotshkin, I. Matei, B. Costa ­Silva, G.  Moreno ­Bueno, M. Hergueta ­Redondo, C. Williams, G. García ­Santos,  C. Ghajar, et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1038/nm.275 3 Qian, B.Z., and J.W.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.03.01 4 Qian, B., Y. Deng, J.H.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10.1371/journal.pone.000656 2 Qian, B.Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"475:222– 225. http://dx.doi.org/10.1038/nature1013 8 Quail, D.F., and J.A.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
"http://dx.doi.org/10   .1038/nm.339 4 Richardsen, E., R.D.",OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
http://dx.doi.org/10   .1111/j.1365­2559.2008.03058.,Non-OADS,/arxiv_data1/oa_pdf/a2/86/JEM_20141555.PMC4548055.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10   .1093/nar/gku65 2 Badarinarayana, V., Y.C.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1093/nar/gki101 2 Bednarski, J.J., A. Nickless, D. Bhattacharya, R.H. Amin, M.S.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1084/jem.2011207 8 Bolland, D.J., A.L.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.09.00 7 Chen, C., K. Ito, A. Takahashi, G. Wang, T. Suzuki, T. Nakazawa, T.  Yamamoto, and K. Yokoyama.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10   .1016/j.bbrc.2011.06.14 8 Chicoine, J., P .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.00 2 Collart, M.A., and O.O.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.gene.2011.09.03 3 Collart, M.A., O.O.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/   j.cellsig.2012.12.01 8 Cooke, A., A. Prigge, and M. Wickens.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1074/   jbc.M110.15076 3 Decker, C.J., and R. Parker.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1101/gad.7.8.163 2 Deluen, C., N. James, L. Maillet, M. Molinete, G. Theiler, M. Lemaire, N.  Paquet, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1128/MCB.22.19.6735-   6749.200 2 Ebert, A., S. McManus, H. T agoh, J. Medvedovic, G. Salvagiotto, M. Novatchkova,  I. Tamir, A. Sommer, M. Jaritz, and M. Busslinger.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.02.00 5 Fortunel, N.O., A. Hatzfeld, and J.A.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi   .org/10.1073/pnas.060799610 4 Lemaire, M., and M.A.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80466- 5 Liu, H., M. Schmidt-Supprian, Y. Shi, E. Hobeika, N. Barteneva, H. Jumaa,   R. Pelanda, M. Reth, J. Skok, K. Rajewsky, and Y. Shi.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"21:1179– 1189. http://dx.doi.org/10.1101/gad.152930 7 Loh, B., S. Jonas, and E. Izaurralde.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1101/gad.226951.11 3 Lu, L., D. Lejtenyi, and D.G.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/ 10.1002/(SICI)1521-4141(199908)29:08<2484:: AID-IMMU2484>   3.0.CO;2- B Lutz, J., M.R.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/   ni.182 7 Malynn, B.A., G.D. Yancopoulos, J.E.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"171:843– 859. http://dx.doi.org/10.1084/jem.171.3.84 3 McKinsey, T.A., C.L.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/S0968-0004(01)02031- X Medvedovic, J., A. Ebert, H. Tagoh, I.M.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.08.01 1 Meffre, E., R. Casellas, and M.C.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/   10.1038/8081 6 Miller, J.E., and J.C. Reese.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1128/MCB.02304-0 6 Morita, M., Y .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/   emboj.2011.32 0 Mulder, K.W., A.B.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1093/nar/gkm17 5 Muljo, S.A., and M.S.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/ni87 0Frischmeyer-Guerrerio, P.A., R.A. Montgomery, D.S.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/   10.1101/gad.103140 3 Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P .J.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/   10.1073/pnas.060594410 3 Hu, G., J. Kim, Q. Xu, Y .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1101/   gad.176960 9 Huang, D.W., B.T.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/nprot.2008.21 1 Isono, K., T.A.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.08.01 6 Ito, K., T. Inoue, K. Y okoyama, M. Morita, T. Suzuki, and T. Yamamoto.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
http://dx.doi.org/10.1111/j.1365-2443.2011.01492.,Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10   .1016/ j.cell.2008.03.02 4 Jung, D., and F .W .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/   S0092-8674(04)00039- X Jung, D., C. Giallourakis, R. Mostoslavsky, and F .W .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1146/   annurev.immunol.23.021704.11583 0 Khanna, K.K., and S.P.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/   350423a 0 Koralov, S.B., S.A. Muljo, G.R.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.02.02 0 Kosak, S.T., J.A.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
http://dx.doi.org/10.1101/gad.202091 1,Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/ng134 4 Neely , G.G., K. Kuba, A. Cammarato, K. Isobe, S. Amann, L. Zhang, M. Murata,   L. Elmén, V .",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.02 3 Papadaki, O., S. Milatos, S. Grammenoudi, N. Mukherjee, J.D.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"182:6779– 6788. http://dx.doi.org/10.4049/jimmunol.090037 7 Quong, M.W., A. Martensson, A.W.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1084/jem.2003118 0 Rajewsky, K. 1996.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/381751a 0 Reichlin, A., Y .",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/   10.1084/jem.193.1.1 3 Reynaud, D., I.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/   ni.162 6 Sallés, F.J., W.G.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10   .1006/meth.1998.070 5 Sayegh, C.E., S. Jhunjhunwala, R. Riblet, and C. Murre.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"22:1717) http://dx.doi.org/10.1101/gad.125430 5 Schlissel, M.S., L.M.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"173:711– 720. http://dx.doi.org/10.1084/jem.173.3.71 1Shih, T.A., M. Roederer, and M.C.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1038/ni77 6 Su, I.H., A. Basavaraj, A.N.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"4:124– 131. http://dx.doi.org/10.1038/ni87 6 Trapnell, C., L. Pachter, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp12 0 Trapnell, C., B.A.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"28:511– 515. http://dx.doi.org/10.1038/nbt.162 1 Verma-Gaur, J., A. Torkamani, L. Schaffer, S.R.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/   10.1073/pnas.120839810 9 Wahle, E., and G.S.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1016/j.bbagrm.2013.01.00 3 Wang, Y.H., R.P.",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
"http://dx.doi.org/10.1359/   jbmr.07041 1 Watanabe, C., M. Morita, T. Hayata, T. Nakamoto, C. Kikuguchi, X. Li,   Y .",OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
http://dx.doi.org/10.1016/0092-8674(85)90141- 2,Non-OADS,/arxiv_data1/oa_pdf/5f/0f/JEM_20150384.PMC4548056.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1038/417452 a Kebaier, C., T. Voza, and J. Vanderberg.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/   j.jhep.2010.04.03 7 Kurushima, H., M. Ramprasad, N. Kondratenko, D.M.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/   S1473-3099(09)70329- 9 Moorthy, V.S., M.F.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/S0140-   6736(03)15267- 1 Pinzon-Ortiz, C., J. Friedman, J. Esko, and P. Sinnis.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1074/jbc   .M10403820 0 Pradel, G., and U. Frevert.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1053/jhep.2001.2423 7 Pradel, G., S. Garapaty, and U. Frevert.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1194/ jlr.M01541 2 Sturm, A., R. Amino, C. van de Sand, T. Regen, S. Retzlaff, A. Rennenberg,  A. Krueger, J.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1126/   science.112972 0 Tavares, J., P. Formaglio, S. Thiberge, E. Mordelet, N. Van Rooijen, A.  Medvinsky, R. Ménard, and R. Amino.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
210:905– 915. http://dx.doi.org/10.1084/jem.2012113 0Statistics for data analysis.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1007/BF0204124 4 Baer, K., M. Roosevelt, A.B.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1006/jmbi.1996.028 4 Bruña-Romero, O., J.C. Hafalla, G. González-Aseguinolaza, G. Sano, M.  Tsuji, and F. Zavala.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi   .org/10.1016/S0020-7519(01)00265- X Bykov, I., P. Ylipaasto, L. Eerola, and K.O.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi   .org/10.1186/1476-5926-2-S1-S3 4 Cerami, C., U. Frevert, P. Sinnis, B. Takacs, and V. Nussenzweig.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1084/jem.179.2.69 5 Coppi, A., R. Tewari, J.R. Bishop, B.L.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi   .org/10.1016/j.chom.2007.10.00 2 Danforth, H.D., M. Aikawa, A.H. Cochrane, and R.S.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
http://dx.doi   .org/10.1111/j.1550-7408.1980.tb04680.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1084/jem.177.5.128 7 Frevert, U., P. Sinnis, J.D.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi   .org/10.1016/0166-6851(95)02563- 4 Frevert, U., S. Engelmann, S. Zougbédé, J. Stange, B. Ng, K. Matuschewski,  L. Liebes, and H. Yee.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/   10.1371/journal.pbio.003019 2 Frevert, U., I. Usynin, K. Baer, and C. Klotz.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
http://dx.doi.org/10.1111/j.1462-5822.2006.00777.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/j.leukres.2004.12.01 1 Usynin, I., C. Klotz, and U. Frevert.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
http://dx.doi.org/10.1111/j.1462-5822.2007.00982.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
http://dx.doi.org/10.1111/j.1550-7408.1990   .tb01260.,Non-OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/0047-0740(80)90033- 9 Vreden, S.G. 1994.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1016/0169-4758(94)90084- 1 White, N.J., S. Pukrittayakamee, T.T.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi   .org/10.1016/S0140-6736(13)60024- 0 Widmann, J.J., R.S.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
"http://dx.doi.org/10.1083/jcb.52.1.15 9 Yoshida, N., R.S.",OADS,/arxiv_data1/oa_pdf/4d/78/JEM_20110575.PMC4548058.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10 .1161/ATVBAHA.114   .30341 6 Grynkiewicz, G., M. Poenie, and R.Y.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.3109/   0036551810909202 2 Hotchkiss, R.S., G. Monneret, and D. Payen.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1038/nri355 2 Jang, J.H., C.S.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1016/j   .plipres.2011.12.00 3 Kim, S.D., H.Y.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1378/chest.11-035 2 Li, P., M. Li, M.R.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"339:520– 532. http://dx.doi.org/10.1056/NEJM19980820339080 6 Maguire, O., C. Collins, K. O’Loughlin, J. Miecznikowski, and H. Minderman.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1002/cyto   .a.2106 8 Matute-Bello, G., C.W.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi   .org/10.1164/ajrccm.163.1.990903 4 McDonald, B., R. Urrutia, B.G.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi   .org/10.1016/j.chom.2012.06.01 1 Rohrbach, A.S., D.J.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi   .org/10.1038/nchembio.14 0 Wang, Y., M. Li, S. Stadler, S. Correll, P. Li, D. Wang, R. Hayama, L.  Leonelli, H. Han, S.A. Grigoryev, et al.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10   .1083/jcb.20080607 2 Xiao, H., J. Siddiqui, and D.G.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
http://dx.doi.org/10   .1128/IAI.01220-0 5was used.,Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
Online supple - mental material is available at http://www.jem.org/cgi/content/full/jem   .20141813/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1038/nm.215 6 Angus, D.C., W.T.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1097/00003246-   200107000-0000 2 Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D.S.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1126/   science.109238 5 Cohen, J.",Non-OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
"http://dx.doi.org/10.1038/nature0132 6 Colley, W.C., T.C.",OADS,/arxiv_data1/oa_pdf/cc/e8/JEM_20141813.PMC4548059.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi   .org/10.1038/nature0424 7 Arroyo, A.G., J.T.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)80131- 4 Brakebusch, C., R. Grose, F. Quondamatteo, A. Ramirez, J.L.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1093/emboj/19.15.399 0 Campos, L.S., D.P.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1242/dev.0119 9 Essers, M.A.G., S. Offner, W.E.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1038/nature0781 5 Frommhold, D., A. Ludwig, M.G.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1084/jem.2007084 6 Grassinger, J., D.N.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1182/blood-2009-01-   19798 8 Hameyer, D., A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E.  Bindels, J. Jonkers, P .",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1152/physiolgenomics   .00019.200 7 Hu, Y., and G.K. Smyth.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/j.jim   .2009.06.00 8 Hynes, R.O.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00971- 6 Jordan, C.T., C.M.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 6 Klimmeck, D., J. Hansson, S. Raffel, S.Y.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi   .org/10.1093/hmg/ddl17 5 Rognoni, E., M. Widmaier, M. Jakobson, R. Ruppert, S. Ussar, D. Katsougkri,  R.T. Böttcher, J.E.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi   .org/10.1038/nm.349 0 Schmidt, S., I. Nakchbandi, R. Ruppert, N. Kawelke, M.W .",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1083/   jcb.20100714 1 Shattil, S.J., C. Kim, and M.H.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1038/nm.193 1 Taooka, Y ., J. Chen, T .",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1083/jcb.145.2.41 3 Trumpp, A., M. Essers, and A. Wilson.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1038/nri272 6 Ussar, S., H.-V .",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/   j.yexcr.2006.06.03 0 van der Loo, J.C., X. Xiao, D. McMillin, K. Hashino, I. Kato, and D.A.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi   .org/10.1172/JCI368 7 Wilson, A., and A. Trumpp.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1038/   nri177 9 Wilson, A., E. Laurenti, G. Oser, R.C.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1126/science.106408 1 Yamaguchi, M., K. Ikebuchi, F. Hirayama, N. Sato, Y. Mogi, J. Ohkawara,  Y. Yoshikawa, K. Sawada, T. Koike, and S. Sekiguchi.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.09.05 3 Zou, P., H. Yoshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F. Tsukahara,  Y. Maru, K. Nakayama, K.I.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10   .1074/mcp.M111.01679 0 Kuijpers, T.W ., E. van de Vijver, M.A.J.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1182/blood-2008-10-18215 4 Magnon, C., and P.S.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1038/nm.191 7 Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo,  E.A.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.04 7 Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y. Tateishi,  K. Nakayama, and K.I.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/j.stem.2011.06.01 4 Mazo, I.B., and U.H.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1084/jem.2009131 8 Morrison, S.J., and D.T.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10   .1038/nature1298 4 Moser, M., B. Nieswandt, S. Ussar, M. Pozgajova, and R. Fässler.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1038/nm172 2 Moser, M., K.R.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/   10.1126/science.116386 5 Moser, M., M. Bauer, S. Schmid, R. Ruppert, S. Schmidt, M. Sixt, H.-V .",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1038/nm.192 1 Pellinen, T., S. Tuomi, A. Arjonen, M. Wolf, H. Edgren, H. Meyer, R. Grosse,  T. Kitzing, J.K. Rantala, O. Kallioniemi, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.08.00 1 Potocnik, A.J., C. Brakebusch, and R. Fässler.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80216- 2 Raghavan, S., C. Bauer, G. Mundschau, Q. Li, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
http://dx.doi.org/10.1083/jcb.150.5.114 9,Non-OADS,/arxiv_data1/oa_pdf/ff/33/JEM_20150269.PMC4548061.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20142274/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi   .org/10.1016/j.jpeds.2010.04.02 0 Ablasser, A., J.L.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"503:530– 534. http://dx.doi.org/10.1038/nature1264 0 Audry, M., M. Ciancanelli, K. Yang, A. Cobat, H.H.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.04.05 9 Casanova, J.L., and L. Abel.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1126/science.114296 3 Casanova, J.L., M.E.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi   .org/10.1084/jem.2014052 0 Casrouge, A., S.Y.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1126/science.112834 6 Griffin, D.E.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
http://dx.doi.org/10.1084/jem.2010156 8TaqMan RT -qPCR.,OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1084/jem.2011131 6 Honda, K., and T. Taniguchi.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1038/nri190 0 Jakobsen, M., K. Stenderup, C. Rosada, B. Moldt, S. Kamp, T.N.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1038/mt.2009.14 1 Kanehisa, M., S. Goto, Y. Sato, M. Kawashima, M. Furumichi, and M.  Tanabe.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/   10.1093/nar/gkt107 6 Lafaille, F.G., I.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1212/   WNL.000000000000099 9 Liu, S., X. Cai, J. Wu, Q. Cong, X. Chen, T. Li, F. Du, J. Ren, Y.T.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1126/science.aaa263 0 Menachery, V.D., T.J. Pasieka, and D.A.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1128/JVI.00706-1 0 Mogensen, T.H.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi   .org/10.1128/CMR.00046-0 8 Mori, M., M. Y oneyama, T. Ito, K. Takahashi, F .",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1074/jbc   .M31061620 0 Osterlund, P ., V .",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1128/JVI.79.15   .9608-9617.200 5 Paludan, S.R., A.G. Bowie, K.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"11:143– 154. http://dx.doi.org/10.1038/nri293 7 Pérez de Diego, R., V .",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.08.01 4 Piirilä, H., J. Väliaho, and M. Vihinen.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10   .1002/humu.2040 5 Rieux-Laucat, F., and J.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1126/   science.126079 1 Sancho-Shimizu, V., R. Perez de Diego, E. Jouanguy, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1016/j.coviro   .2011.10.01 6 Sancho-Shimizu, V ., R. Pérez de Diego, L. Lorenzo, R. Halwani, A. Alangari,  E. Israelsson, S. Fabrega, A. Cardon, J. Maluenda, M. Tatematsu, et al.",OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"24:1719– 1723. http://dx.doi.org/10.1101/gr.176701.11 4 Takahasi, K., M. Horiuchi, K. Fujii, S. Nakamura, N.N.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"http://dx.doi.org/10.1093/clinids/20.2.41 4 Zhang, S.Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D.  Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
"317:1522– 1527. http://dx.doi.org/10.1126/science.113952 2 Zhang, S.Y., M. Herman, M.J. Ciancanelli, R. Pérez de Diego, V. Sancho- Shimizu, L. Abel, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
http://dx.doi.org/   10.1016/j.coi.2012.11.00 1,OADS,/arxiv_data1/oa_pdf/0b/f1/JEM_20142274.PMC4548062.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/lupus-2015- 000110).,Non-OADS,/arxiv_data1/oa_pdf/77/0d/lupus-2015-000110.PMC4548064.pdf
"21; http://www.mirbase.org/, released in June 2014).",Non-OADS,/arxiv_data1/oa_pdf/7c/68/JCTH-3-149.PMC4548348.pdf
"[3] http://www.who.int/mediacentre/factsheets/fs204/en, accessed July 2014.",Non-OADS,/arxiv_data1/oa_pdf/7c/68/JCTH-3-149.PMC4548348.pdf
"9. http://files.easl.eu/easl-recommendations-on-treatment-of-hepatitis-C.pdf, accessed February 2015.",Non-OADS,/arxiv_data1/oa_pdf/89/71/JCTH-3-140.PMC4548349.pdf
"10. http://www.hcvguidelines.org/, accessed February 2015.",Non-OADS,/arxiv_data1/oa_pdf/89/71/JCTH-3-140.PMC4548349.pdf
The online version of the original article can be found athttp://www.jcthnet.com/index.php/archive?id=184.,Non-OADS,/arxiv_data1/oa_pdf/49/c7/JCTH-3-162.PMC4548350.pdf
"Under DSHEA, dietarysupplements are not held to the same standards as prescrip-tion drugs and can be marketed without clinical safety studies(http://www.fda.gov/RegulatoryInformation/default.htm).",Non-OADS,/arxiv_data1/oa_pdf/ce/01/JCTH-3-093.PMC4548352.pdf
"7. http://www.fda.gov/cder/livertox/clinical.pdf, accessed January 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ce/01/JCTH-3-093.PMC4548352.pdf
"18. http://www.marketresearch.com/Marketdata-Enterprises-Inc-v416/Weight- Loss-Status-Forecast-8016030, accessed January 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ce/01/JCTH-3-093.PMC4548352.pdf
29. http://www.fda.gov/iceci/enforceme ntactions/warningletters/2013/ucm371203.,Non-OADS,/arxiv_data1/oa_pdf/ce/01/JCTH-3-093.PMC4548352.pdf
51. https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/1e/c7/JCTH-3-109.PMC4548353.pdf
[109] http://apps.who.int/iris/bitstream/10665/129448/1/9789241507608_eng.,OADS,/arxiv_data1/oa_pdf/36/c6/JCTH-3-117.PMC4548356.pdf
Received: 3 January 2013; Revised: 22 February 2013; Accepted: 25 February 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.002XX.,Non-OADS,/arxiv_data1/oa_pdf/b4/11/JCTH-1-022.PMC4548358.pdf
"[35] http://emedicine.medscape.com/article/177632, accessed December, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d5/58/JCTH-2-240.PMC4548361.pdf
"[55] http://www.hcvguidelines.org/sites/default/files/full_report.pdf, accessed February, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/58/JCTH-2-240.PMC4548361.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f3/e7/jjm-08-06-18158.PMC4548401.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7e/6a/jjm-08-06-15985.PMC4548402.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a3/d6/jjm-08-06-18691.PMC4548403.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/74/91/jjm-08-06-18353.PMC4548404.pdf
Available from: http://www.who.int/trade/glossary/ story002/en/.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JRPP-4-115.PMC4548429.pdf
Available from: http://www.bscn.nl/ sanctions‑consulting/sanctions‑list‑countries.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JRPP-4-115.PMC4548429.pdf
Available from: http://www.fecca.org.au/projects/ past‑projects/multicultural‑community‑quality‑use‑of‑medic ines‑program.,Non-OADS,/arxiv_data1/oa_pdf/c9/d7/JRPP-4-123.PMC4548430.pdf
Available  from: http://www.health.qld.gov.au/consent/documents/ ic‑guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/d7/JRPP-4-123.PMC4548430.pdf
Available from: http://www.nps.org.au/ media‑centre/media‑releases/repository/Pharmacists‑ca n‑help‑prevent‑medicines‑related‑problems‑Australians.,Non-OADS,/arxiv_data1/oa_pdf/c9/d7/JRPP-4-123.PMC4548430.pdf
Available from: https://www.tisnational.gov.au/ Non‑English‑speakers/Help‑using‑TIS‑National‑services/ Agencies‑and‑businesses‑using‑TIS‑National‑ interpreters.,Non-OADS,/arxiv_data1/oa_pdf/c9/d7/JRPP-4-123.PMC4548430.pdf
Available from: http://www.fda.gov/downloads/ drugs/guidancecomplianceregulatoryinformation/guidances/ ucm269921 [Last accessed on Feb 2015].,Non-OADS,/arxiv_data1/oa_pdf/00/73/JRPP-4-147.PMC4548434.pdf
Available from: http://apps.who.int/classifications/ icd10/browse/2010/en [Last accessed on 2010 Mar 12].,OADS,/arxiv_data1/oa_pdf/63/f9/JRPP-4-167.PMC4548437.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f7/9f/jjm-08-06-19180.PMC4548468.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ Introduction 4-Nonylphenol (4-NP) is a typical endocrine disruptor which  originates as a result of the microbial metabolism of nonylphe - nol polyethoxylates that are widely used as surfactants [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
"Alteration of hepatic anti-oxidant systems by  4-nonylphenol, a metabolite of alkylphenol  polyethoxylate detergents, in Far Eastern catfish  Silurus asotus Kwan Ha Park Department of Aquatic Life Medicine, College of Ocean Science and T echnology, Kunsan National University Gunsan, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30, Article ID: e2015006, 7 pages http://dx.doi.org/10.5620/eht.e2015006 eISSN: 2233-6567  Objectives  This study aimed to estimate the effects of 4-nonylphenol (NP), a ubiqui - tously present surfactant in aquatic environments, on the anti-oxidant systems of the liv - er in the Far Eastern catfish Silurus asotus .",Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
"Keywords  Anti-oxidant enzymes, Far Eastern catfish Silurus asotus , Glutathione, 4-Nonyl - phenol Correspondence:  Kwan Ha Park 558 Daehak-ro, Gunsan 573-701, Korea Tel: +82-63-469-1885    Fax: +82-63-463-9493 E-mail: khpark@kunsan.ac.kr Received:  April 23, 2015 Accepted:  May 28 2015 Published online:  July 2, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
"http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2015;30:e2015006 Through docking studies with enzymes, Jayakanthan et al.",OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
http://e-eht.org/ Page 3 of 7Kwan Ha Park  | 4-Nonylphenol and catfish tween the hepatopancreas and whole body weight.,Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
"http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2015;30:e2015006 Malondialdehyde Levels The hepatic concentration of MDA, which reflects the degree  of tissue lipid peroxidation, is illustrated in Figure 1A.",Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
http://e-eht.org/ Page 5 of 7Kwan Ha Park  | 4-Nonylphenol and catfish Superoxide Dismutase Activity Changes in SOD activity are illustrated in Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2015;30:e2015006 been reported to control pro-oxidants in cells [23].,Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
Available from: http://echa.europa.eu/documents/10  162/14598345/support_document_4-nonylphenol+ethoxylat es_20130612_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
http://e-eht.org/ Page 7 of 7Kwan Ha Park  | 4-Nonylphenol and catfish antioxidant defense enzymes.,Non-OADS,/arxiv_data1/oa_pdf/a5/d6/eht-30-e2015006.PMC4548496.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ Introduction Graphene is typically composed of sp2-hybridized carbon at - oms packed densely in a honeycomb crystal lattice arranged in a  two-dimensional structure, resulting in a large surface area on both sides of the planar axis.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"The huge versatility of the GFNs Screening of toxic potential of graphene family  nanomaterials using in vitro  and alternative in vivo   toxicity testing systems Nivedita Chatterjee1, Ji Su Yang1, Kwangsik Park2, Seung Min Oh3, Jeonggue Park4,   Jinhee Choi1 1School of Environmental Engineering, Graduate School of Energy and Environmental System Engineering, University of Seoul,  Seoul; 2College of Pharmacy, Dongduk Women’s University, Seoul; 3Fusion T echnology Laboratory, Hoseo University, Asan;  4Korea Environmental Institute, Seoul, Korea • Original ArticleOpen Access Environmental Health and Toxicology Volume: 30, Article ID: e2015007, 7 pages http://dx.doi.org/10.5620/eht.e2015007 eISSN: 2233-6567  Objectives  The widely promising applications of graphene nanomaterials raise consider - able concerns regarding their environmental and human health risk assessment.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"Keywords  Alternative toxicity testing, Human bronchial epithelial cells, Caenorhabditis ele - gans , Graphene family nanomaterialsCorrespondence:  Jinhee Choi 163 Siripdae-ro, Dongdaemun-gu,   Seoul 130-743, Korea Tel: +82-2-6490-2869 Fax: + 82-2-6490-2859 E-mail: jinhchoi@uos.ac.kr Received:  March 14, 2015   Accepted:  June 4, 2015  Published online:  July 15, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2015;30:e2015007 not only aiming for their potential future applications in the do - main of electronics, photonics, composite materials, energy  generation and storage, sensors and metrology, and biomedi - cine, specifically, biosensors, bioimaging and therapeutics, tissue  engineering, and drug delivery etc., but also raised serious con - cerns about their environmental and human health impacts  [1,3-5].",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"Materials and Methods  Graphene Family Nanomaterials    The powdered GOs (SLGO and FLGO) and GNPs with dif - ferent surface functionalization (pristine, COOH and NH 2)  were purchased from Cheap Tubes.com (http://www.cheap - tubes.com/) and stocks prepared in distilled water at 1000 mg/ L with sonication.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"http://e-eht.org/ Page 3 of 7Nivedita Chatterjee, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2015;30:e2015007 with respect to control cells (without GFNs).,Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"http://e-eht.org/ Page 5 of 7Nivedita Chatterjee, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2015;30:e2015007 be more toxic in Beas2B cells and GOs (SLGO and FLGO)  were more toxic to the nematode C. elegans’  reproduction capa - bility.,Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"http://e-eht.org/ Page 7 of 7Nivedita Chatterjee, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/c7/eht-30-e2015007.PMC4548497.pdf
"Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.015302  Received January 5, 2015; accepted July 17, 2015.From the University of Texas Medical School at Houston and Memorial Hermann Heart & Vascular Institute, Houston.Presented at the 2014 American Heart Association meeting; November 15–19, 2014; Chicago, IL.Correspondence to Anthony L. Estrera, MD, Department of Cardiothoracic and Vascular Surgery, University of Texas Medical School at Houston, 6400  Fannin St, Ste 2850, Houston, TX 77030.",Non-OADS,/arxiv_data1/oa_pdf/ef/0d/cir-132-748.PMC4548541.pdf
"Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.115.306027Objective —Despite successful translation of bioresorbable vascular grafts for the repair of congenital heart disease, stenosis  remains the primary cause of graft failure.",Non-OADS,/arxiv_data1/oa_pdf/05/42/atv-35-2003.PMC4548543.pdf
"The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.115.306027/-/DC1.Correspondence to Toshiharu Shinoka, MD, PhD, Tissue Engineering Program, Nationwide Children’s Hospital, 700 Children’s Dr, T2294, Columbus,  OH 43205.",Non-OADS,/arxiv_data1/oa_pdf/05/42/atv-35-2003.PMC4548543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/0e/jer-11-4-183.PMC4548672.pdf
Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 183The implications of multidiscipline and globalization Haemi Jee The words ‘globalization’ and ‘multidiscipline’ have been in  popping up everywhere as if they are the need-to-have words to  express the envisioning identity of an entity.,Non-OADS,/arxiv_data1/oa_pdf/fd/0e/jer-11-4-183.PMC4548672.pdf
It certainly is not the only course  but one of the multiple paths necessary to strengthen the scientif -http://dx.doi.org/10.12965/jer.150222Editorial  Journal of Exercise Rehabilitation 2015;11(4):183-184,Non-OADS,/arxiv_data1/oa_pdf/fd/0e/jer-11-4-183.PMC4548672.pdf
http://dx.doi.org/10.12965/jer.150222Jee H  •  The implications of multidiscipline and globalization 184    http://www.e-jer.orgic findings necessary to improve the quality of lives.,Non-OADS,/arxiv_data1/oa_pdf/fd/0e/jer-11-4-183.PMC4548672.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/c8/jer-11-4-185.PMC4548673.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 185*Corresponding author:  Kihong Kim  Department of Special Physical Education, College of Sports Science, Y ongin  University, 134 Y ongin Daehakro, Cheoin-gu, Y ongin 17092, Korea Tel: +82-31-8020-2666, Fax: +82-31-8020-2883, E-mail: jamnikim@hanmail.net Received:  July 31, 2015/ Accepted:  August 18, 2015Special Olympics in Korea and its application as a regular  curriculum in the Korean special schools for social  rehabilitation Kihong Kim* Department of Special Physical Education, Yongin University, Yongin, Korea The purpose of this study was to apply Special Olympics (SO) move - ment and its curricula events to the social rehabilitation of the students  with intellectual disabilities in Korean special school.",Non-OADS,/arxiv_data1/oa_pdf/26/c8/jer-11-4-185.PMC4548673.pdf
(2001) noted the possible  transition from SO to community based program which suggest  the availability of transition to special school as well.http://dx.doi.org/10.12965/jer.150219Review Article Journal of Exercise Rehabilitation 2015;11(4):185-187,Non-OADS,/arxiv_data1/oa_pdf/26/c8/jer-11-4-185.PMC4548673.pdf
http://dx.doi.org/10.12965/jer.150219Kim K  •  Special Olympics in Korea for social rehabilitation 186    http://www.e-jer.orgTHE POSSIBILITY OF SPECIAL  EDUCATIONAL CURRICULUM WITH SO  MOVEMENTS AND SPORT PROGRAMS The suggestions of possible application of SO were examined by  Wilhite and Kleiber (1992) that those with mild developmental  disabilities could be better served through community based sport  and recreation program from SO.,Non-OADS,/arxiv_data1/oa_pdf/26/c8/jer-11-4-185.PMC4548673.pdf
http://www.e-jer.org     187 http://dx.doi.org/10.12965/jer.150219Kim K  •  Special Olympics in Korea for social rehabilitation duced to lifetime friendships and great rewards.,Non-OADS,/arxiv_data1/oa_pdf/26/c8/jer-11-4-185.PMC4548673.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 188*Corresponding author:  Chan-Ho Jin  Department of Leisure and Gaming, Hanseo University, 46 Hanseo 1-ro, Haemi- myeon, Seosan 31962, Korea  Tel: +82-41-660-1494, Fax: +82-505-979-7959, E-mail: sportsman@hanseo.ac.kr Received:  June 24, 2015/ Accepted:  August 8, 2015Research on the effects of integrated resorts in Korea on  gambling addiction  Chan-Ho Jin* Department of Leisure and Gaming, Hanseo University, Seosan, Korea This research discusses the effects of the integrated resorts centered  around casinos being implemented in Korea.",Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
"Furthermore, Lippo http://dx.doi.org/10.12965/jer.150217Review Article Journal of Exercise Rehabilitation 2015;11(4):188-191",Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
"http://www.e-jer.org     189 http://dx.doi.org/10.12965/jer.150217Jin CH  •  Gambling addiction and exercise rehabilitation & Caesars Consortium, a venture between Chinese and American  companies, will be starting construction in late 2015.",Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
"http://dx.doi.org/10.12965/jer.150217Jin CH  •  Gambling addiction and exercise rehabilitation 190    http://www.e-jer.orggeneral public and an investigation that selects from gamblers  (Kim and Gho, 2009).",Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
http://www.e-jer.org     191 http://dx.doi.org/10.12965/jer.150217Jin CH  •  Gambling addiction and exercise rehabilitation Neurosci 2005;8:1445-1449.,Non-OADS,/arxiv_data1/oa_pdf/65/d9/jer-11-4-188.PMC4548674.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 192*Corresponding author:  Chang Ju Kim  Department of Physiology, College of Medicine, Kyung Hee University,   26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea Tel: +82-2-961-0407, Fax: +82-2-964-2195, E mail: changju@khu.ac.kr Received:  July13, 2015/ Accepted:  August 17, 2015Treadmill exercise alleviates stress-induced impairment  of social interaction through 5-hydroxytryptamine 1A  receptor activation in rats Tae-Woon Kim1, Baek-Vin Lim2, Kijeong Kim3, Jin-Hee Seo4, Chang-Ju Kim1,* 1Department of Physiology, Kyung Hee University School of Medicine, Seoul, Korea 2Department of Exercise Prescription, Division of Leisure & Sports Science, Dongseo University, Busan, Korea 3Department of Exercise & Sport Science, College of Natural Sciences, University of Ulsan, Ulsan, Korea 4Division of Sports Science, Baekseok University, Cheonan, Korea Brain-derived neurotrophic factor (BDNF) and its receptors tyrosine ki - nase B (trkB), and cyclic adenosine monophosphate response element  binding protein (CREB) have been suggested as the neurobiological risk factors causing depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
Tryptophan hy ­ droxylase (TPH) is the rate­limiting enzyme of 5­HT synthesis http://dx.doi.org/10.12965/jer.150225Original Article Journal of Exercise Rehabilitation 2015;11(4):192-197,Non-OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"http://www.e-jer.org     193 http://dx.doi.org/10.12965/jer.150225Kim TW, et al.",OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"http://dx.doi.org/10.12965/jer.150225Kim TW, et al.",OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"•  Treadmill exercise alleviates social interaction impairment 194    http://www.e-jer.org5­HT 1A, and anti­goat antibody for pCREB were used as the sec ­ ondary antibodies.",Non-OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"http://www.e-jer.org     195 http://dx.doi.org/10.12965/jer.150225Kim TW, et al.",OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"http://dx.doi.org/10.12965/jer.150225Kim TW, et al.",OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"•  Treadmill exercise alleviates social interaction impairment 196    http://www.e-jer.organd Russo­Neustadt, 2009).",Non-OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"http://www.e-jer.org     197 http://dx.doi.org/10.12965/jer.150225Kim TW, et al.",OADS,/arxiv_data1/oa_pdf/89/27/jer-11-4-192.PMC4548675.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 198*Corresponding author:  Joo-Y oung Kim College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil,   Seodaemun-gu, Seoul 03760, Korea  Tel: +82-2-3277-3016, Fax: +82-505-979-7959, E-mail: jooyoungkim75@gmail.com Received:  July 4, 2015 / Accepted:  August 15, 2015Exhaustive submaximal endurance and resistance  exercises induce temporary immunosuppression via  physical and oxidative stress Chan-Ho Jin1, Il-Young Paik2, Yi-Sub Kwak3, Yong-Seok Jee4, Joo-Young Kim5,* 1Department of Leisure and Gaming, Hanseo University, Seosan, Korea 2Department of Physical Education, Yonsei University, Seoul, Korea 3Department of Physical Education, Dongeui University, Busan, Korea 4Department of Physical Activity Design, Hanseo University, Seosan, Korea 5School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"However, regard -http://dx.doi.org/10.12965/jer.150221Original Article Journal of Exercise Rehabilitation 2015;11(4):198-203",Non-OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"http://www.e-jer.org     199 http://dx.doi.org/10.12965/jer.150221Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"http://dx.doi.org/10.12965/jer.150221Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
•  Immunosuppression during exhaustive physical activities 200    http://www.e-jer.orgspectively.,Non-OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"http://www.e-jer.org     201 http://dx.doi.org/10.12965/jer.150221Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"http://dx.doi.org/10.12965/jer.150221Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
•  Immunosuppression during exhaustive physical activities 202    http://www.e-jer.org2007).,Non-OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"http://www.e-jer.org     203 http://dx.doi.org/10.12965/jer.150221Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/28/53/jer-11-4-198.PMC4548676.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 204*Corresponding author:  Anna Hafsteinsson Östenberg  Department of Sports Science, Linnaeus University, SE-351 95 Växjö, Sweden  Tel: +46-734-216-246, Fax: +46-470-708-000,   E-mail: anna.hafsteinsson-ostenberg@lnu.se Received:  June 5, 2015 / Accepted:  August 15, 2015Experiences of returning to elite beach volleyball after  shoulder injury  Sofie Bele1, Anna Hafsteinsson Östenberg1,*, Rita Sjöström2,3, Marie Alricsson1,3 1Department of Sports Science, Linnaeus University, Kalmar/Växjö, Sweden 2Region Jämtland Härjedalen, Unit of Research Education & Development, Östersund, Sweden 3Swedish Winter Sport Research Centre, Department of Health Sciences, Mid Sweden University, Östersund, Sweden The purpose of this study was to examine beach volleyball players’ ex - perience regarding shoulder injury and how it affects their return to  play.",Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
It has also been shown that high internal motivation to return to  elite sport after injury brings a renewed positive attitude towards http://dx.doi.org/10.12965/jer.150213Original Article Journal of Exercise Rehabilitation 2015;11(4):204-210,Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://www.e-jer.org     205 http://dx.doi.org/10.12965/jer.150213Bele S, et al.",OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://dx.doi.org/10.12965/jer.150213Bele S, et al.",OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
•  Experiences of injury in elite beach volleyball 206    http://www.e-jer.orgafter such an injury.,Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://www.e-jer.org     207 http://dx.doi.org/10.12965/jer.150213Bele S, et al.",OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://dx.doi.org/10.12965/jer.150213Bele S, et al.",OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
•  Experiences of injury in elite beach volleyball 208    http://www.e-jer.orgsponses that have been observed in connection with sports injuries.,Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://www.e-jer.org     209 http://dx.doi.org/10.12965/jer.150213Bele S, et al.",Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"http://dx.doi.org/10.12965/jer.150213Bele S, et al.",OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"•  Experiences of injury in elite beach volleyball 210    http://www.e-jer.orgPodlog L, Eklund RC.",Non-OADS,/arxiv_data1/oa_pdf/94/54/jer-11-4-204.PMC4548677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 211*Corresponding author:  Hye-Sang Park Department of Sports Health Management, University of Suwon, 17 Wauan-gil,  Hwaseong 18323, Korea  Tel: +82-31-229-8103, Fax: +82-31-229-2563, E-mail: wini-phs@hanmail.net Received:  July12, 2015 / Accepted:  August 17, 2015The effects of isometric exercise types on pain and  muscle activity in patients with low back pain Hyun-Seung Rhyu1, Hun-Kyung Park2, Jung-Sub Park3, Hye-Sang Park4,* 1Department of Sports Health Medicine, College of Health Science, Jungwon University, Geosan-gun, Chungcheongbuk-do, Korea 2Department of Physiology, Kyung Hee University College of Medicine, Seoul, Korea 3Department of Physical Education, Korea Air Force Academy, Cheongju, Korea 4Department of Sports Health Management, College of Physical Education, University of Suwon, Hwaseong, Korea The purpose of the present study is to evaluate the effects of isometric  exercise types on low back pain (LBP) patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"Traction therapy has been used for reducing pain in the LBP (Diab  and Moustafa, 2013; Wegner et al., 2013).http://dx.doi.org/10.12965/jer.150224Original Article Journal of Exercise Rehabilitation 2015;11(4):211-214",Non-OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"http://dx.doi.org/10.12965/jer.150224Rhyu HS, et al.",OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"•  The effects of isometric exercise on low back pain 212    http://www.e-jer.orgI­Zer exercise device is developed for isometric exercise, and  this device induces intermittent movement in the spinal vertebrae  by traction, and results in correction of alignment in the balance  of the left and right muscles.",Non-OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"http://www.e-jer.org     213 http://dx.doi.org/10.12965/jer.150224Rhyu HS, et al.",OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"http://dx.doi.org/10.12965/jer.150224Rhyu HS, et al.",OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"•  The effects of isometric exercise on low back pain 214    http://www.e-jer.orgREFERENCES Choi G, Raiturker PP, Kim MJ, Jin CD, Chae YS, Lee SH.",Non-OADS,/arxiv_data1/oa_pdf/2c/9c/jer-11-4-211.PMC4548678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 215*Corresponding author:  Bog Ja Jeoung Department of Exercise Rehabilitation & Welfare, College of Health Science,   191 Hambakmoei-ro, Y eonsu-gu, Incheon 21936, Korea Tel: +82-32-820-4766; Fax: +82-32-820-4049, E-mail: bogja05@gachon.ac.kr Received:  July 9, 2015 / Accepted:  August 5, 2015A Study of relationship between frailty and physical  performance in elderly women Bog Ja Jeoung1,*, Yang Chool Lee2  1Department of Exercise Rehabilitation & Welfare, College of Health Science, Incheon, Korea  2Department of Sports & Leisure Studies, Gachon University, Seongnam, Korea Frailty is a disorder of multiple inter-related physiological systems.",Non-OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"Frailty, a primary pathway to disability, has been defined as a  pathological condition that results in a constellation of signs and http://dx.doi.org/10.12965/jer.150223Original Article Journal of Exercise Rehabilitation 2015;11(4):215-219",Non-OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"http://dx.doi.org/10.12965/jer.150223Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"•  Frailty and physical performance 216    http://www.e-jer.orgsymptoms, and is characterized by high susceptibility to adverse  health outcomes, impending decline in physical function, and  high risk of death (Ferrucci et al., 2004; Fried et al., 2004).",Non-OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"http://www.e-jer.org     217 http://dx.doi.org/10.12965/jer.150223Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"http://dx.doi.org/10.12965/jer.150223Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
•  Frailty and physical performance 218    http://www.e-jer.orgthe data could be further used to develop corresponding exercise  programs.,Non-OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"http://www.e-jer.org     219 http://dx.doi.org/10.12965/jer.150223Jeoung BJ, et al.",OADS,/arxiv_data1/oa_pdf/ee/ba/jer-11-4-215.PMC4548679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 220*Corresponding author:  Seungbun Hong Graduate School of Education, Y ongin University, 134 Y ongin Daehakro, Cheoin- gu, Y ongin 17092, Korea Tel: +82-10-4927-3125, Fax: +82-31-8020-2891, E-mail: shong528@gmail.com  Received:  May 11, 2015 / Accepted:  August 5, 2015Validation of the student athletes’ motivation towards  sports and academics questionnaire to Korean student- athletes Sunghee Park1, Seungbun Hong2,*, Miyoung Lee3  1Performance Psychology Center, Kwangwoon University, Seoul, South Korea  2Graduate School of Education, Yongin University, Yongin, Korea 3College of Physical Education and Sport Science, Kookmin University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"Researchers (Stephan and  Brewer, 2008) have attributed elite athletes’ high degree of athlet - ic identity to a devotion to their sport, in which these athletes’ are http://dx.doi.org/10.12965/jer.150202Original Article Journal of Exercise Rehabilitation 2015;11(4):220-227",Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://www.e-jer.org     221 http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
•  Validation of SAMSAQ-Kr 222    http://www.e-jer.orgdent-athletes’ athletic identity and academic motivation might  offer highlight help provide ways to assist student-athletes to bal - ance their athletic and academic careers.,Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://www.e-jer.org     223 http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
•  Validation of SAMSAQ-Kr 224    http://www.e-jer.orgwere misfit for the South Korean student-athletes.,Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://www.e-jer.org     225 http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
•  Validation of SAMSAQ-Kr 226    http://www.e-jer.orgduced that can examine student-athletes in earlier life.,Non-OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"http://www.e-jer.org     227 http://dx.doi.org/10.12965/jer.150202Park S, et al.",OADS,/arxiv_data1/oa_pdf/c8/9f/jer-11-4-220.PMC4548680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 228*Corresponding author:  Ga Eul Y oo  Department of Music Therapy, Graduate School, Ewha Womans University,   52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea  Tel: +822-3277-4232, Fax: +82-2-3277-6918, E-mail: bbird27@hotmail.com  †Co-primary authors.",Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"As the field of music therapy ex - pands based on the scientific evidences in regard to music and hu - man behaviors, it becomes more important to understand the  quantitative and qualitative relationships between therapeutic http://dx.doi.org/10.12965/jer.150216Original Article Journal of Exercise Rehabilitation 2015;11(4):228-235",Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://www.e-jer.org     229 http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"•  Surface EMG activation during hand percussion playing 230    http://www.e-jer.orgwere placed on three muscles of each participant’s dominant hand:  the flexor digitorum superficialis (FDS) as one of the main finger  and wrist flexors; the extensor digitorum (ED), as one of the main  finger and wrist extensors; and the flexor pollicis brevis (FPB), as  the thumb abductor (Fig.",Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://www.e-jer.org     231 http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
•  Surface EMG activation during hand percussion playing 232    http://www.e-jer.orgat 80 bpm elicited significantly lower mean EMG amplitudes than  at 100 bpm ( P=0.006) and during playing at 120 bpm ( P=0.007).,Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://www.e-jer.org     233 http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
•  Surface EMG activation during hand percussion playing 234    http://www.e-jer.orgtempo.,Non-OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"http://www.e-jer.org     235 http://dx.doi.org/10.12965/jer.150216Chong HJ, et al.",OADS,/arxiv_data1/oa_pdf/17/f6/jer-11-4-228.PMC4548681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
"Copyright © 2015 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 236*Corresponding author:  Dae Hyung Lee Department of Obstetrics and Gynecology, Y eungnam University School of  Medicine, 170 Hyunchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-620-3436, Fax: +82-53-654-0676, E-mail: leebhy@ynu.ac.kr Received:  July 17, 2015 / Accepted:  August 17, 2015Inflammatory gossypiboma in young female athlete Dae Hyung Lee* Department of Obstetrics and Gynecology, Yeungnam University School of Medicine, Daegu, Korea Retained surgical gauze that was left inside the patient during a surgi - cal procedure is called gossypiboma or textiloma.",Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
Contrast enhanced abdominal computerized to - mography was also revealed that 9 cm sized mass lesion with ir -http://dx.doi.org/10.12965/jer.150227Original Article Journal of Exercise Rehabilitation 2015;11(4):236-238,Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
http://www.e-jer.org     237 http://dx.doi.org/10.12965/jer.150227Lee DH.,Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
http://dx.doi.org/10.12965/jer.150227Lee DH.,Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
•  Gossypiboma in young female athlete 238    http://www.e-jer.orgute to increase the incidence of gossypiboma.,Non-OADS,/arxiv_data1/oa_pdf/f3/f2/jer-11-4-236.PMC4548682.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/41/ppa-9-1189.PMC4548719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1189–1194Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1189OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8706 9Analysis of the characteristics and prognosis of  advanced non-small-cell lung cancer in older  patients Ying gao1,* Fei gao2,* Jin-lu Ma1,* Xiao-zhi Zhang1 Yi li1 li-ping song1 Dong-li Zhao1 1Department of radiotherapy  Oncology, First Affiliated hospital  of Xi’an Jiaotong University,   2Department of neurology, First  Affiliated hospital of Xi’an Medical  University, Xi’an, People’s republic  of china *These authors contributed equally  to this workObjective:  Lung cancer is still the leading cause of cancer-related deaths worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a2/41/ppa-9-1189.PMC4548719.pdf
"The number is expected to increase and estimated to  represent 70% of all with cancer by 2030.4 Despite the quickly increasing incidence  of elderly patients, the elderly lung cancer patients have been significantly underrep - resented in clinical trials.5 Because the advanced age has often been associated with a  poor performance status and comorbidities, the advanced age has been a prevalent cause  for not administering treatment according to the guidelines.6,7 Some trials suggested correspondence: Ying gao; Dong-li Zhao Department of radiotherapy Oncology,  First Affiliated Hospital of Xi’an Jiaotong  University, 277 Yan Ta West road,  Xi’an 710061, People’s republic of china Tel +86 29 8532 4029 email togaoying@163.co m;   jdyfy223@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gao et al Running head recto: Advanced non-small-cell lung cancer in older patients DOI: http://dx.doi.org/10.2147/PPA.S87069",Non-OADS,/arxiv_data1/oa_pdf/a2/41/ppa-9-1189.PMC4548719.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a2/41/ppa-9-1189.PMC4548719.pdf
"Available from:  http://cteo.cancer.go v. Accessed March 31, 2003.",Non-OADS,/arxiv_data1/oa_pdf/a2/41/ppa-9-1189.PMC4548719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/dddt-9-4761.PMC4548720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4761–4778Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4761Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8624 2effects of chalcone derivatives on players  of the immune system Jian Sian Lee Syed Nasir Abbas Bukhari Norsyahida Mohd Fauzi Drug and Herbal Research Center,   Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Kuala Lumpur,   MalaysiaAbstract:  The immune system is the defense mechanism in living organisms that protects  against the invasion of foreign materials, microorganisms, and pathogens.",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/dddt-9-4761.PMC4548720.pdf
"It is suggested that macrophages infected by Mycobacterium tubercu - losis may secrete a heat-labile factor that is cytotoxic to the T lymphocytes, causing Correspondence: Norsyahida Mohd Fauzi Drug and Herbal Research Center,  Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan Raja Muda  Abdul Aziz, 50300 Kuala Lumpur,  Malaysia Tel +603 9289 8053 email drnorsyahida@ukm.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lee et al Running head recto: Effects of chalcone derivatives on players of immune system DOI: http://dx.doi.org/10.2147/DDDT.S86242",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/dddt-9-4761.PMC4548720.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/dddt-9-4761.PMC4548720.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/dddt-9-4761.PMC4548720.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4825–4834Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4825MeTho Dologyopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8040 3how we make cell therapy in Italy Tiziana Montemurro Mariele Viganò Silvia Budelli elisa Montelatici Cristiana lavazza luigi Marino Valentina Parazzi lorenza lazzari Rosaria giordano Cell Factory, Unit of Cell Therapy and  Cryobiology, Fondazione IRCCS Ca’  granda ospedale Maggiore Policlinico,   Milano, ItalyAbstract:  In the 21st century scenario, new therapeutic tools are needed to take up the social  and medical challenge posed by the more and more frequent degenerative disorders and by the  aging of population.",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Our goal is to openly share our experience in this novel fascinating therapeutic  scenario.Correspondence: Rosaria giordano Cell Factory, Unit of Cell Therapy and  Cryobiology, Fondazione IRCCS Ca’  granda ospedale Maggiore Policlinico,  Via F Sforza 35, 20122 Milano, Italy Tel +39 02 5503 4057 Fax +39 02 5503 2796 email rosaria.giordano@policlinico.mi.i tJournal name: Drug Design, Development and Therapy Article Designation: Methodology Y ear: 2015 Volume: 9 Running head verso: Montemurro et al Running head recto: How we make cell therapy in Italy DOI: http://dx.doi.org/10.2147/DDDT.S80403",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Available from: http://ec.europa.eu/health/files/eudralex/   vol-4/2008_11_25_gmp-an1_en.pd f. Accessed January 15, 2015.10 5HJLRQH&OHDQURRPDVHSWLFJRZQLQJ$FWLYLW\ 7XWRU 6FKHGXOHG GDWD([HFXWLRQGDWH2XWFRPH (YDOXDWLRQGDWH7XWRU VLJQDWXUH9(5,),('%< 4$5(91'$7(''00<<<< 3$*('2&80(17 &2'( $33529('%< 43 43VLJQDWXUH 6WRFNPDQDJHPHQW (TXLSPHQWPDQDJHPHQW (QYLURQPHQWDOPRQLWRULQJYLDEOHDQGQRQ YLDEOHSDUWLFOHV4XDOLILFDWLRQRIWKHRSHUDWRU7KHRUHWLFDOWUDLQLQJ)21'$=,21(,5&&6&$ ¶*5$1'$ 263('$/(0$**,25(32/,&/,1,&2 ,67,787 2',5,&29(52(&85$$ &$5$77(5(6&,(17,),&2',1$7 85$38%%/,&$ '0  9LD)UDQFHVFR6IRU]D0LODQR± 7HOHIRQR±)D [ &RGLFH)LVFDOHH3DUW,9 $0LFURELRORJLFDOFRQWURODIWHUDVHSWLF JRZQLQJ 0LFURELRORJ\DSSOLHGWRHQYLURQPHQWDO FRQWDPLQDWLRQLQDVHSWLFSURGXFWLRQ 0DWHULDORUGHUV ([HFXWLRQRIDWOHDVWORDGLQJXQORDGLQJ RIWKHVWRFN ,QGRRUDQGRXWGRRUTXDOLILFDWLRQ PDLQWHQDQFH /HFWXUH 6$6DQGSDUWLFOHFRXQWHUXVH3UDFWLFHWHVW /RPEDUGLD6LVWHPD6RQLIRULR Figure 2 Example of the training program for the Cell Factory personnel (first page of the training form).",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Available from: http://ec.europa.eu/health/documents/eudralex/vol-4/ index_en.ht m. Accessed January 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
"Available from: http://ec.europa.eu/health/files/eudralex/ vol-4/2008_11_25_gmp-an1_en.pd f. Accessed January 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/60/27/dddt-9-4825.PMC4548721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4793–4805Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4793Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7911 6Role of short-acting nitroglycerin in the  management of ischemic heart disease william e Boden1–3 Santosh K Padala1–3 Katherine P Cabral4 ivo R Buschmann5 Mandeep S Sidhu1–3 1Department of Medicine, Division of  Cardiology, Albany Medical College,   2Department of Medicine, Division of  Cardiology, Albany Stratton veterans  Affairs Medical Center, 3Department  of Medicine, Division of Cardiology,   Albany Medical Center, 4Department  of Pharmacy, Albany College Pharmacy  and Health Sciences, Albany, NY, USA;   5Department of Angiology, Medical  University of Brandenburg & Charité,   Berlin, GermanyAbstract:  Nitroglycerin is the oldest and most commonly prescribed short-acting anti-anginal  agent; however, despite its long history of therapeutic usage, patient and health care provider  education regarding the clinical benefits of the short-acting formulations in patients with angina  remains under-appreciated.",Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
"CHD in women younger than 75 years of age presents more frequently as angina than Correspondence: Mandeep S Sidhu Department of Medicine, Division of  Cardiology, Albany Medical College,  47 New Scotland Avenue, Albany,  NY 12208, USA Tel +1 518 262 5076 Fax +1 518 262 5082 email sidhum@mail.amc.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Boden et al Running head recto: Short-acting nitroglycerin in ischemic heart disease DOI: http://dx.doi.org/10.2147/DDDT.S79116",Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
Available from: http://www.medsafe.,Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/12/dddt-9-4793.PMC4548722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/e7/cia-10-1369.PMC4548723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1369–1375Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1369OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8956 8Association of brachial-ankle pulse wave velocity  with atherosclerosis and presence of coronary  artery disease in older patients Chang-Min Chung1,2 Yu-hsiang Tseng3 Yu-sheng lin3 Jen-T e hsu4 Po-Chang Wang3 1school of Traditional Chinese  Medicine, College of Medicine, Chang  gung University, Taoyuan County,   2Chang gung University of science  and T echnology, Chiayi County,   3Division of Cardiology, Chang  gung Memorial hospital, Chiayi,   4Department of Medicine, College  of Medicine, Chang gung University,   Taoyuan County, TaiwanObjective:  Brachial-ankle pulse wave velocity (baPWV) is a simple and reproducible measure  of arterial stiffness and is extensively used to assess risk of cardiovascular disease in Asia.",Non-OADS,/arxiv_data1/oa_pdf/2f/e7/cia-10-1369.PMC4548723.pdf
"baPWV requires Correspondence: Chang-Min Chung Division of Cardiology, Chiayi Chang  gung Memorial hospital, 6, sector West  Chai-Pu road, Pu-Tz City, Chai Yi hsien,  Taiwan Tel +886 5 362 1000 ext 2854 Fax +886 5 362 3005 email cmchung02@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chung et al Running head recto: Atherosclerosis and coronary artery disease DOI: http://dx.doi.org/10.2147/CIA.S89568",Non-OADS,/arxiv_data1/oa_pdf/2f/e7/cia-10-1369.PMC4548723.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2f/e7/cia-10-1369.PMC4548723.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2f/e7/cia-10-1369.PMC4548723.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/dddt-9-4835.PMC4548724.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4835–4845Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4835Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6487 7Nonalcoholic steatohepatitis: emerging targeted  therapies to optimize treatment options Sandra Milic1 ivana Mikolasevic1,2 irena Krznaric-Zrnic1 Marija Stanic3 Goran Poropat1 Davor Stimac1 vera vlahovic-Palcevski4 Lidija Orlic2 1Department of Gastroenterology,   UHC Rijeka, Rijeka, Croatia;   2Department of Nephrology, Dialysis  and Kidney Transplantation, UHC  Rijeka, Rijeka, Croatia; 3Department  of Hematology, UHC Rijeka, Rijeka,   Croatia; 4Department for Clinical  Pharmacology, University of Rijeka  Medical School, UHC Rijeka, Rijeka,   CroatiaAbstract:  Diet and lifestyle changes have led to worldwide increases in the prevalences of  obesity and metabolic syndrome, resulting in substantially greater incidence of nonalcoholic fatty  liver disease (NAFLD).",Non-OADS,/arxiv_data1/oa_pdf/60/fc/dddt-9-4835.PMC4548724.pdf
"Patients who develop NASH can remain asymptomatic for years, but carry a seri - ous risk of liver fibrosis/cirrhosis and hepatocellular carcinoma, and therefore of Correspondence: Sandra Milic Department of Gastroenterology,  UHC Rijeka, Krešimirova 42,  51000, Rijeka, Croatia Tel +385 51 658 122 Fax +385 51 658 122 email smilic05@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Milic et al Running head recto: Treatment options for nonalcoholic steatohepatitis DOI: http://dx.doi.org/10.2147/DDDT.S64877",Non-OADS,/arxiv_data1/oa_pdf/60/fc/dddt-9-4835.PMC4548724.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/60/fc/dddt-9-4835.PMC4548724.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/fc/dddt-9-4835.PMC4548724.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/sar-6-083.PMC4548725.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 83–91Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  83ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S8566 7Opioid-use disorder among patients on long-term  opioid therapy: impact of final DSM-5 diagnostic  criteria on prevalence and correlates Joseph A Boscarino1 Stuart N Hoffman1 John J Han2 1Center for Health Research,   2Department of Pain Medicine,   Geisinger Clinic, Danville, PA, USA Correspondence: Joseph A Boscarino   Geisinger Clinic, 100 N Academy Avenue,  MC 44-00, Danville, PA 17822-4400, USA   Tel +1 570 214 9622   Fax +1 570 214 9451   Email jaboscarino@geisinger.ed uAims:  Previously, we estimated the prevalence and risk factors for prescription opioid -use  disorder among outpatients on opioid therapy using the Diagnostic and Statistical Manual of  Mental Disorders  (DSM)-5 and DSM-4 criteria.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/sar-6-083.PMC4548725.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/sar-6-083.PMC4548725.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/sar-6-083.PMC4548725.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/69/dmso-8-387.PMC4548726.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 387–398Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  387Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8725 3lixisenatide accelerates restoration of  normoglycemia and improves human beta-cell  function and survival in diabetic immunodeficient  nOD– scid IL-2rgnull riP-DTr mice engrafted with  human islets chaoxing Yang1 Matthias loehn2 agata Jurczyk1 natalia Przewozniak1 linda leehy1 Pedro l herrera3 leonard D Shultz4 Dale l greiner1 David M harlan5 rita Bortell1 1Program in Molecular Medicine,   Diabetes center of excellence,   University of Massachusetts Medical  School, Worcester, M a, USa; 2Sanofi- aventis, Diabetes Division, Frankfurt,   germany; 3University of geneva,   geneva, Switzerland; 4The Jackson  laboratory, Bar harbor, M e, USa;   5Department of Medicine, Diabetes  center of excellence, University  of Massachusetts Medical School,   Worcester, M a, USa correspondence: rita Bortell   Program in Molecular Medicine, Diabetes  center of excellence, University of  Massachusetts Medical School,   368 Plantation Street, aS7-2055,  Worcester, Ma 01605, USa   Tel +1 508 856 3788   Fax +1 508 856 4093   email rita.bortell@umassmed.ed uObjective:  Glucagon-like peptide-1 induces glucose-dependent insulin secretion and, in rodents,  increases proliferation and survival of pancreatic beta cells.",Non-OADS,/arxiv_data1/oa_pdf/3d/69/dmso-8-387.PMC4548726.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/3d/69/dmso-8-387.PMC4548726.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/69/dmso-8-387.PMC4548726.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/04/c6/10.1177_2058460115595660.PMC4548728.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/ec/dd/10.1177_2058460115594199.PMC4548729.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/17/9c/10.1177_2058460115584112.PMC4548730.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/ef/12/10.1177_2058460115584111.PMC4548731.pdf
"other and by charges and currents (details can be found at, for example, http://en.wikipedia.org/wiki/maxwell’s_equations).",Non-OADS,/arxiv_data1/oa_pdf/ef/12/10.1177_2058460115584111.PMC4548731.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/a0/28/10.1177_2058460115583034.PMC4548732.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/c2/2b/10.1177_2058460115589124.PMC4548733.pdf
Available at: https://www.circlecvi.com/fea- tures/flow.php (accessed 26 June 2014).,OADS,/arxiv_data1/oa_pdf/c2/2b/10.1177_2058460115589124.PMC4548733.pdf
Available at: http://www.medis.nl/prod- ucts/qflow.html (accessed 26 June 2014).,OADS,/arxiv_data1/oa_pdf/c2/2b/10.1177_2058460115589124.PMC4548733.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/63/b2/10.1177_2058460115592061.PMC4548734.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/a1/ppa-9-1195.PMC4548736.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1195–1206Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1195OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8848 2Adherence to self-care in patients with heart  failure in the heartcycle study Wim stut1 carolyn Deighan2 John g cleland3 Tiny Jaarsma4 1Philips research europe, eindhoven,   the netherlands; 2The heart  Manual Department, nhs lothian,   edinburgh, UK; 3national heart and  lung institute, royal Brompton and  harefield hospitals imperial college,   london, UK; 4Department of social  and Welfare studies, Faculty of  health sciences, linköping University,   linköping, swedenPurpose:  The purpose of this study was to evaluate a novel online education and coaching  program to promote self-care among patients with heart failure.",Non-OADS,/arxiv_data1/oa_pdf/61/a1/ppa-9-1195.PMC4548736.pdf
"Usually, this is carried out in face-to-face correspondence: Wim stut Philips research europe, high Tech  Campus 34, Office HTC34.5.006, 5656  Ae eindhoven, the netherlands Tel +31 40 279 6465 Fax +31 40 274 6321 email wim.stut@philips.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Stut et al Running head recto: HF self-care adherence in HeartCycle DOI: http://dx.doi.org/10.2147/PPA.S88482",Non-OADS,/arxiv_data1/oa_pdf/61/a1/ppa-9-1195.PMC4548736.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/61/a1/ppa-9-1195.PMC4548736.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4807–4823Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4807Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9020 8Translational challenges of animal models in  Chagas disease drug development: a review eric Chatelain1 Nandini Konar2 1Drugs for Neglected Diseases  initiative (DND i), Geneva,   Switzerland; 2Merck & Co, inc,   whitehouse Station, NJ, USAAbstract:  Chagas disease, or American trypanosomiasis, caused by Trypanosoma cruzi   parasite infection is endemic in Latin America and presents an increasing clinical challenge  due to migrating populations.",Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
"Following activation  of the immune response, parasitemia reduces to subpatent levels (below the microscopic Correspondence: eric Chatelain Drugs for Neglected Diseases initiative  (DND i), 15 Chemin Louis Dunant,  1202 Geneva, Switzerland Tel +41 22 906 9230 Fax +41 22 906 9231 email echatelain@dndi.or g Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Chatelain and Konar Running head recto: Animal models and drug development in Chagas disease DOI: http://dx.doi.org/10.2147/DDDT.S90208",Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
Avaiable  from: http://www.dndi.org/media-centre/press-releases/1700-e1224.,Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/39/dddt-9-4807.PMC4548737.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/85/cia-10-1381.PMC4548738.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1381–1391Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1381OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8849 9hormonal determinants of the severity of  andropausal and depressive symptoms in middle- aged and elderly men with prediabetes Michał Rabijewski1 Lucyna Papierska2 Roman Kuczerowski1 Paweł Piątkiewicz1 1Department of Internal Diseases,   Diabetology and endocrinology,   Medical University of Warsaw,   2Department of endocrinology,   Medical Centre for Postgraduate  education, Warsaw, PolandAbstract:  Andropausal and depressive symptoms are common in aging males and may be  associated with hormone deficiency.",Non-OADS,/arxiv_data1/oa_pdf/41/85/cia-10-1381.PMC4548738.pdf
"One of the conditions associated with aging males is the decreasing of testosterone  levels by 1%–2% per year after the age of 40 years.2 The prevalence of “biochemical  hypogonadism” is high: 23.3% in 40-year-old to 79-year-old men from the European  Male Ageing Study;3 but this does not necessarily mean clinical hypogonadism because  the majority of men with low testosterone levels remain asymptomatic.4 However, some  aging men do develop symptomatic hypogonadism, which is associated with diffuse  symptoms, such as sexual dysfunction, metabolic disorders, overall dissatisfaction, as well Correspondence: Michał Rabijewski Department of Internal Diseases,  Diabetology and endocrinology, Medical  University of Warsaw, 8 Kondratowicza  street, 03-242 Warsaw, Poland Tel/fax +48 22 326 5817 email mrabijewski@wum.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rabijewski et al Running head recto: Hormonal determinants of andropausal/depressive symptoms in prediabetes DOI: http://dx.doi.org/10.2147/CIA.S88499",Non-OADS,/arxiv_data1/oa_pdf/41/85/cia-10-1381.PMC4548738.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/41/85/cia-10-1381.PMC4548738.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/41/85/cia-10-1381.PMC4548738.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1673–1683International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1673OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8600 2Efficacy and safety of the long-acting β2-agonist  olodaterol over 4 weeks in Japanese patients with  chronic obstructive pulmonary disease Masakazu Ichinose1 Ayako Takizawa2 T oshiyasu Izumoto2 Yusuke Tadayasu2 alan l hamilton3 Christina Kunz4 Y oshinosuke Fukuchi5 1Department of Respiratory Medicine,  T ohoku University Graduate School  of Medicine, Sendai, Japan; 2nippon  Boehringer Ingelheim Co. Ltd,  T okyo, Japan; 3Boehringer Ingelheim,  Burlington, Ontario, Canada;  4Boehringer Ingelheim Pharma GmbH  & Co. KG, Biberach an der Riß,  Germany; 5Juntendo University School  of Medicine, T okyo, JapanBackground:  Olodaterol is a novel long-acting β2-agonist with proven $24-hour duration of  action in preclinical and clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
"Keywords:  trough FEV1, trough FVC, plasma concentration, pulmonary function, once-daily,  dose-finding Introduction Chronic obstructive pulmonary disease (COPD), characterized by airflow limitation that  is not fully reversible and progressive deterioration in lung function,1,2 is associated with  chronic and progressive dyspnea, cough, and sputum production.3 The introduction of  the long-acting β2-agonists salmeterol and formoterol allowed effective maintenance  treatment of COPD in patients with symptoms inadequately controlled by short-acting  agents.4,5 However, the 12-hour duration of action of these therapies necessitates  twice-daily dosing.3 With the development of newer long-acting β2-agonists, such as  indacaterol, with a 24-hour duration of action,6 there is an intriguing possibility of a  once-daily (QD) posology, particularly in combination with other QD long-acting mus - carinic antagonists such as tiotropium, which may improve treatment adherence.7Correspondence: Masakazu Ichinose Department of Respiratory Medicine,  Tohoku University Graduate School of  Medicine, 1-1 Seiryo-machi, Aoba-ku,   Sendai 980-8574, Japan Tel +81 22 717 8534 Fax +81 22 717 8549 email ichinose@rm.med.tohoku.ac.j pJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ichinose et al Running head recto: Efficacy and safety of olodaterol in Japanese patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S86002",Non-OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
"Available from: http://www.gold - copd.org/uploads/users/files/GOLD_Report_2013_Feb20.pd f. Accessed  February 17, 2015.",OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/53/copd-10-1673.PMC4548739.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/d7/48/10.1177_2058460115588098.PMC4548743.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/74/08/10.1177_2058460115578324.PMC4548744.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/15/c8/10.1177_2058460115592442.PMC4548745.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/b0/a4/10.1177_2058460115579934.PMC4548747.pdf
Available at:http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010- 06-14_QuickReference_5x7.pdf 17.,OADS,/arxiv_data1/oa_pdf/b0/a4/10.1177_2058460115579934.PMC4548747.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/7b/98/10.1177_2058460115580877.PMC4548748.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/90/ott-8-1997.PMC4548749.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1997–2003OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1997Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8155 8Inactivity of imatinib in gastrointestinal stromal  tumors (GIsTs) harboring a KIT activation-loop  domain mutation (exon 17 mutation pN822K) Gianluca spitaleri1 roberto Biffi2 Massimo Barberis3 Caterina Fumagalli3 Francesca T offalorio1 Chiara Catania1 Cristina Noberasco1 Chiara Lazzari1 Filippo de Marinis1 T ommaso De pas4 1Division of Chest Medical Oncology,   2Division of abdominal surgery,   3Division of pathology, 4Oncology  Unit of Thymic cancer, rare T umors  and sarcomas, european Institute of  Oncology, Milan, ItalyAbstract:  The development of gastrointestinal stromal tumors (GISTs) is largely driven by  mutations in the KIT and PDGFRα genes.",Non-OADS,/arxiv_data1/oa_pdf/6a/90/ott-8-1997.PMC4548749.pdf
"In detail, there was a clear benefit of adjuvant imatinib in patients with  KIT exon 11 deletions (not KIT exon 11 insertions or point mutations).Correspondence: Gianluca spitaleri european Institute of Oncology,  ripamonti 435, 20141 Milan, Italy Tel +39 025 748 9482 Fax +39 029 437 9235 email gianluca.spitaleri@ieo.i t Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Spitaleri et al Running head recto: Imatinib in GISTs harboring exon 17 mutations DOI: http://dx.doi.org/10.2147/OTT.S81558",Non-OADS,/arxiv_data1/oa_pdf/6a/90/ott-8-1997.PMC4548749.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/90/ott-8-1997.PMC4548749.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/90/ott-8-1997.PMC4548749.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/80/jir-8-161.PMC4548750.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 161–171Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  161RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S7032 5Inflammatory etiopathogenesis of systemic lupus  erythematosus: an update Malgorzata J Podolska Mona HC Biermann Christian Maueröder Jonas Hahn Martin Herrmann Department of Internal Medicine  3,  Institute for Clinical Immunology and  Rheumatology, Friedrich-Alexander  University of erlangen-Nuremberg,   erlangen, Germany Correspondence: Martin Herrmann   Department of Internal Medicine  3,  Institute for Clinical Immunology and  Rheumatology, Friedrich-Alexander  University of erlangen-Nürnberg,  Ulmenweg  18, 91054 erlangen, Germany   Tel +49 9131 853 6990  Fax +49 9131 853 5776  email m artin.",Non-OADS,/arxiv_data1/oa_pdf/35/80/jir-8-161.PMC4548750.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/35/80/jir-8-161.PMC4548750.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/80/jir-8-161.PMC4548750.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ott-8-2157.PMC4548751.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2157–2167OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2157Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7220 2Merkel cell carcinoma of the head and neck:  pathogenesis, current and emerging treatment  options Alok T Saini Brett A Miles Department of Otolaryngology –  Head and Neck Surgery, Mount Sinai  Hospital, New Y ork, NY, USAAbstract:  Merkel cell carcinoma (MCC) is a relatively uncommon, neuroendocrine, cutaneous  malignancy that often exhibits clinically aggressive features and is associated with a poor pro­ gnosis.",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ott-8-2157.PMC4548751.pdf
"Risk factors include male sex, increased age, fair skin,  previous malignancies, UV light exposure, and immunosuppression (specifically, HIV  or organ transplantation).9–12 There is a tendency for early and frequent locoregional Correspondence: Brett A Miles Department of Otolaryngology – Head  and Neck Surgery, Mount Sinai Hospital,  One Gustave L Levy Place, Box 1189,  New York, NY 10029, USA email brett.miles@mountsinai.or g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Saini and Miles Running head recto: Merkel cell carcinoma of the head and neck DOI: http://dx.doi.org/10.2147/OTT.S72202",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ott-8-2157.PMC4548751.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer ­reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ott-8-2157.PMC4548751.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ott-8-2157.PMC4548751.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/5e/ott-8-2147.PMC4548752.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2147–2156OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2147Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7031 6Current and emerging treatment options for  hairy cell leukemia Montserrat López-Rubio1 Jose Antonio Garcia-Marco2 1Department of Hematology, Hospital  Universitario Príncipe de Asturias,   Alcalá de Henares, 2Department  of Hematology, Hospital Universitario  Puerta de Hierro Majadahonda,   Majadahonda, Madrid, SpainAbstract:  Hairy cell leukemia (HCL) is a lymphoproliferative B-cell disorder characterized by  pancytopenia, splenomegaly, and characteristic cytoplasmic hairy projections.",Non-OADS,/arxiv_data1/oa_pdf/8e/5e/ott-8-2147.PMC4548752.pdf
"BRAF mutations are absent in both  variants.4 Before the introduction of purine analogs (PAs), splenectomy and treatment with  interferon alpha led to clinical and hematological responses; however, these were Correspondence: Montserrat López- Rubio Department of Hematology, Hospital  Universitario Príncipe de Asturias,  Carretera de Alcalá-Meco, s/n 28805,  Alcalá de Henares, Madrid, Spain email montserratlr@outlook.e s Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: López-Rubio and Garcia-Marco Running head recto: Current and emerging treatment options for HCL DOI: http://dx.doi.org/10.2147/OTT.S70316",Non-OADS,/arxiv_data1/oa_pdf/8e/5e/ott-8-2147.PMC4548752.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8e/5e/ott-8-2147.PMC4548752.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/5e/ott-8-2147.PMC4548752.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/52/vhrm-11-489.PMC4548753.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 489–492Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  489Edito Rialopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/VHRM.S8973 6Nonvitamin K antagonist oral anticoagulants  (Noa Cs): the tide continues to come in andrew Blann University of Birmingham Centre  for Cardiovascular Sciences, City  Hospital, Birmingham, UK Correspondence: andrew Blann   tel/Fax +44 21 507 5076  Email a.blann@bham.ac.u kThrombosis is the major common endpoint in most human diseases.",Non-OADS,/arxiv_data1/oa_pdf/28/52/vhrm-11-489.PMC4548753.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/28/52/vhrm-11-489.PMC4548753.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/52/vhrm-11-489.PMC4548753.pdf
Available  from: http://www.hematology.org/Clinicians/Guidelines-Quality/Quick- Ref/2869.asp x. February  2014 Edition.,Non-OADS,/arxiv_data1/oa_pdf/28/52/vhrm-11-489.PMC4548753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/ad/jpr-8-561.PMC4548754.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 561–569Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  561ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8657 3assessing the prevalence of autoimmune,  endocrine, gynecologic, and psychiatric  comorbidities in an ethnically diverse cohort of  female fibromyalgia patients: does the time from  hysterectomy provide a clue?",Non-OADS,/arxiv_data1/oa_pdf/9f/ad/jpr-8-561.PMC4548754.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/9f/ad/jpr-8-561.PMC4548754.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/ad/jpr-8-561.PMC4548754.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/02/b6/prbm-8-239.PMC4548755.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 239–249Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  239ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S8863 1identity development, intelligence structure, and  interests: a cross-sectional study in a group of italian  adolescents during the decision-making process Monica Pellerone1 alessia Passanisi1 Mario Filippo Paolo Bellomo2 1Faculty of human and social science,   “Kore” University of enna, enna,   2credito emiliano Bank, Piazza  armerina, italy correspondence: Monica Pellerone   Faculty of human and social science,  “Kore” University of enna, Via cittadella  Universitaria, snc, enna, caP 94100, italy   Tel +39 32 9432 4311   email monica.pellerone@unikore.i tBackground:  Forming one’ s identity is thought to be the key developmental task of adolescence,  but profound changes in personality traits also occur in this period.",Non-OADS,/arxiv_data1/oa_pdf/02/b6/prbm-8-239.PMC4548755.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/02/b6/prbm-8-239.PMC4548755.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/02/b6/prbm-8-239.PMC4548755.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/23/opth-9-1499.PMC4548756.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1499–1509Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1499Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8785 0Scotoma analysis of 10–2 visual field testing with  a red target in screening for hydroxychloroquine  retinopathy David J Browning Chong lee Department of Ophthalmology,   Charlotte eye, ear, nose and Throat  associates, Charlotte, nC, UsaObjective:  To quantify the variability of scotomas detected by 10–2 visual field (VF) testing  with a red target in patients taking hydroxychloroquine without and with retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/5c/23/opth-9-1499.PMC4548756.pdf
"Keywords:  ideal body weight, toxicity, red test object, ancillary testing Introduction Screening for hydroxychloroquine retinopathy is dependent on ancillary testing as  the clinical examination is insensitive and nonspecific for retinopathy.1 Since the  early 1990s, the 10–2 visual field (VF) has been the most commonly used ancillary  test.2–4 Multifocal electroretinography (mfERG), spectral domain optical coherence  tomography (SD-OCT), and fundus autofluorescence (FAF) have been introduced  more recently, and gained wider acceptance when advocated in the revised guidelines  of the American Academy of Ophthalmology, but they are still not used as often as Correspondence: David J Browning Department of Ophthalmology, Charlotte  eye, ear, nose and Throat associates,  6035 Fairview road, Charlotte, nC  28210, Usa Tel +1 704 295 3180 Fax +1 704 295 3186 email dbrowning@ceenta.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Browning and Lee Running head recto: Scotoma analysis DOI: http://dx.doi.org/10.2147/OPTH.S87850",Non-OADS,/arxiv_data1/oa_pdf/5c/23/opth-9-1499.PMC4548756.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5c/23/opth-9-1499.PMC4548756.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/23/opth-9-1499.PMC4548756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/prbm-8-231.PMC4548757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 231–238Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  231ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S7538 2Resilience in young people living with violence  and self-harm: evidence from a norwegian  national youth survey lihong huang1 svein Mossige2 1nOVa – norwegian social Research,   Oslo and akershus University college  of applied sciences, 2Department of  Psychology, University of Oslo, Oslo,   norway correspondence: lihong huang   nOVa – norwegian social Research,  Oslo and akershus University college  of applied sciences, Postbox 4 st Olavs  plass, 0130 Oslo, norway   Tel +47 2 4116 3458   email l ihong.huang@nova.hioa.n oAbstract:  The aim of this article is to explore the relationship between resilience and the  psychological problems of young people who reported being victims of violence and who  engaged in self-harm.",Non-OADS,/arxiv_data1/oa_pdf/6c/db/prbm-8-231.PMC4548757.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/6c/db/prbm-8-231.PMC4548757.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/prbm-8-231.PMC4548757.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/94/ijn-10-5219.PMC4548758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5219–5235International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5219OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8284 7d-α-tocopherol polyethylene glycol succinate- based derivative nanoparticles as a novel carrier  for paclitaxel delivery Yupei Wu1,* Qian chu2,* songwei Tan1 Xiangting Zhuang1 Yuling Bao1 Tingting Wu1 Zhiping Zhang1,3,4 1T ongji school of Pharmacy,   2Department of Oncology, Tongji  hospital, T ongji Medical school,   3hubei engineering research center  for NDDs, 4National engineering  research center for Nanomedicine,   huazhong University of science and  Technology, Wuhan, People’s republic  of china *These authors contributed equally  to this workAbstract:  Paclitaxel (PTX) is one of the most effective antineoplastic drugs.",Non-OADS,/arxiv_data1/oa_pdf/83/94/ijn-10-5219.PMC4548758.pdf
"Moreover, sustained and controlled release of drugs at target sites can  last over a period of days or even weeks, thereby offering the following enormous  advantages, such as reduction of dosage, improvement on the pharmacokinetic/dynamic  properties, protection of drugs against degradation, reduced side effects, etc.10 The  developments of nanomedicine have the potential to solve many of modern medicine’s  intractable problems, as evidenced from the fact that over 200 nanomedicine products  are approved or in different stages of clinical trials.11correspondence: Zhiping Zhang National engineering research center for  Nanomedicine, huazhong University of  science and Technology, Wuhan 430030,  People’s republic of china Tel +86 27 8360 1832 email zhipingzhang@mail.hust.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wu et al Running head recto: 4-arm-PEG-TPGS nanoparticles for paclitaxel delivery DOI: http://dx.doi.org/10.2147/IJN.S82847",Non-OADS,/arxiv_data1/oa_pdf/83/94/ijn-10-5219.PMC4548758.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/83/94/ijn-10-5219.PMC4548758.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/94/ijn-10-5219.PMC4548758.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 581–590Journal of Pain Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
"Or use: http://youtu.be/0wzR278zeV ADove press submit your manuscript | www.dovepress.co m Dove press  581ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8574 1effects of a pain self-management intervention  combining written and video elements on   health-related quality of life among people with  different levels of education carol stalker James elander centre for Psychological Research,   Department of life sciences,   University of Derby, Derby, UK correspondence: James elander   centre for Psychological Research,  University of Derby, Kedleston Road,  Derby De22 1gB, UK   Tel +44 1332 593 048   email j.elander@derby.ac.u kAbstract:  Combining written and video material could increase the impact of health educa - tion for people with less education, but more evidence is needed about the impact of combined  materials in different formats, especially in the context of chronic pain self-management.",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
Boston: New England Medical Centre;  1994. http://www.worldcat.org/title/sf-36-physical-and-mental-health- summary-scales-a-users -  29.,Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
"Available from: http://www.online-utility.org/english/ readability_test_and_improve.js p. Accessed June 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1a/ed/jpr-8-581.PMC4548759.pdf
"1,2Anecdotal evidence indicates that the fraction of acantho- cytes varies in individual patients over time, without a clear associationFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"27A relationship between the absence of chorein, altered cytoskeleton organization, and protein phosphorylation was confirmed in a report that phosphoryla-tion of the PI3K subunit p85 was decreased in erythrocytes from ChAcAdjobo-Hermans MJW, Cluitmans JCA, Bosman GJCGM Neuroacanthocytosis Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Thus, hypoperfusion caused by erythrocyte dysfunction mayprovide a partial explanation for neuropathologic changes in patientswith NA.Neuroacanthocytosis Adjobo-Hermans MJW, Cluitmans JCA, Bosman GJCGM Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Curr Neurol Neurosci Rep 2015;15:514, doi: http://dx.doi.org/10.1007/s11910-014-0514-0.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Neurol 2005;252:84–90, doi: http://dx.doi.org/10.1007/s00415-005-0616-3.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Toxicol In Vitro 2014;28:1274– 1279, doi: http://dx.doi.org/10.1016/j.tiv.2014.06.008.6.An X, Mohandas N. Disorders of red cell membrane.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Br J Haematol 2008; 141:367–375, doi: http://dx.doi.org/10.1111/j.1365-2141.2008.07091.x.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Blood Rev 2013;27:167–178, doi: http://dx.doi.org/10.1016/j.blre.2013.04.003.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Blood 2011;117: 5998–6006, doi: http://dx.doi.org/10.1182/blood-2010-11-317024.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Cell Mol Med 2009;13:4364–4376, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Prog Neurobiol 2014;112:24–49, doi: http://dx.doi.org/10.1016/j.pneurobio.2013.10.004.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Trends Pharmacol Sci 2005;26:654–660, doi: http://dx.doi.org/10.1016/j.tips.2005.10.004.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Curr Opin Cell Biol 2000;12:229–234, doi: http://dx.doi.org/10.1016/S0955-0674(99)00080-0.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Nature 2001;410:89–93, doi: http://dx.doi.org/10.1038/35065091.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Lipid Res 2015;56:945–962, doi: http://dx.doi.org/10.1194/jlr.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Brain Res Bull 1994;33:523–528, doi: http://dx.doi.org/10.1016/0361-9230(94)90078-7.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Cell Sci 2012;125:3004–3011, doi: http://dx.doi.org/10.1242/jcs.105114.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"PLoS One2015;10:e0124836, doi: http://dx.doi.org/10.1371/journal.pone.0124836.Adjobo-Hermans MJW, Cluitmans JCA, Bosman GJCGM Neuroacanthocytosis Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Prog Lipid Res 2014;53:1–17, doi: http://dx.doi.org/10.1016/j.plipres.2013.10.002.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Alzheimers Dis2014;41:715–717, doi: http://dx.doi.org/10.3233/JAD-141137.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Blood 2011;118:5652–5663, doi: http://dx.doi.org/10.1182/blood-2011-05-355339.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"FASEB J 2012; 26:1526–1534, doi: http://dx.doi.org/10.1096/fj.11-198317.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Biochem Biophys Res Commun 2013;441:96–101, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.Haematologica 2014;99:570–578, doi: http://dx.doi.org/10.3324/haematol.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Neurobiol Dis2012;46:607–624, doi: http://dx.doi.org/10.1016/j.nbd.2012.03.006.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Methods Enzymol 2009;453:217–249, doi: http://dx.doi.org/10.1016/ S0076-6879(08)04011-1.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Proc Natl Acad Sci U S A 2010;107:832–827, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Nat Rev Mol Cell Biol 2007;8:931–937, doi: http://dx.doi.org/10.1038/nrm2245.36.Francelle L, Galvan L, Brouillet E. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington’s disease.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Front Cell Neurosci 2014;8:295, doi: http://dx.doi.org/10.3389/fncel.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Front Cell Neurosci 2015;9:56, doi: http://dx.doi.org/10.3389/fncel.2015.00056.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Stroke 2011;42:1255– 1260, doi: http://dx.doi.org/10.1161/STROKEAHA.110.600940.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"FEBS J 2012;279:2–11, doi: http://dx.doi.org/10.1111/j.1742-4658.2011.08390.x.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"IUBMB Life 2003;55: 293–298, doi: http://dx.doi.org/10.1080/1521654031000153012.",OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"J Neurosci 2004;24:7727–7739, doi: http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Front Neurol 2013;4: 207, doi: http://dx.doi.org/10.3389/fneur.2013.00207.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Neurol 2014;82:835– 841, doi: http://dx.doi.org/10.1212/WNL.0000000000000188.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Cell Stem Cell 2011;9:493–495, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
"Nature 2014;505:327–334, doi: http://dx.doi.org/10.1038/ nature12984.Neuroacanthocytosis Adjobo-Hermans MJW, Cluitmans JCA, Bosman GJCGM Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/8f/63/tre-05-328-7153-1.PMC4548760.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/fa/ijwh-7-773.PMC4548761.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 773–782International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  773RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S7007 3Migraine in menopausal women: a systematic  review Patrizia Ripa1 Raffaele Ornello1 Diana Degan1 Cindy Tiseo1 Janet Stewart2 Francesca Pistoia1 Antonio Carolei1 Simona Sacco1 1Department of Applied Clinical  Sciences and Biotechnology,   Institute of Neurology, University  of L’Aquila, L’Aquila, Italy; 2Psychology  Division, School of Natural Sciences,   University of Stirling, Scotland, UKAbstract:  Evidence suggests that migraine activity is influenced by hormonal factors, and  particularly by estrogen levels, but relatively few studies have investigated the prevalence  and characteristics of migraine according to the menopausal status.",Non-OADS,/arxiv_data1/oa_pdf/ca/fa/ijwh-7-773.PMC4548761.pdf
"Migraine usually starts after menarche, occurs more frequently during menstrua - tion, and ameliorates during pregnancy and after menopause.3 The “estrogen with - drawal” hypothesis, more than 40 years after having been proposed for the first time,  is still the most commonly referred to, in order to explain the mechanism through  which migraine is triggered by ovarian hormones.4 According to this hypothesis, Correspondence: Simona Sacco Department of Applied Clinical  Sciences and Biotechnology, Institute  of Neurology, University of L’Aquila, via  vetoio, 67100 L’Aquila, Italy Tel +39 0862 43 3552 email simona.sacco@cc.univaq.i t Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Ripa et al Running head recto: Migraine in menopausal women: a systematic review  DOI: http://dx.doi.org/10.2147/IJWH.S70073",Non-OADS,/arxiv_data1/oa_pdf/ca/fa/ijwh-7-773.PMC4548761.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ca/fa/ijwh-7-773.PMC4548761.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/fa/ijwh-7-773.PMC4548761.pdf
The term ‘‘slow OT’’ has been widely used in the literature although some discourage this term.7So-called ‘‘slow OT’’ was first described in 1986 in a family with essential tremor.10It has since been documented in case reports and small case series with the term applied to frequencies as low as 4Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Figure 1.Histogram Analysis Showing the Distribution of Dominant Tremor Frequencies .Rigby HB, Rigby MH, Caviness JN 13 Hz Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Figure 2.Surface Electromyography Tracings and Spectral Analysis in Patients with High-, Intermediate-, and Low-FrequencyOrthostatic Tremor .13 Hz Orthostatic Tremor Rigby HB, Rigby MH, Caviness JN Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"The rows containing significant p-values are in boldRigby HB, Rigby MH, Caviness JN 13 Hz Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Further study is warranted toTable 3.Proportion of Patients Experiencing at Least Partial Benefit from Medication ,10 Hz 10–13 Hz .13 Hz Clonazepam 1/1 2/3 1/5 Gabapentin 2/2 1/2 4/9 Primidone 1/3 – 1/6 Propanolol – – 1/2Topiramate – – 0/4 Valproic acid – – 0/2 Levodopa – – 0/2Pramipexole – – 0/1 Alprazolam – – 0/213 Hz Orthostatic Tremor Rigby HB, Rigby MH, Caviness JN Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Parkinsonism Relat Disord 2014;20:889–893, doi: http://dx.doi.org/10.1016/j.parkreldis.2014.05.006.",OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Mov Disord 2005;20: 1455–1461, doi: http://dx.doi.org/10.1002/mds.20588.",OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Parkinsonism Relat Disord 2014;20:723–725, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"J Neurol 1992;239:209–217, doi: http://dx.doi.org/10.1007/BF00839142.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Mov Disord Clin Pract 2014;1:172–179, doi: http://dx.doi.org/10.1002/mdc3.12053.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Neurology 1996;46:747–752, doi: http://dx.doi.org/10.1212/WNL.46.3.747.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Neurology 1986;36:1241–1245, doi: http://dx.doi.org/10.1212/ WNL.36.9.1241.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Mov Disord 2009;24:1550–1553, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Tremor Other Hyperkinet Mov (NY) 2013;3:1–3, http://www.tremorjournal.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Mov Disord 2013;28:1158–1159, doi: http://dx.doi.org/10.1002/mds.25313.",OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Mov Disord 2011;26:1563– 1565, doi: http://dx.doi.org/10.1002/mds.23610.",OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Acta Neurol Scand 1989;79:119–122, doi: http://dx.doi.org/10.1111/j.1600-0404.1989.tb03722.x.",OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Handb Clin Neurol 2011;100:457–462, doi: http://dx.doi.org/10.1016/B978-0-444-52014- 2.00035-5.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
"Muscle Nerve 1993;16:1254–1260.Rigby HB, Rigby MH, Caviness JN 13 Hz Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/d6/07/tre-05-324-7132-1.PMC4548762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/cc/tcrm-11-1243.PMC4548763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1243–1249Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1243ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8935 5Value of serial platelet indices measurements  for the prediction of pulmonary embolism  in patients with deep venous thrombosis Utkan sevuk1 Mehmet Veysi Bahadir2 Rojhat altindag3 erkan Baysal3 Baris Yaylak3 nurettin ay4 Firat ayaz1 ertan Demirtas5 1Department of Cardiovascular  surgery, Diyarbakir gazi Yasargil  education and Research hospital,   Diyarbakir, T urkey; 2Department of  general surgery, Dicle University,   Diyarbakir, T urkey; 3Department of  Cardiology, Diyarbakir gazi Yasargil  education and Research hospital,   Diyarbakir, T urkey; 4Department of  general surgery, Diyarbakir gazi  Yasargil education and Research  hospital, Diyarbakir, T urkey;   5Department of Cardiovascular  surgery, liv hospital, ankara, T urkeyBackground:  To date, no validated biomarkers with high sensitivity and specificity have been  established for diagnosis of pulmonary embolism (PE) in patients with deep venous thrombosis  (DVT).",Non-OADS,/arxiv_data1/oa_pdf/66/cc/tcrm-11-1243.PMC4548763.pdf
"d-Dimer testing is sensitive, but not specific for diagnosing PE.3 To date, no validated  biomarkers with high sensitivity and specificity have been established for diagnosis  of PE in patients with DVT.Correspondence: Utkan sevuk Diyarbakir gazi Yasargil egitim ve  arastirma hastanesi, Kalp ve Damar  Cerrahisi Klinigi, 3 kat, Uckuyular,  Diyarbakir 21010, Turkey Tel +90 505 530 7095 email utkansevuk@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Sevuk et al Running head recto: Platelet indices measurements for the prediction of pulmonary embolism DOI: http://dx.doi.org/10.2147/TCRM.S89355",Non-OADS,/arxiv_data1/oa_pdf/66/cc/tcrm-11-1243.PMC4548763.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/66/cc/tcrm-11-1243.PMC4548763.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/cc/tcrm-11-1243.PMC4548763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1235–1242Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1235Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6565 0Patient considerations in the management of   ulcerative colitis – role of vedolizumab Megha Kothari Prashant Mudireddy Arun Swaminath Division of Gastroenterology and  Hepatology, Lenox Hill Hospital-NSLiJ,   New Y ork, NY, USAAbstract:  Ulcerative colitis (UC) is a subtype of inflammatory bowel disease which causes  inflammation of the large intestine and affects approximately 7.6–24.6 per 100,000 persons.",Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
"Treatment with IFX has shown nearly a 60%–70% response  rate in UC, but up to 40% are primary nonresponders, and 10% per year develop  secondary nonresponse to IFX therapy.3–5 While primary nonresponse may be due to  proinflammatory pathways that bypass TNF-alpha, secondary nonresponse has been  correlated with the development of antidrug antibodies, accelerated drug clearance,  albumin concentration, and degree of systemic inflammation.6 Additionally, response  to a second anti-TNF is lower than in anti-TNF-naïve patients.4Correspondence: Arun Swaminath Division of Gastroenterology and  Hepatology, Lenox Hill Hospital- NSLiJ, 100 east 75th Street, 2nd Floor,  New York, NY 10075, USA Tel +1 212 434 6963 Fax +1 212 434 6275 email aswaminath@nshs.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Kothari et al Running head recto: Role of vedolizumab in ulcerative colitis DOI: http://dx.doi.org/10.2147/TCRM.S65650 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
Or use: http://youtu.be/UtFlq6k0ND gvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
The European Crohn’s and Colitis Organization’s  ulcerative management guidelines ( https://www.ecco-ibd.,Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/07/tcrm-11-1235.PMC4548764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/f8/ott-8-2139.PMC4548765.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2139–2145OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2139Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8627 0Clinical efficacy of percutaneous vertebroplasty  combined with intensity-modulated radiotherapy  for spinal metastases in patients with nsclc Yi li1,2 Yi Qing1 Zhimin Zhang3 Mengxia li1 Jiaying Xie1 ge Wang1 Dong Wang1 1Department of cancer center,   research institute of surgery, Daping  hospital, Third Military Medical  University, 2Department of Oncology,   Beibei Traditional Chinese Medical  hospital, chongqing, 3Department of  Oncology, Wuhan general hospital  of guangzhou command, People’s  Liberation Army, Wuhan, Hubei,   People’s Republic of ChinaObjective:  This study aimed to evaluate the safety and efficacy of percutaneous vertebroplasty  (PVP) combined with intensity-modulated radiotherapy (IMRT) for metastatic lesions of patients  with non-small-cell lung cancer (NSCLC) at centrum vertebrae.",Non-OADS,/arxiv_data1/oa_pdf/db/f8/ott-8-2139.PMC4548765.pdf
"Standard treatments include systemic therapies,  such as hormonal therapy, analgesics and bisphosphonates, and local, focused on the  lesion, such as radiotherapy (RT) and surgery.2 RT has been used for spinal hemangiomas correspondence: Dong Wang Department of cancer center, research  institute of surgery, Daping hospital,  Third Military Medical University, 10  changjiangzhilu road, chongqing 400042,  People’s Republic of China Tel +86 23 6875 7151 Fax +86 23 6889 4062 email dongwang64@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Li et al Running head recto: Clinical efficacy of percutaneous vertebroplasty combined with IMRT DOI: http://dx.doi.org/10.2147/OTT.S86270",Non-OADS,/arxiv_data1/oa_pdf/db/f8/ott-8-2139.PMC4548765.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/db/f8/ott-8-2139.PMC4548765.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/f8/ott-8-2139.PMC4548765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ott-8-2129.PMC4548766.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2129–2137OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2129Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8758 0simultaneous hepatectomy and splenectomy  versus hepatectomy alone for hepatocellular  carcinoma complicated by hypersplenism: a  meta-analysis Wei li shi-Qiang shen shan-Min Wu Zu-Bing chen chao hu rui-chen Yan Department of general surgery,   renmin hospital of Wuhan University,   Wuhan, People’s republic of chinaBackground:  This study systematically compared the efficacy and safety of simultaneous  hepatectomy and splenectomy (HS) with hepatectomy (H) alone in patients with hepatocellular  carcinoma (HCC) and hypersplenism.",Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ott-8-2129.PMC4548766.pdf
"Hypersplenism results in pancytopenia, and hepatectomy in patients with hypersplenic correspondence: shi-Qiang shen Department of general surgery,  renmin hospital of Wuhan University,  hubei Zhang road, Wuchang District  no 99 Wuhan 430060, hubei Province,  People’s republic of china Tel +86 27 8804 1911 Fax +86 27 8804 1911 email shenshiqiang2014@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Li et al Running head recto: HS versus H for HCC with hypersplenism DOI: http://dx.doi.org/10.2147/OTT.S87580",Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ott-8-2129.PMC4548766.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ott-8-2129.PMC4548766.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ott-8-2129.PMC4548766.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1511–1517Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1511Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8869 3refractive cylinder outcomes after calculating  toric intraocular lens cylinder power using total  corneal refractive power James a Davison1 richard Potvin2 1Wolfe eye Clinic, Marshalltown, ia,   Usa; 2science in Vision, akron, nY,   UsaPurpose:  To determine whether the total corneal refractive power (TCRP) value, which is  based on measurement of both anterior and posterior corneal astigmatism, is effective for toric  intraocular lens (IOL) calculation with AcrySof® Toric IOLs.",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
"The initial study of AcrySof® Toric IOL (Alcon, Fort Worth, TX, USA)  performance showed that out of 256 patients implanted with toric IOLs, 12% had 1.0  D of residual astigmatism postoperatively.5Correspondence: richard Potvin science in Vision, 6197 Dye road,  akron, nY 14001, Usa Tel +1 407 697 6008 Fax +1 716 442 5110 email rick@scienceinvision.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Davison and Potvin Running head recto: TCRP and toric IOL planning DOI: http://dx.doi.org/10.2147/OPTH.S88693",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
"The cases had the following characteristics: regular  anterior corneal astigmatism, no pathology which might pre - clude accurate manifest refraction or recovery from surgery,  implantation with AcrySof® IQ Toric hydrophobic single- piece acrylic lenses, IOL spherical power based on axial length  and keratometry from the IOLMaster® (Carl Zeiss Meditec,  Jena, Germany), and TCRP from the Pentacam at the 3.0 mm   apex/ring setting on the power distribution map for ker - atometry entry into the Alcon AcrySof Toric IOL Calculator  (http://www.acrysoftoriccalculator.com /).",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/2a/opth-9-1511.PMC4548767.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/fa/jpr-8-591.PMC4548768.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 591–601Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  591Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S6425 1Chronic pain in hypermobility syndrome   and ehlers–Danlos syndrome (hypermobility  type): it is a challenge Mark C Scheper1,2 Janneke e de vries1–3 Jeanine verbunt3,4 Raoul HH engelbert1,2 1School of Physiotherapy, Amsterdam  University of Applied Sciences,   Amsterdam, 2Department of  Rehabilitation, Academic Medical  Center, University of Amsterdam,   Amsterdam, 3Department of  Rehabilitation Medicine, CAPHR i  School for Public Health and  Primary Care, Maastricht University,   Maastricht; 4Adelante, Center  of expertise in Rehabilitation  and Audiology, Hoensbroek, the  Netherlands Correspondence: Mark C Scheper   School of Physiotherapy, Amsterdam  University of Applied Sciences,  Tafelbergweg 51, 1105BD Amsterdam,  the Netherlands   email m.c.scheper@hva.n lAbstract:  Generalized joint hypermobility (GJH) is highly prevalent among patients diagnosed  with chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/fa/jpr-8-591.PMC4548768.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/fa/jpr-8-591.PMC4548768.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/fa/jpr-8-591.PMC4548768.pdf
"Ultrasound-targeted micro - bubble destruction (UTMD) is a noninvasive gene transfer Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> Received 17 May 2015 | Accepted 22 August 2015 | Published 25 August 2015© 2015 Molecular Vision 930Experimental endostatin-GFP gene transfection into human  retinal vascular endothelial cells using ultrasound-targeted  cationic microbubble destruction Yan Xu,1 Zongyuan Xie,2 Yu Zhou,1 Xiyuan Zhou,3 Pan Li,1 Zhigang Wang,1 Qunxia Zhang1 1Institute of Ultrasound Imaging and Department of Ultrasound, Secon d Affiliated Hospital of Chongqing Medical University;  Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing, P .R.",Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  931technology that provides a new means for carrying out gene  therapy [ 11].,Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  932the amount of unbound DNA from the total amount of DNA  added initially.,Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  933Western blot analysis:  All HREC groups were collected  72 h after transfer.,Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
"Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  934(+16.32±3.28) after the bound DNA, but the size of the CMBs  has no obvious change, and the size and the zeta potential of  NMBs had no obvious change after the bound DNA.",Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  935Bcl-xl mRNA decreased (Figure 4).,Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
"Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  936cells in vitro and into rat retinas and choroids in vivo, thus  inhibiting the development of choroidal neovascularization  [21]; however, the gene transfection efficiency was modest,  similar to other researchers’ reports [ 23,24].",Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
"Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  937compared with those of the other groups, indicating that the  growth of the HRECs in the CMB group had been restrained.",Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
Molecular Vision  2015; 21:930-938 <http://www.molvis.org/molvis/v 21/930> © 2015 Molecular Vision  93810.,Non-OADS,/arxiv_data1/oa_pdf/c3/15/mv-v21-930.PMC4548789.pdf
"The Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> Received 18 December 2014 | Accepted 22 August 2015 | Published 25 August 2015© 2015 Molecular Vision 939GABAAα1 and GABAAρ1 subunits are expressed in cultured human  RPE cells and GABAA receptor agents modify the intracellular  calcium concentration Zhen-Ying Cheng,1,2 Xu-Ping Wang,3 Katrina L. Schmid,4 Xu-Guang Han,5 Hui Song,1 Xin Tang1 (#The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
"Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  940GABAAR agonist muscimol increases [Ca2+]i in rat astrocytes  [18], as well as in embryonic and early postnatal neocor - tical cells [ 19], embryonic rat ventral spinal cord neurons  [20], embryonic rat striatal neurons [ 21], and rat cerebellar  Purkinje neurons [ 22].",Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
"Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  941membrane was incubated with the polyclonal goat anti-human  GABAAα1 antibody (1:100, Santa Cruz Biotechnology, Santa  Cruz, CA), polyclonal goat anti-human GABAAρ1 antibody  (1:100, Santa Cruz, CA), or monoclonal mouse anti-human  β-Actin antibody (Zhongshan Jinqiao Company, Beijing,  China) overnight at 4 °C, and then was followed by incubation  with horseradish peroxidase (HRP)-conjugated secondary  antibody (1:10,000) for 1 h at 37 °C.",Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
"Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  942GABAAα1 and GABAAρ1 protein expression in cultured human  RPE:  Western blots revealed intense bands at 51 kDa, 48 kDa,  and 43 kDa for samples incubated with the anti-GABAAα1,  anti-GABAAρ1, and anti-β-Actin antibody, respectively, in  cultured human RPE and retinal samples (positive control;  Figure 3A).",Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
"Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  943DISCUSSION GABAAα1 and GABAAρ1 mRNAs and proteins were expressed  in the cultured human RPE cells; the protein was primarily  located in the cell membrane, and was also present in the  cytoplasm, but was not observed in the nucleus.",OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  944antagonist picrotoxin has been shown to attenuate the  muscimol-induced [Ca2+]i increase in postnatal mouse  retinal ganglion cells [ 26].,Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  945[62].,Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  94621.,Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
Molecular Vision  2015; 21:939-947 <http://www.molvis.org/molvis/v 21/939> © 2015 Molecular Vision  94745.,Non-OADS,/arxiv_data1/oa_pdf/f8/dc/mv-v21-939.PMC4548790.pdf
"KIR molecules Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> Received 31 May 2015 | Accepted 22 August 2015 | Published 25 August 2015© 2015 Molecular Vision 948Possible association of killer cell immunoglobulin-like receptor  genotypes and haplotypes with dry eye disease in a Han Chinese  population Guifang Ren,1 Huiyu Li,2 Wenben Qiao,3 Hua Shen,3 Yunlong Zhuang,3 Tiejun Shao,1 Haipeng Hu,1 Xiuping  Zhang1 1Department of Ophthalmology, The 4th People's Hospital of Jinan, Shandong Province, P .",Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
"Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  949play an important role in anti-inflammation immunity by  providing activating or inhibitory signals to regulate the  activation of NK cells and T cell subsets [ 13,14].",Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
"Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  950RESULTS KIR genotype frequencies in control subjects and patients:   In our study, all tested KIR genes were detected in the  healthy control and DED patient groups.",Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  951(13.92%) in the healthy controls and the patients with DED.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  952be increased in Japanese psoriasis vulgaris cases [ 14].,Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  953Han Chinese and Caucasian populations suggested the role of  the natural selection of certain genes over the others.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
Molecular Vision  2015; 21:948-954 <http://www.molvis.org/molvis/v 21/948> © 2015 Molecular Vision  95413.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/mv-v21-948.PMC4548791.pdf
"However, thus far, little  is known about the expression and biologic functions of the Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> Received 6 April 2015 | Accepted 22 August 2015 | Published 25 August 2015© 2015 Molecular Vision 919EMT-associated factors promote invasive properties of uveal  melanoma cells Laura Asnaghi,1 Gülçin Gezgin,2 Arushi Tripathy,1 James T. Handa,3 Shannath L. Merbs,3,4 Pieter A. van der  Velden,2 Martine J. Jager,2 J. William Harbour,5 Charles G. Eberhart1,3,4 1Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD; 2Department of Ophthalmology,  Leiden University Medical Center, Leiden, The Netherlands; 3Department of Ophthalmology, Johns Hopkins University, School  of Medicine, Baltimore, MD; 4Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD; 5Ocular  Oncology, Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of  Medicine, Miami, FL Purpose:  Transcription factors regulating the epithelial-to-mesenchymal transition (EMT) program contribute to car - cinogenesis and metastasis in many tumors, including cutaneous melanoma.",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  920EMT factors in the melanoma cells arising in the uveal tract  of the eye, which are genetically and biologically distinct  from those in the skin [ 11,12].",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  921to analyze 28 tumor specimens.,Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  922Statistical analysis:  Levels of significance were determined  by the two-sided Student t test.,Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  923with Matrigel, which mimics the composition and the proper - ties of the ECM (Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  924our tumor cell lines, we performed loss-of-function studies  using shRNA that specifically targets this key EMT factor.",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  925cells using two separate shRNAs constructs, which reduced  expression by approximately 40%–60% at the mRNA and  protein levels, as compared to scramble controls (Figure  5A,B).",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  926Accumulating evidence indicates that an EMT-like  program contributes to neoplastic transformation, metastatic  progression, and drug resistance in cutaneous melanoma, but thus far, this program has not been studied in uveal  melanoma.",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  927as oncosuppressor proteins, activating an MITF-regulated  differentiation program, while ZEB1 and Twist1 repress  differentiation and cooperate with BRAF in promoting  melanoma progression [ 42].",Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  928Not significant.,Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
Molecular Vision  2015; 21:919-929 <http://www.molvis.org/molvis/v 21/919> © 2015 Molecular Vision  92923.,Non-OADS,/arxiv_data1/oa_pdf/51/38/mv-v21-919.PMC4548792.pdf
"These samples were compared with  control samples obtained from patients scheduled for routine  cataract surgery.Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> Received 27 April 2015 | Accepted 22 August 2015 | Published 25 August 2015© 2015 Molecular Vision 911Distinctive and pervasive alterations in aqueous humor protein  composition following different types of glaucoma surgery Cyril Rosenfeld,1 Marianne O. Price,1 Xianyin Lai,2,3 Frank A. Witzmann,2 Francis W. Price Jr4 1Cornea Research Foundation of America, Indianapolis, IN; 2Department of Cellular & Integrative Physiology, Indiana  University School of Medicine, Indianapolis, IN; 3Department of Biochemistry & Molecular Biology, Indiana University School of  Medicine, Indianapolis, IN; 4Price Vision Group, Indianapolis, IN Purpose:  To investigate whether specific glaucoma surgeries are associated with differences in aqueous humor protein  concentrations compared to eyes without filters.",Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
"Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  912METHODS This cross-sectional study involved the collection of 37  aqueous humor samples from 37 patients between 21 October  2011 and 5 March 2014 at Price Vision Group (Indianapolis,  IN).",Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  913procedure twice.,Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
"Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  914Appendix 7, Appendix 8, Appendix 9, and Appendix 10 –  Functional Analyses Controls versus Trabeculectomies).",Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
"Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  915mildly fibrosed and watertight to reduce the risk of hypotony,  or insufficient intraocular pressure, in the early postopera - tive period.",Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  916grafted eyes may be an indicator of what happens to virgin  non-grafted corneas over a longer timeframe.,Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  917APPENDIX 6.,Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
Molecular Vision  2015; 21:911-918 <http://www.molvis.org/molvis/v 21/911> © 2015 Molecular Vision  91820.,Non-OADS,/arxiv_data1/oa_pdf/d9/9d/mv-v21-911.PMC4548793.pdf
"Methods Patients The clinical database of the Movement Disorders Outpatient Clinic of the 1st Neurology Department, Athens Medical School, was used for the current analyses, after approval was obtained from ourFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Motor and Non-motor Features Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Motor and Non-motor Features Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Motor and Non-motor Features Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Parkinsonism Relat Disord 2003;9:225–231, doi: http://dx.doi.org/10.1016/ S1353-8020(02)00057-3.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Ann Neurol 1985;17:329–333, doi: http://dx.doi.org/ 10.1002/ana.410170404.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Tremor Other Hyperkinet Mov (NY) 2014;4:252, doi: http://dx.doi.org/10.7916/D876 5CG0.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Parkinsonism Relat Disord 2012;18:407–413, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Eur J Neurol 2013;20:1440–1444, doi: http://dx.doi.org/10.1111/ene.12256.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Mov Disord 2008;23:1602–1605, doi: http://dx.doi.org/10.1002/mds.22161.",OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Tremor Other Hyperkinet Mov (NY) 2014;4:216, doi: http://dx.doi.org/10.7916/D82J68TH.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Parkinsonism Relat Disord 2014;20:17–21, doi: http://dx.doi.org/10.1016/j.parkreldis.2013.09.004.",OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Mov Disord 2009;24:1662– 1668, doi: http://dx.doi.org/10.1002/mds.22655.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"QJM 1999;92:473–480, doi: http://dx.doi.org/10.1093/ qjmed/92.8.473.",OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"22.Benito-Leon J, Louis ED, Bermejo-Pareja F. Reported hearing impairment in essential tremor: A population-based case-control study.Neuroepidemiology 2007;29:213–217, doi: http://dx.doi.org/10.1159/000112463.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Parkinsonism Relat Disord 2014;20:S94–S98, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Tremor Other Hyperkinet Mov (NY) 2014;4:162, doi: http://dx.doi.org/10.7916/ D82V2D91.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Epigenetics might provide answers.Parkinsonism Relat Disord 2012;18:711–716, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Parkinsonism Relat Disord 2012;18:279–284, doi: http://dx.doi.org/10.1016/j.parkreldis.2011.11.004.Motor and Non-motor Features Ghika A, Kyrozis A, Potagas C, et al.",OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndrome.Parkinsonism Relat Disord 2011;17:456–458, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"J Neurol Neurosurg Psychiatry 2011;82:261–265, doi: http://dx.doi.org/10.1136/jnnp.2010.215681.Ghika A, Kyrozis A, Potagas C, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
Motor and Non-motor Features Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/35/b6/tre-05-335-7055-1.PMC4548968.pdf
"Patient- centeredness (i.e., providing care that is responsive to individual patient preferences) is increasingly recognized as a crucial yet oftenFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"When asked how educated they felt their doctor was about tremor (i.e., question 6), 6.6% endorsed ‘‘not very well-educated’’, 24.8% endorsed a value that was between ‘‘not very well-educated’’ and ‘‘moderately well-educated’’, 19.5% endorsed ‘‘moderately well- educated’’, 31.6% endorsed a value that was between ‘‘moderately educated’’ and ‘‘extremely well-educated’’, and 17.7% endorsedLouis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"For instance, not everyone would be interested in a surgical approach or need a psychiatrist.’’87 (7.4) Anxiety ‘‘Anxiety caused by dealing with tremor.’’ 79 (6.8) Depression ‘‘Dealing with the depression associated with tremor.’’ 73 (6.3) Education for patients ‘‘Assembly of a wide range of information resources that someone with essential tremors may consult.’’59 (5.1) Support groups ‘‘Caring circles.’’ ‘‘Creating an area where people with ET can get together and talk.’’57 (4.9) Research ‘‘Comprehensive research….Until the cause is identified, the treatments will be unsatisfactory.’’53 (4.5) Education and support for family members of patients‘‘Counseling should include the family members who are living with it as well, both as caregivers and potentially future patients.’’49 (4.2) Treat the whole person ‘‘A health and wellness approach to lessen the tremors.’’ ‘‘Treat the entire person, physical, mental, emotional, etc.’’46 (3.9) Assistive devices or new technologies to lessen tremor‘‘Assistive devices which could be taken home and tried, like a computer mouse.’’ ‘‘Gadgets to help with eating and writing.’’43 (3.7)Defining the Treatment Gap in Essential Tremor Louis ED, Rohl B, Rice C Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"Sometimes that helps with the tremors.’’ ‘‘Stress reduction and its effects on tremor.’’37 (3.2) Dietary/nutrition counseling‘‘How to arrange my life so as to minimize tremor, e.g., no caffeine, fewer carbs.’’35 (3.0) Help with employment or workplace issues‘‘Dealing with employer’s misconceptions.’’ ‘‘Career counseling.’’ ‘‘Counseling for younger people in careers dealing with the problem.’’29 (2.5) Cognitive issues ‘‘Cognitive functions as related to tremors.’’ ‘‘Cognitive and memory issues related to long term use of tremor meds.’’26 (2.2) Fewer barriers and better access to treatment‘‘Have more centers in all states making it easier for ET patients to get to.’’22 (1.9) Multidisciplinary care and coordinated care across specialties‘‘Build teams of specialists trained in the treatment of essential tremors.’’ ‘‘Communication between providers to discuss all of the patient’s unique medical needs.’’22 (1.9) Doctors who understand complex illness and who understand the complexity of ET‘‘A doctor who understands how different diseases or illnesses may affect the tremor and be understanding of the patient’s challenges.’’ ‘‘Health professionals who know about ET and a comprehensive interprofessional team.’’22 (1.9) More educated doctors ‘‘Better training for clinicians and doctors to recognize essential tremor as an illness separate from other similar illnesses.’’21 (1.8) Specific alternative therapies or treatments (e.g., acupuncture, natural remedies, massage therapy)‘‘Alternative therapies such as acupuncture.’’ ‘‘Alternative medications (prescription and traditional alternative medication) for those of us who respond poorly to the traditionally prescribed meds.’’15 (1.3) Prognosis ‘‘Examples of what you will and will not be able to do (as ET progresses.’’ ‘‘Preparkinson’s possibility.’’ ‘‘The stages of tremor.’’14 (1.2) Help for younger or pediatric patients‘‘Treating tremor in the younger population (under 50).’’ 13 (1.1) Social worker to help coordinate services‘‘A social worker or someone to work towards maintaining your independence.’’ ‘‘Counselor to talk about life needs (disability insurance).’’13 (1.1)Louis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"ET, Essential Tremor.Defining the Treatment Gap in Essential Tremor Louis ED, Rohl B, Rice C Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"Table 3.Respondents’ Ratings of the Potential Importance of Specialists in the Treatment of Patients with ET (Survey Question 3) Not Important– Only Slightly– Somewhat ImportantModerately ImportantVery Important– Essential Neurologist specializing in movement disorders 61 (4.3) 67 (4.7) 1288 (91.0) Clinical trials specialist 220 (15.7) 222 (15.7) 969 (68.6) Gait and balance specialist 274 (19.3) 258 (18.2) 885 (62.5) Physiatrist or physical therapist 295 (20.9) 249 (17.6) 874 (61.7) Neurosurgeon 314 (22.5) 274 (19.6) 809 (57.9) Dietician 360 (25.7) 258 (18.4) 788 (56.1) Speech pathologist 385 (27.6) 283 (20.3) 727 (52.1) General neurologist 387 (28.1) 286 (20.7) 707 (51.2) Psychiatrist 420 (29.8) 280 (19.9) 707 (50.3) Social worker 530 (38.0) 279 (20.0) 587 (42.1) Genetics counselor 535 (38.3) 305 (21.8) 558 (40.0) Someone who can evaluate you for memory problems 575 (41.2) 298 (21.3) 525 (37.6) Hearing specialist 848 (60.6) 259 (18.5) 291 (20.9) The number of respondents per row ranged from 1,380 to 1,418.Louis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"I would like to see a more complete diagnostic test—involving gait, tremor, memory—instead of the extremely basic tests used so far.’’116 (9.5)Defining the Treatment Gap in Essential Tremor Louis ED, Rohl B, Rice C Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"A general neurologist should know when to quit and send the patient for proper assessment.’’ ‘‘MD’s for the most part do not take it too seriously, but I finally got my Dr. to send a referral to a center for Movement disorders.’’46 (3.7) A doctor who gives advice ‘‘A doctor who gives advice.’’ ‘‘More input from the doctor.’’40 (3.3) More information about new research findings‘‘No one seems to give me any information on new treatments or new research that has been done.’’ ‘‘Notification of emerging therapies.’’38 (3.1) A holistic approach to treatment ‘‘Doctor relies on prescription drugs to mitigate ET challenges rather than alternatives such as acupuncture, massage, relaxation techniques.’’ ‘‘Right now we just monitor and medicate…I would like a holistic approach.’’34 (2.8) A better educated neurologist ‘‘Currently, I am seeing a neurologist who doesn’t seem familiar with essential tremor.’’ ‘‘I have a general neurologist who doesn’t seem to be able to answer my questions.’’33 (2.7)Louis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"office is an artificial environment that doesn’t reproduce certain situations I experience.’’16 (1.3) More information about clinical trials and research that is currently recruiting‘‘I would like for the doctor to be more informed about any new ideas or clinical trials.’’ ‘‘Discuss knowledge of advances and clinical trials.’’ ‘‘A clinical trial specialist to inform me of any new treatments that are undergoing testing and where one can obtain the medication being tested.’’16 (1.3)Defining the Treatment Gap in Essential Tremor Louis ED, Rohl B, Rice C Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"I ended up in a memory clinic.’’ ‘‘Memory problems.’’11 (0.9) Financial constraints to accessing treatment‘‘Tremors occur in common people, not only people with money, but the treatments seem to be out of reach for common people with average incomes.’’ ‘‘Ability to get a second opinion—this is an insurance problem.’’11 (0.9) Less of a ‘‘guessing game’’ (i.e., trial and error empiric approach to treatment)‘‘It seems to be a hit or miss attempt at ameliorating tremor.’’ ‘‘Try this one, then try that one.’’8 (0.7) Hearing problems ‘‘No one has mentioned hearing problems to me—are/might they occur because of tremor?’’5 (0.4) Help for young patients ‘‘My son has been to 3 different neurologists and because he is young, the neurologists just don’t seem to care about his quality of life or try different regimens.’’5 (0.4) Suggest products to buy that would help with tremor‘‘Information on assistive technology.’’ ‘‘Available items you can purchase to help you reduce your tremor.’’2 (0.2) ET, Essential Tremor.Louis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"009.Defining the Treatment Gap in Essential Tremor Louis ED, Rohl B, Rice C Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
"(Please rate from 0 to 10, with 0 5not very well educated, 55moderately well educated, 10 5extremely well informed).Louis ED, Rohl B, Rice C Defining the Treatment Gap in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/27/7b/tre-05-331-7085-1.PMC4548969.pdf
She had failed to recognize this association during clinic visits with the referring general neurologist.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"No myoclonus seen at rest or with stimuli.Murgai AA, LeDoux MS Memantine-induced Myoclonus Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Ann Pharmacother 2008;42:443–447, doi: http://dx.doi.org/10.1345/aph.1K619.Memantine-induced Myoclonus Murgai AA, LeDoux MS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Neurology 2014;83:1387, doi: http://dx.doi.org/10.1212/WNL.0000000000000863.",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"J Neurol 1987;235:90–94, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Parkinsonism Relat Disord 2003;9:185–192, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Mov Disord 1996;11:104–106, doi: http://dx.doi.org/10.1002/mds.870110123.",OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Age Ageing 2012;41:695–696, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"Neuropsychopharmacology 2004;29:1070–1079.Murgai AA, LeDoux MS Memantine-induced Myoclonus Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/14/78/tre-05-337-7088-1.PMC4548970.pdf
"About the Global Inﬂuenza Initiative Founded in 2012, the GII is a global expert scientiﬁc forumchaired by Prof. Stanley Plotkin and composed of scientists,researchers, and clinicians with expertise in epidemiology,infectious diseases, immunology, and public health (seehttp://www.globalinﬂuenzainitiative.org/).",Non-OADS,/arxiv_data1/oa_pdf/46/c1/irv0009-0001.PMC4549096.pdf
We remain an independent scientiﬁc body as outlined indetail on the GII Web site (http://www.globalinﬂuenzaini-tiative.org/).,Non-OADS,/arxiv_data1/oa_pdf/46/c1/irv0009-0001.PMC4549096.pdf
Available at http://www.who.int/mediacentre/factsheets/fs211/en/ (Accessed28 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/2b/49/irv0009-0003.PMC4549097.pdf
Available at http://www.jcu.edu.au/ sottreport/ (Accessed 22 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/2b/49/irv0009-0003.PMC4549097.pdf
Available at http://www.who.int/bulletin/volumes/92/5/13-124412-ab/en/ (Accessed 19 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/2b/49/irv0009-0003.PMC4549097.pdf
Available at http://www.who.int/csr/disease/swineﬂu/transmission_zones/en/ (Acce-ssed 29 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/2b/49/irv0009-0003.PMC4549097.pdf
Available at http://www.who.int/inﬂuenza/ vaccines/virus/recommendations/en/ (Accessed 29 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/2b/49/irv0009-0003.PMC4549097.pdf
Available at http://www.who.int/mediacentre/factsheets/fs211/en/ (Accessed 29 May 2015).Cheng et al.,OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.who.int/wer/2012/wer8747.pdf?ua=1 (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.paho.org/hq/ index.php?option=com_content&view=article&id=1864&Itemid=2234&lang=en (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.paho.org/hq/index.php?option=com_content&view= article&id=5605%3Amortality-data-health-americas-2012&catid=2391 %3Arho-databases&Itemid=2392&lang=en (Accessed 29 May 2015).,OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.census.gov/popest/ (Accessed 18 October 2013).,OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.ibge.gov.br/english/estatistica/populacao/censo2010/ (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.who.int/ inﬂuenza/gisrs_laboratory/ﬂunet/en/ (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at: http://www.cdc.gov/ﬂu/weekly/ (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.who.int/choice/ demography/mortality_strata/en/index.html (Accessed 29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
Available at http://www.paho.org/hq/index.php?option=com_doc man&task=doc_view&gid=16018&Itemid=4318&lang=es (Accessed29 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/63/irv0009-0013.PMC4549098.pdf
http://www.cdc.gov/ﬂu/weekly.Cr/C19epey et al.,OADS,/arxiv_data1/oa_pdf/3c/e7/irv0009-0039.PMC4549101.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"Although female TG spent a similar amount of time on the accelerating rotarod compared to female WT (geno-type effect p/C210.05), RAPA treatment significantly in- creased the latency to fall from the accelerating rotarod by a log-ratio of 0.1954 90.0202 (1.2-fold increase) in female WT ( pB0.0001) and by a log-ratio of 0.2813 90.0162Rapamycin in the treatment of synucleinopathy Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"* pB0.05, WT control versus WT RAPA; ** pB0.05, WT control versus TG control; *** pB0.05, TG control versus TG RAPA.Rapamycin in the treatment of synucleinopathy Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"6 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"Data were analyzed by a two-way ANOV A followed by Bonferonni post hoc n /C309, *pB0.05, ** pB0.01.Rapamycin in the treatment of synucleinopathy Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"8 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"2010; 30: 1166/C175.Rapamycin in the treatment of synucleinopathy Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"10 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2015, 5: 28743 - http://dx.doi.org/10.3402/pba.v5.28743",Non-OADS,/arxiv_data1/oa_pdf/83/f0/PBA-5-28743.PMC4549373.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/e6/rjv111.PMC4549374.pdf
", 2009 ) version 6.7 (http://david.abcc.",Non-OADS,/arxiv_data1/oa_pdf/bb/04/kfv122.PMC4549394.pdf
Available at: http://csmedia2.corning.com/LifeSciences/ Media/pdf/transwell_guide.pdf doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/04/kfv122.PMC4549394.pdf
Available at: http://www.cancer.gov/dictionary?cdrid ¼6611 65.,Non-OADS,/arxiv_data1/oa_pdf/bb/04/kfv122.PMC4549394.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/17/5f/jjm-08-06-16998.PMC4549488.pdf
The full  guideline is available at: http://www.moh.gov.sa/depts/ Proofs/Pages/Guidelines.aspx7 Methods.,Non-OADS,/arxiv_data1/oa_pdf/a3/3a/SaudiMedJ-36-1004.PMC4549580.pdf
Available from: http://www.moh.gov.sa/ depts/Proofs/Pages/Guidelines.aspx   8.,Non-OADS,/arxiv_data1/oa_pdf/a3/3a/SaudiMedJ-36-1004.PMC4549580.pdf
Available from: http://www.moh.gov.sa/endepts/Proofs/Pages/ GuidelineAdaptation.aspx   9.,Non-OADS,/arxiv_data1/oa_pdf/a3/3a/SaudiMedJ-36-1004.PMC4549580.pdf
Available from: http://apps.who.int/iris/bitstream/ 10665/75146/1/9789241548441_eng.pdf,Non-OADS,/arxiv_data1/oa_pdf/a3/3a/SaudiMedJ-36-1004.PMC4549580.pdf
Available from: http://www.moh.,Non-OADS,/arxiv_data1/oa_pdf/a3/3a/SaudiMedJ-36-1004.PMC4549580.pdf
Available from: http://data.unaids.org/Publications/fact- sheets01/yemen_en.pdf   5.,OADS,/arxiv_data1/oa_pdf/95/83/SaudiMedJ-36-1012.PMC4549582.pdf
Available from URL: http://june12post.com/national- population-commissions-population-figures-for-nigeria-states-for-2006-population-and-housing-census-real-or-imagined/12.,Non-OADS,/arxiv_data1/oa_pdf/ed/09/SaudiMedJ-36-928.PMC4549588.pdf
Available from: http://www.ms.ro/documente/14%20 diagnosticul%20si%20tratamentul%20hipoglicemiei%20 neonatale_9180_7493.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/SaudiMedJ-36-947.PMC4549591.pdf
Available from: http://www.ms.ro/ documente/13%20urmarirea%20nou%20nascutului%20 cu%20risc%20pentru%20sechele%20neurologice%20si%20 de%20dezvoltare_9180_7492.pdf  17.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/SaudiMedJ-36-947.PMC4549591.pdf
Available from: http://www.fda.gov/downloads/Radiation- EmittingProducts/RadiationEmittingProductsandProcedures/ MedicalImaging/MedicalX-Rays/ucm116505.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/7f/ae/SaudiMedJ-36-973.PMC4549595.pdf
[Updated 2014; 2015 March 15] Available from  URL: http://www.els.net [doi: 10.1002/9780470015902.,Non-OADS,/arxiv_data1/oa_pdf/77/38/SaudiMedJ-36-980.PMC4549596.pdf
Available from:  http://onlinedictionary.datasegment.com/word/incarcerated   3.,OADS,/arxiv_data1/oa_pdf/e7/dc/SaudiMedJ-36-983.PMC4549597.pdf
Available from: http://www.reuters.com/article/2012/10/16/ us-fda-advisory-bowel-idUSBRE89F1GJ20121016   5.,Non-OADS,/arxiv_data1/oa_pdf/e7/dc/SaudiMedJ-36-983.PMC4549597.pdf
Available from: http://www.orpha.,Non-OADS,/arxiv_data1/oa_pdf/e7/dc/SaudiMedJ-36-983.PMC4549597.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/e7/dc/SaudiMedJ-36-983.PMC4549597.pdf
Available from: http://www.childrenshospital.org/centers-and-services Case Reports Case reports will only be considered for unusual topics that add something new  to the literature.,Non-OADS,/arxiv_data1/oa_pdf/e7/dc/SaudiMedJ-36-983.PMC4549597.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/a3/44/srep13377.PMC4549630.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0c/TOORTHJ-9-372.PMC4549894.pdf
Available from: http://www.sigmaaldrich.com/materials‑science/polymer‑ science/resomer.html.,Non-OADS,/arxiv_data1/oa_pdf/12/b1/ABR-4-147.PMC4549919.pdf
Available from: http://www.chem.agilent.com/Library/applications.,OADS,/arxiv_data1/oa_pdf/12/b1/ABR-4-147.PMC4549919.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Effect of dietary calcium on BMD and fracture risk P Burckhardt 8 AUGUST 2015 |www.nature.com/bonekey",Non-OADS,/arxiv_data1/oa_pdf/c5/d2/bonekey201577.PMC4549924.pdf
The structural  model retrieved from Modeller is rendered as a cartoon using PyMol  [http://www.pymol.org]a b Figure 4:  Ramchandran plot analysis of kypoetin (a) and darbepoetin  alfa (b)a b Figure 5:  The three-dimensional structures of glycosylated kypoetin  (a) and darbepoetin alfa (b).,Non-OADS,/arxiv_data1/oa_pdf/97/93/ABR-4-142.PMC4549927.pdf
Available from:  http://www.trai.gov.in/annualreport/AnnualReport_09_10 English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/80/ABR-4-144.PMC4549928.pdf
Available from: http://www.medical-dictionary.,Non-OADS,/arxiv_data1/oa_pdf/53/f5/CCD-6-327.PMC4549982.pdf
In: Spanish Society of Diseases Infectious Clinical Microbiology Available from: http://www.seimc.org/documentos/protocolos/microbiologia/.,Non-OADS,/arxiv_data1/oa_pdf/df/63/CCD-6-405.PMC4549996.pdf
http://www.who.int/ healthinfo/statistics/mortality/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/6d/KITP-12-25471.PMC4550022.pdf
GUS http://demografia.stat.gov.pl/bazademografia/.,Non-OADS,/arxiv_data1/oa_pdf/e6/6d/KITP-12-25471.PMC4550022.pdf
As cited in: http://www.ncbi.nlm.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/02/a7/KITP-12-25484.PMC4550029.pdf
Pol Arch Med Wew  2008; 118: 248-254.12. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1924/ein- thoven-bio.html.,Non-OADS,/arxiv_data1/oa_pdf/02/a7/KITP-12-25484.PMC4550029.pdf
Available at: http://www.xarelto.com/en/infor - mation-on-xarelto/summary-of-product-characteristics/.,Non-OADS,/arxiv_data1/oa_pdf/96/b0/KITP-12-25468.PMC4550032.pdf
"For more information, see: http://ritchielab.psu.edu/ritchielab/software/.",Non-OADS,/arxiv_data1/oa_pdf/15/5f/gepi0039-0376.PMC4550090.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2187–2198OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2187Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7734 2epothilones in epithelial ovarian, fallopian tube, or  primary peritoneal cancer: a systematic review Flora Zagouri1 Theodoros n sergentanis2 Dimosthenis chrysikos2 Meletios- athanassios  Dimopoulos1 aristotle Bamias1 1Department of clinical Therapeutics,   alexandra hospital, 2First  Propaedeutic surgical Department,   hippokration hospital, University of  athens, athens, greeceAbstract:  Ovarian cancer is the most lethal gynecologic malignancy; consequently, there is  a need for effective therapies.",Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
"Epothilones are microtubule-stabilizing agents that inhibit cell growth.4,5 They  bind to the β-tubulin subunit of the αβ-tubulin dimer of microtubules and induce  microtubule polymerization and stabilization, resulting in G2/M arrest and the induc - tion of apoptosis.4,5 Epothilones are less susceptible than taxanes to overexpression  of P-glycoprotein, the presence of certain tubulin isoforms (class III β-tubulin), and correspondence: Flora Zagouri Department of clinical Therapeutics,  alexandra hospital, University of athens,  Vasilissis Sofias Avenue and Lourou  street, athens 11521, greece Tel +30 21 3216 2541 Fax +30 21 3216 2511 email florazagouri@yahoo.co.u k Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zagouri et al Running head recto: Epothilones and ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S77342",Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
Available  from: http://seer.cancer.gov/csr/1975_2009_pops0 9.,Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/d8/ott-8-2187.PMC4550178.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/lra-8-057.PMC4550180.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 57–70Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  57Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S6480 6Ophthalmic regional blocks: management,  challenges, and solutions Howard D Palte Department of Anesthesiology,   Perioperative Medicine and Pain  Management, Miller School of  Medicine, University of Miami, Miami,   FL, USA Correspondence: Howard D Palte   Bascom Palmer eye institute,   900 Nw 17th Street, 6th Floor,   Miami, FL 33136, USA   email hpalte@med.miami.ed uAbstract:  In the past decade ophthalmic anesthesia has witnessed a major transformation.",Non-OADS,/arxiv_data1/oa_pdf/7d/44/lra-8-057.PMC4550180.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/7d/44/lra-8-057.PMC4550180.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/lra-8-057.PMC4550180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/ae/ott-8-2199.PMC4550181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2199–2208OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2199Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8594 8Disruption of nF- κB signaling by fluoxetine  attenuates MgMT expression in glioma cells Tao song1 hui li2 Zhiliang Tian3 chaojiu Xu4 Jingfang liu1 Y ong guo1 1Department of n eurosurgery,   Xiangya hospital, central south  University, 2Department of  immunology and Microbiology,   Medical school of Jishou University,   3Department of n eurosurgery,   4Department of Oncology,   The hospital of Xiangxi  autonomous Prefecture, Jishou,   People’s republic of chinaBackground:  Resistance to temozolomide (TMZ) in glioma is modulated by the DNA repair  protein O6-methylguanine-DNA methyltransferase (MGMT).",Non-OADS,/arxiv_data1/oa_pdf/33/ae/ott-8-2199.PMC4550181.pdf
"Attenuation of MGMT expression or protein  function prior to alkylating agent chemotherapy prevents O6-methylguanine repair  and consequently sensitizes tumors to TMZ.2correspondence: Yong guo Department of neurosurgery, Xiangya  hospital, central south University,  87 Xiangya road, changsha 410008,  People’s republic of china Tel +86 731 8432 8878 email guoyongcsu@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Song et al Running head recto: Fluoxetine reduces MGMT expression DOI: http://dx.doi.org/10.2147/OTT.S85948",Non-OADS,/arxiv_data1/oa_pdf/33/ae/ott-8-2199.PMC4550181.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/33/ae/ott-8-2199.PMC4550181.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ae/ott-8-2199.PMC4550181.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 2159–2175Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2159Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6580 9Treatments for traumatic brain injury with  emphasis on transcranial near-infrared laser  phototherapy Larry D Morries1 Paolo Cassano2 Theodore A Henderson1,3 1Neuro-Laser Foundation, Lakewood,   CO, 2Harvard Medical School,   Depression Clinical and Research  Program, Massachusetts General  Hospital, Boston, MA, 3The Synaptic  Space, Centennial, CO, USAAbstract:  Traumatic brain injury (TBI) is a growing health concern affecting civilians and  military personnel.",Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
"The Centers for Disease  Control and Prevention estimated that 1.5 million Americans sustained TBI annually  in 2000.1 As of 2006, the estimates had risen to 1.7 million brain injuries annually.2,3  Undoubtedly, these point prevalence proportions will increase as military personnel  return home,4 and the problem of repeated mild TBI (mTBI) becomes more recognized  in sports.5 Current estimates of the prevalence of TBI among veterans range from 9.6%6  to 20%,7 with an estimated total of more than 300,000 cases of TBI among military  personnel since 2000.4 The current estimates of the combined number of sports-related  concussions and brain injuries in the US are 1.6–3.8 million annually.8–10Correspondence: Theodore A  Henderson The Synaptic Space, 3979 east Arapahoe  Road, Suite 200, Centennial, CO 80112,  USA Tel +1 720 493 1101 Fax +1 720 493 1107 email thesynapticspace7@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Morries et al Running head recto: Near-infrared laser phototherapy for brain injury DOI: http://dx.doi.org/10.2147/NDT.S65809 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
Or use: http://youtu.be/gO__MbMjYg 4video abstract,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
Available from: http://www.cdc.gov/TraumaticBrainInjury /.,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
"Avail - able from: http://dvbic.dcoe.mil/dod-worldwide-numbers-tb i. Accessed  January 25, 2015.",OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/2d/ndt-11-2159.PMC4550182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/6d/ott-8-2179.PMC4550183.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2179–2186OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2179Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8822 4The association between mir-499 polymorphism  and cancer susceptibility: a meta-analysis Zhongfei Xu enjiao Zhang Weiyi Duan changfu sun shuang Bai Xuexin Tan Department of Oral and Maxillofacial  surgery, school of stomatology, china  Medical University, shenyang, People’s  republic of chinaBackground:  MicroRNAs are a class of new noncoding RNA that play important roles in  the pathogenesis of tumor.",Non-OADS,/arxiv_data1/oa_pdf/d8/6d/ott-8-2179.PMC4550183.pdf
"So SNPs in miRNA sequence may affect the correspondence: Zhongfei Xu Department of Oral and Maxillofacial  surgery, school of stomatology, china  Medical University, no 117, nanjing  north street, heping District, shenyang  110002, People’s republic of china Tel +86 24 2289 1026 Fax +86 24 8660 2310 email xzf7090@outlook.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: miR-499 rs3746444 polymorphism and cancer susceptibility DOI: http://dx.doi.org/10.2147/OTT.S88224",Non-OADS,/arxiv_data1/oa_pdf/d8/6d/ott-8-2179.PMC4550183.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d8/6d/ott-8-2179.PMC4550183.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/6d/ott-8-2179.PMC4550183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/ott-8-2169.PMC4550184.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2169–2178OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8597 1Morphologic patterns and imaging features of  intracranial hemangiopericytomas: a retrospective  analysis haopeng Pang1 Zhenwei Yao1 Yan ren1 guobing liu2 Jiawen Zhang1 Xiaoyuan Feng1 1Department of radiology, affiliated  huashan hospital of Fudan University,   People’s republic of china;   2Department of n uclear Medicine,   Zhongshan hospital, Fudan University,   shanghai, People’s republic of chinaObjectives:  Hemangiopericytomas (HPCs) are rare intracranial tumors.",Non-OADS,/arxiv_data1/oa_pdf/a9/2e/ott-8-2169.PMC4550184.pdf
"The exact cellular composition of HPC tumors has remained largely unclear, although  some researchers suggest that HPCs are mainly composed of pluripotent perivascular  cells called Zimmermann pericytes, which are modified smooth muscle contractile  cells surrounding the capillaries.6 The immunohistochemical profiles of HPCs show  marked morphological variability, and they exhibit features overlapping with other correspondence: Xiaoyuan Feng Department of radiology, huashan  hospital, Fudan University, Mid wu lu  mu qi road, shanghai 200040, People’s  republic of china Tel +86 139 0197 0690 Fax +86 21 5288 8357 email xy feng@shmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Pang et al Running head recto: Morphologic patterns and imaging features of intracranial HPCs DOI: http://dx.doi.org/10.2147/OTT.S85971",Non-OADS,/arxiv_data1/oa_pdf/a9/2e/ott-8-2169.PMC4550184.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a9/2e/ott-8-2169.PMC4550184.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/ott-8-2169.PMC4550184.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/be/gfv096.PMC4550440.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford journals.org .,OADS,/arxiv_data1/oa_pdf/26/be/gfv096.PMC4550440.pdf
"3[1], http://www.kidney-international.org (17 December 2014, date last accessed) 5.",Non-OADS,/arxiv_data1/oa_pdf/26/be/gfv096.PMC4550440.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/66/gav044.PMC4550542.pdf
Tests for evaluating lower urinary tract infection such as pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 103-108 http://dx.doi.org/10.5534/wjmh.2015.33.2.103,Non-OADS,/arxiv_data1/oa_pdf/48/b7/wjmh-33-103.PMC4550592.pdf
pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 109-116 http://dx.doi.org/10.5534/wjmh.2015.33.2.109,Non-OADS,/arxiv_data1/oa_pdf/f5/73/wjmh-33-109.PMC4550593.pdf
"Scrotal US showed a mixed echoic mass mixed with a small, spindle-shaped echo-genic reflector and a filiform anechoic area within the pa-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 117-120 http://dx.doi.org/10.5534/wjmh.2015.33.2.117",Non-OADS,/arxiv_data1/oa_pdf/33/75/wjmh-33-117.PMC4550594.pdf
CONFLICT OF INTEREST 　No potential conflict of interest relevant to this article  was reported.pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 April 33(2): 121 http://dx.doi.org/10.5534/wjmh.2015.33.2.121,Non-OADS,/arxiv_data1/oa_pdf/85/b4/wjmh-33-121.PMC4550595.pdf
Males have been found to have higher mortality rates than females pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 45-49 http://dx.doi.org/10.5534/wjmh.2015.33.2.45,Non-OADS,/arxiv_data1/oa_pdf/72/8f/wjmh-33-45.PMC4550596.pdf
In addition to some patients’ complaints of poor glans tumescence pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 50-61 http://dx.doi.org/10.5534/wjmh.2015.33.2.50,Non-OADS,/arxiv_data1/oa_pdf/07/28/wjmh-33-50.PMC4550597.pdf
They believe that treatments drawn pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 62-72 http://dx.doi.org/10.5534/wjmh.2015.33.2.62,Non-OADS,/arxiv_data1/oa_pdf/7d/c0/wjmh-33-62.PMC4550598.pdf
Several studies have reported that serum pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 73-80 http://dx.doi.org/10.5534/wjmh.2015.33.2.73,Non-OADS,/arxiv_data1/oa_pdf/fb/39/wjmh-33-73.PMC4550599.pdf
"Many urologists  and physicians believe that LUTS can also be affected by seasonal variation and, in particular, get worse in cold pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 81-87 http://dx.doi.org/10.5534/wjmh.2015.33.2.81",Non-OADS,/arxiv_data1/oa_pdf/3b/e8/wjmh-33-81.PMC4550600.pdf
"The postoperative outcomes of HoLEP, such as urinary stream and patient satisfaction, are comparable to those of transurethral resection of the prostate, which has been a pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 88-94 http://dx.doi.org/10.5534/wjmh.2015.33.2.88",Non-OADS,/arxiv_data1/oa_pdf/23/7e/wjmh-33-88.PMC4550601.pdf
"The patient may recall hearing a cracking (pop-up) sound, followed by rapid detu-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 August 33(2): 95-102 http://dx.doi.org/10.5534/wjmh.2015.33.2.95",Non-OADS,/arxiv_data1/oa_pdf/50/65/wjmh-33-95.PMC4550602.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Table 4 Judged response to ﬂuid challengeResponse classiﬁcation [no.",Non-OADS,/arxiv_data1/oa_pdf/f7/a5/134_2015_Article_3850.PMC4550653.pdf
"Editor: H. F. Rosenberg Address correspondence to Per Venge, per.venge@medsci.uu.se.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /CVI.00347-15 .",Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1016/S0167-4838(00)00163-1 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Clin J Am Soc Nephrol 5:2229 – 2235. http://dx.doi.org/10.2215/CJN.00980110 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Gut 38:414 – 420. http://dx.doi.org/10.1136/gut.38.3.414 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi .org/10.1016/j.cca.2012.05.010 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1016/0022-1759(94)90044-2 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.3109 /00365519509089604 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Acta Paediatr 94:661– 666. http://dx.doi.org/10 .1080/08035250510031610 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10 .1007/s00216-008-2561-3 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Am J Emerg Med 30:1639 – 1649. http://dx.doi.org/10.1016/j.ajem.2012.03.004 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1080/00365540601113693 .15.,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1016/S1473 -3099(13)70318-9 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1056 /NEJMp1408040 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
BMCFam Pract 15:80. http://dx.doi.org/10.1186/1471-2296-15-80 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
J Am Board Fam Med 27:424 – 426. http://dx.doi.org/10.3122/jabfm.2014.03.130315 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Ann Intensive Care 3:22. http://dx.doi.org/10.1186/2110-5820-3-22 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1016/j.medmal.2014 .01.002 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Diagn Microbiol Infect Dis 59:131– 136. http://dx.doi.org/10.1016/j.diagmicrobio.2007.04.019 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
PediatrInfect Dis J 19:598 – 602. http://dx.doi.org/10.1097/00006454-200007000 -00003 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1093/rheumatology/38.12.1249 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.1016/j.jcrc.2014.08.017 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Crit Care 18:427. http://dx.doi.org/10.1186/cc13856 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10.3343/alm.2014.34.4.263 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Lancet Infect Dis 14:189. http://dx.doi.org/10.1016 /S1473-3099(13)70325-6 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Am J Respir Crit Care Med 190:1102– 1110. http://dx.doi.org/10.1164/rccm.201408-1483OC .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Pediatr Infect Dis J 18:666 – 671. http://dx.doi.org/10 .1097/00006454-199908000-00003 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Pediatr Res 45: 871– 876. http://dx.doi.org/10.1203/00006450-199906000-00016 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Scand J Infect Dis37:882– 889. http://dx.doi.org/10.1080/00365540500348929 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org/10 .1136/ard.61.6.522 .,Non-OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
J Immunol Methods 414:65– 68. http://dx.doi.org /10.1016/j.jim.2014.07.011 .,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
Pediatr Res 56:796 – 803. http://dx.doi.org/10 .1203/01.PDR.0000142586.47798.5E .Venge et al.,OADS,/arxiv_data1/oa_pdf/38/f0/zcd1025.PMC4550662.pdf
http://dx.doi.org /10.1016/S2214-109X(14)70361-4 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1016/S2213-2600(14)70033-5 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Clin Vaccine Immunol 20:663– 672. http://dx.doi.org/10.1128 /CVI.00690-12 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1016/S1473-3099(14)70845-X .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi .org/10.4049/jimmunol.1400676 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.4161/hv.29108 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1128/IAI.72.1.238-246.2004 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org /10.1128/IAI.72.2.1065-1071.2004 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Int J Immunopharmacol 16:435– 444. http://dx.doi.org/10.1016/0192 -0561(94)90033-7 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Proc Natl Acad Sc iUSA 105:4656 – 4660. http://dx.doi.org/10 .1073/pnas.0800043105 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1038/44385 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1038/nm.1935 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1371/journal.pone.0021566 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Tuberculosis (Edinb) 90:329 – 332. http://dx.doi.org/10.1016/j.tube.2010.06.002 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1128/IAI.69.4.2666-2674.2001 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1371/journal .ppat.1000392 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1038/nri2274 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1002/eji.201040455 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Nat Med 13:843– 850. http://dx.doi.org/10 .1038/nm1592 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
J Immunol 182:8047– 8055. http://dx.doi.org/10 .4049/jimmunol.0801592 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1371/journal.pone.0005930 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10 .1164/rccm.201003-0334OC .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1002/eji.201141569 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1371/journal .pone.0088149 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1128/IAI.71.10.5831-5844.2003 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1128/CVI.00079-10 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Cytometry A 79:167– 174. http://dx.doi.org/10.1002/cyto.a.21015 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
J Immunol 168:29 – 43. http://dx.doi.org/10 .4049/jimmunol.168.1.29 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
J Clin Invest 116:1514 – 1524. http://dx.doi.org/10.1172/JCI27564 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
J Immu-nol168:4620 – 4627. http://dx.doi.org/10.4049/jimmunol.168.9.4620 .,OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
J Clin Invest 113:401– 413. http://dx.doi .org/10.1172/JCI18991 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1172 /JCI38482 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Infect Immun 70:4501– 4509. http://dx.doi.org/10.1128/IAI.70.8.4501-4509.2002 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Annu Rev Immunol 27:393– 422. http://dx.doi.org/10.1146/annurev .immunol.021908.132703 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1084 /jem.20071367 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Clin Dev Immunol 2012: 628293. http://dx.doi.org/10.1155/2012/628293 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1038/nature06672 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1002/eji.201343751 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
Clin Vaccine Immunol 17:618 – 625. http://dx.doi.org/10.1128/CVI.00368-09 .,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1165/rcmb.2010 -0241OC .Immunogenicity of Aerosol-Delivered BCG to Macaques September 2015 Volume 22 Number 9 cvi.asm.org 1003 Clinical and Vaccine Immunology,Non-OADS,/arxiv_data1/oa_pdf/66/46/zcd992.PMC4550663.pdf
http://dx.doi.org/10.1038/nm.3409 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Vet Res Commun 26:587– 600. http://dx.doi.org/10 .1023/A:1020960402112 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Epidemiol Infect 112:421– 437. http://dx.doi.org/10.1017/S09502 68800057848 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1517/17425247.2.3.489 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Adv Drug Deliv Rev 65:36 – 48. http://dx.doi .org/10.1016/j.addr.2012.09.037 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10 .1016/j.vaccine.2010.01.046 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1371/journal.pon e.0035083 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org /10.1016/j.vaccine.2012.02.027 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org /10.1128/JVI.01247-13 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1038/npp.2011.200 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.2174/187152711799219334 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Hum Gene Ther 23:451– 459. http://dx.doi.org /10.1089/hum.2011.178 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.Hum Gene Ther Clin Dev 25:40 – 49. http://dx.doi.org/10.1089/humc .2013.231 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Nat Biotechnol 30:883– 888. http://dx.doi.org/10.1038/nbt.2344 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10 .1016/j.vaccine.2014.07.010 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1371/journal.pone.0080559 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Immunology 129: 75– 86. http://dx.doi.org/10.1111/j.1365 -2567.2009.03164.x .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
J Exp Med 205:869 – 882. http://dx.doi.org/10.1084 /jem.20071087 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
Immunity 19:71– 82. http://dx.doi.org/10.1016/S1074-7613(03)00174-2 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.4103 /2231-4040.85541 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1002/app.25930 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10 .1126/science.1138963 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
J Immunol 192: 4221– 4232. http://dx.doi.org/10.4049/jimmunol.1302569 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi.org/10.1007/978-1-60327-360-2_2 .,Non-OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
http://dx.doi .org/10.1016/j.jconrel.2009.08.023 .,OADS,/arxiv_data1/oa_pdf/3f/2f/zcd1004.PMC4550664.pdf
"16compared lipogenic enzyme rates of various fat depots (omental, perirenal, subcutaneous, and intermuscular) to ﬁnd © Anil K G Kadegowda, Asher Wright, and Susan K Duckett *Correspondence to: Susan K Duckett; Email: sducket@clemson.eduSubmitted: 06/09/2014; Revised: 07/18/2014; Accepted: 07/22/2014 http://dx.doi.org/10.4161/adip.32112 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2010; 88:1999-2008; PMID:20154153; http://dx.doi.org/ 10.2527/jas.2009-2439 3.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
Lipids 2012; 47:1143-53; PMID:23077002; http://dx.doi.org/10.1007/s11745-012-3723-9 5.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2009; 87:1218-46; PMID:18849378; http://dx.doi.org/10.2527/jas.2008-1427 6.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
Meat Sci 2004; 66:567-77; PMID:22060866; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2008; 86:1678-89; PMID:18375659; http://dx.doi.org/10.2527/jas.2007-0756 8.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2009; 87:2961-70;PMID:19502506; http://dx.doi.org/10.2527/jas.2009- 1850 9.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2013; 91:1454-67;PMID:23345568; http://dx.doi.org/10.2527/jas.2012- 5914 312 Volume 3 Issue 4 Adipocyte,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2009; 87:1120-8; PMID:19028850; http://dx.doi.org/ 10.2527/jas.2008-1420 12.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
Livest Prod Sci 1986; 14:349-64;http://dx.doi.org/10.1016/0301-6226(86)90014-X 16.,OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2008; 86:2115-25;PMID:18310487; http://dx.doi.org/10.2527/jas.2007- 0750 18.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Biol Chem 1996;271:29847-53; PMID:8939924; http://dx.doi.org/ 10.1074/jbc.271.47.29847 20.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Anim Sci 2013; 91:1614-23;PMID:23408826; http://dx.doi.org/10.2527/jas.2012- 5590 22.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
Lipids 2013;48:967-76; PMID:23929455; http://dx.doi.org/ 10.1007/s11745-013-3823-1 23.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
Domest Anim Endocrinol 2007; 32:1- 14; PMID:16431073; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
J Food Sci 1994; 59:1262-6; http://dx.doi.org/ 10.1111/j.1365-2621.1994.tb14691.x 27.,Non-OADS,/arxiv_data1/oa_pdf/71/28/kadi-03-04-964532.PMC4550688.pdf
"A Ztransformation, followed by a Ztest, was performed on all of the positively identiﬁed proteins (/H1102298% conﬁdence) with two sample sets at a time (i.e., WT bioﬁlm versus /H9004agrbioﬁlm or WT bioﬁlm versus WT planktonic) to assess signiﬁcant differences in relative protein abundance as previously described (48).Identiﬁed proteins were functionally grouped by UniProt identiﬁer uti-lizing David bioinformatic resource 6.7 ( http://david.abcc.ncifcrf.gov/ ) FIG 8 Proposed model of S. aureus bioﬁlm-induced macrophage dysfunc- tion.",OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
"Protein-protein interactions were predicted by using STRING 9.05 (http://string-db.org ) (88, 89).",OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/ j.mib.2011.10.012 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1111/j.1462-5822.2011.01720.x .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Curr Opin Microbiol 14:668 – 675. http://dx.doi.org/10.1016/ j.mib.2011.09.007 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
J Immunol 186: 6585– 6596. http://dx.doi.org/ 10.4049/jimmunol.1002794 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Proc Natl Acad Sc iUSA 104: 8113– 8118. http://dx.doi.org/10.1073/ pnas.0610226104 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/ j.biomaterials.2006.11.046 .Scherr et al.,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1111/j.1469-0691.2005.01274.x .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1007/978-3-540-75418-3_10 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/j.jaci.2007.06.005 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1038/nrmicro2539 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1086/374747 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/j.micinf.2004.08.016 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1038/ nri3244 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.01841-06 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
J Immunol 171: 4329 – 4339. http://dx.doi.org/ 10.4049/jimmunol.171.8.4329 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1086/ 528992 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/j.cimid.2005.11.002 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1371/journal.pone.0042476 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Arch Immunol Ther Exp(Warsz) 61:413– 420. http://dx.doi.org/10.1007/s00005-013-0240-3 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.01142-10 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
FEMS Mi-crobiol Lett 330: 56 – 65. http://dx.doi.org/10.1111/j.1574 -6968.2012.02533.x .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1099/jmm.0.031922-0 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1111/j.1462-5822.2006.00858.x .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/ journal.pone.0003198 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.4049/jimmunol.175.6.3907 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Virulence 2:445– 459. http://dx.doi.org/10.4161/ viru.2.5.17724 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/ journal.pone.0005822 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1074/jbc.M113.502039 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/j.mib.2011.12.010 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1007/ BF00414719 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1016/j.femsre.2003.09.003 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000052 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.00046-11 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/ IAI.68.3.1304-1311.2000 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.2217/fmb.12.107 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/ journal.pone.0062513 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1021/pr4012602 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/journal.pone.0011634 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Mol Microbiol 79:814 – 825. http://dx.doi.org/10.1111/j.1365 -2958.2010.07490.x .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.00095-13 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Mol Gen Genet 202: 58 – 61. http://dx.doi.org/10.1007/ BF00330517 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/journal.pone.0054661 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.01444-13 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1371/journal.pone.0012580 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.4049/jimmunol.1303408 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
J Immunol 194: 3861–3872 http://dx.doi.org/10.4049/ jimmunol.1402689 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1002/jor.21414 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Infect Immun 70:6339 – 6345. http://dx.doi.org/10.1128/IAI.70.11.6339 -6345.2002 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1073/ pnas.1305121110 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1093/infdis/jis495 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
J Innate Immun 7:187–198 http://dx.doi.org/10.1159/000368048 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/ IAI.01313-06 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1086/656043 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1093/infdis/ jis192 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.00442-12 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1073/pnas.1001815107 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1038/nm.2451 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/JB.01161-10 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1038/nrmicro1838 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
J Clin Microbiol 48: 4504 – 4511. http://dx.doi.org/10.1128/JCM.01050-10 .,OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1128/IAI.01655 -13.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
mBio 4:e00537- 00512. http://dx.doi.org/10.1128/mBio.00537-12 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1007/978-1-59745-468-1_10 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.3257-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1093/nar/ gkn923 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1093/nar/ 28.18.3442 .,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
http://dx.doi.org/10.1093/ nar/gks1094 .Bioﬁlm-Mediated Macrophage Dysfunction July/August 2015 Volume 6 Issue 4 e01021-15®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/mBio.01021-15.PMC4550693.pdf
Nucleic Acids Res 34:635– 646. http://dx.doi.org/10.1093/ nar/gkj469 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
Nat Rev Microbiol 8:857– 866. http://dx.doi.org/10.1038/nrmicro2457 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
Cell38:871– 878. http://dx.doi.org/10.1016/0092-8674(84)90282-4 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1146/annurev-micro-090110-102946 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
Noncoding RNAs binding to the nucleoid protein HU in Escherichia coli.J Bacteriol 194:6046 – 6055. http://dx.doi.org/10.1128/JB.00961-12 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1016/0923-2508(91)90033-7 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1093/nar/19.7.1375 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.1997.6121983.x .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1006/jmbi.2001.5150 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1093/nar/18.13.3941 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1371/journal.pone.0072954 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
RNA molecules bound to the folded bacte- rial genome stabilize DNA folds and segregate domains of supercoiling.Cold Spring Harb Symp Quant Biol 38:31– 41. http://dx.doi.org/10.1101/ SQB.1974.038.01.006 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1126/ science.1067799 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1016/j.molcel.2011.09.010 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1074/jbc.M201978200 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1074/jbc.M108456200 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.04796.x .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1111/j.1365-2958.2008.06239.x .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1126/science.1204697 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1074/ jbc.270.17.10291 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1093/emboj/18.19.5434 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1006/jmbi.1997.1310 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/ 10.1093/emboj/16.12.3666 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/10.1021/bi1007589 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
Gene 315: 63– 69. http://dx.doi.org/ 10.1016/S0378-1119(03)00728-5 .,OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
RNA polymerase idling and clearance in gal promoters: use of supercoiled minicircle DNA template made in vivo.Proc Natl Acad Sc iUSA 90:472– 476. http://dx.doi.org/10.1073/ pnas.90.2.472 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
http://dx.doi.org/ 10.1099/mic.0.025536-0 .,Non-OADS,/arxiv_data1/oa_pdf/87/05/mBio.00998-15.PMC4550694.pdf
"Using tools from the Protein Data Bank in Europe( http://www.ebi.ac.uk/pdbe/ ), we investigated in detail the struc- ture of P. aeruginosa AmiC bound to its known ligand acetamide.",Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
"The amiC gene is encoded in an operon including the amiL ,amiE ,amiB ,amiC , amiR , and amiS genes (36) ( http://www.pseudomonas.com ).",Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
"The issue of how CNP contacts AmiC in P. aeruginosa needs to be addressed, as AmiC is predicted to be located in the bacterialcytoplasm ( http://www.pseudomonas.com ).",Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
GASH structural superposition software (32) was usedon the web server ( http://sysimm.ifrec.osaka-u.ac.jp/gash/ ).,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1002/ppul.21011 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2009.12.011 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/ j.jcf.2011.11.004 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1126/science.1121357 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1128/ IAI.70.6.3085-3093.2002 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
Mol Microbiol 43:809 – 821. http://dx.doi.org/10.1046/j.1365 -2958.2002.02803.x .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1038/nrmicro1836 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1007/s00253-009-2045-1 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.1126/science.1112422 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1371/ journal.ppat.0030035 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.3390/ijms140612186 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1099/mic.0.046755-0 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1111/j.1742-4658.2007.06109.x .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1210/edrv -15-2-135 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1378/chest.11-0824 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1152/japplphysiol.90442.2008 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1210/endo.133.6.8243333 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1152/ japplphysiol.01249.2011 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
Trends Biochem Sci 20:478 – 480. http://dx.doi.org/10.1016/ S0968-0004(00)89105-7 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1006/ jmbi.2001.4922 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.1038/35017602 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1126/science.1062246 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1002/ prot.340140216 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
BMC Bioinformatics 6:221. http://dx.doi.org/10.1186/ 1471-2105-6-221 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/j.jmb.2006.06.060 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1002/(SICI)1096 -987X(19981115)19:14 /H110211639::AID-JCC10 /H110223.0.CO;2-B .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1093/nar/ gks1039 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1264/jsme2.ME13151 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1093/emboj/18.19.5175 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.1016/S0016-5085(98)70083-6 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1074/ jbc.M412494200 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
FEBS Lett 445:57– 62. http://dx.doi.org/10.1016/ S0014-5793(99)00081-2 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1046/j.1365-2958.2002.03207.x .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.4049/ jimmunol.179.5.2979 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.2174/0929866511009011383 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1074/ jbc.M600680200 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/ j.brainres.2005.02.051 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1074/jbc.M708596200 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1039/b006484j .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
BMC Microbiol 7:42.http://dx.doi.org/10.1186/ 1471-2180-7-42 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1002/rcm.2954 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/0197-0186(90)90154-L .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/ j.pupt.2012.11.001 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1073/ pnas.0511100103 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1128/JB.01633-09 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.1016/0263 -7855(96)00018-5 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/10.2174/ 1874285800903010128 .,Non-OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
Methods 25:402– 408. http://dx.doi.org/10.1006/meth.2001.1262 .,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
http://dx.doi.org/ 10.1016/j.pep.2005.01.016 .Rosay et al.,OADS,/arxiv_data1/oa_pdf/54/88/mBio.01033-15.PMC4550695.pdf
monkey ( http://www.datamonkey.org ).,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
"For phopivirus, codon usage frequencies were determined using the Cusp program (Europeanmolecular biology open software suite, http://emboss.sourceforge.net/ apps/cvs/emboss/apps/cusp.html ).",OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
The secondary structure for HAV was obtained from Rfam( http://rfam.sanger.ac.uk/family/RF00228#tabview /H11005tab3 ).,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1038/nature06536(2008) .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1101/ cshperspect.a006841 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
Virol J 7:52.http://dx.doi.org/10.1186/1743-422x-7-52 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1128/mBio.00166-12 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1007/s00705 -013-1749-9 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1007/s00705-013 -1749-9 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1056/NEJMoa1404505 .,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1056/NEJMoa1411100 .,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.2217/fmb.12.5 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1128/JVI.01957-07 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1046/j.1365 -2893.2001.00295.x .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/ 10.1016/j.virusres.2007.01.005 .,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1099/0022-1317-72-7-1677 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1002/ jmv.1890100105 .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1093/infdis/163.2.286 .,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1007/s10329-009-0172-z .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1093/molbev/mst197(2013) .,Non-OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
http://dx.doi.org/10.1093/molbev/ msn067 .Anthony et al.,OADS,/arxiv_data1/oa_pdf/8d/83/mBio.01180-15.PMC4550696.pdf
Homologues of HMW1C were identiﬁed by using the NCBI BLAST program ( http://blast.ncbi.nlm.nih.gov/ Blast.cgi ) with the nontypeable Haemophilus inﬂuenzae HMW1C protein (GenBank no.,OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
Identity and similarity were determined usingthe EMBOSS Needle program ( http://www.ebi.ac.uk/Tools/psa/emboss- _needle/ ).,OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1038/ nrmicro1100 .,OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2012.07973.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2003.03450.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1021/bi00250a003 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1111/mmi.12265 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
J Bacteriol 189: 8088 – 8098. http://dx.doi.org/10.1128/JB.01318-07 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1046/j.1365 -2958.1999.01415.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1371/journal.ppat.1000919 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1074/jbc.M801819200 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
Mol Microbiol 27:617– 630. http://dx.doi.org/10.1046/j.1365-2958.1998.00711.x .,OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1128/IAI.74.4.2245-2258.2006 .,OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
J Bacteriol189:430 – 436. http://dx.doi.org/10.1128/JB.01319-06 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/ 10.1128/mBio.00372-12 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1002/path.1700500312 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1128/ JB.188.5.1798-1807.2006 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2001.02487.x .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
http://dx.doi.org/10.1074/ jbc.M114.579326 .,Non-OADS,/arxiv_data1/oa_pdf/1c/16/mBio.01206-15.PMC4550697.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006722).,Non-OADS,/arxiv_data1/oa_pdf/bc/e2/bmjopen-2014-006722.PMC4550704.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/6c/bmjopen-2015-008641.PMC4550706.pdf
Swann S. Active birth yoga https://www.yogababy.com.au/links/ articles/active-birth-yoga/ 47.,Non-OADS,/arxiv_data1/oa_pdf/5f/6c/bmjopen-2015-008641.PMC4550706.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008286).,Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
"London: Department of Health, 2008. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/ publicationsandstatistics/publications/publicationspolicyandguidance/DH_085825 7.",Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
27 September 2011. http://www.yorkshirepost.co.uk/ news/nhs-walk-in-centre-to-close-and-hours-to-be-cut-at-another-1-3811300 10.,Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
"BBC News .2 8 June, 2012. http://www.bbc.co.uk/news/uk-politics-18503034 11.",Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
"London: King ’s Fund, 2009. http://www.kingsfund.org.uk/sites/files/kf/General- practice-in-England-an-overview-Sarah-Gregory-The-Kings-Fund-September-2009.pdf 12.",Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
"Pharmafield Blog .3 June, 2013. http://www.pharmafield.co.uk/be/post/2013/06/03/ NHS-walk-in-centres-are-dying-out.aspx 13.",Non-OADS,/arxiv_data1/oa_pdf/51/70/bmjopen-2015-008286.PMC4550707.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007903).,Non-OADS,/arxiv_data1/oa_pdf/da/d9/bmjopen-2015-007903.PMC4550708.pdf
doi:10.1136/bmjopen-2015- 008030 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008030).,Non-OADS,/arxiv_data1/oa_pdf/8c/68/bmjopen-2015-008030.PMC4550710.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/68/bmjopen-2015-008030.PMC4550710.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008765).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
"Baltimore, MD, 2014. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and- Reports/NationalHealthExpendData/downloads/highlights.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
"Cambridge, MA, 2008. http://www.nehi.net/writable/ publication_files/file/waste_clinical_care_report_final.pdf 4.",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
"Washington DC, 2013. http://www.iom.edu/Reports/2012/Best-Care-at-Lower-Cost-The-Path-to-Continuously-Learning-Health-Care-in-America.aspx (accessed 14 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
2013. https://www.aseonline.org/ArticleDetailsPage/tabid/7442/ArticleID/586/Why-Does-Health-Care-Cost-so-Much-Hospitals-Don ’t-Know-What-Their-Costs-Are.aspx 10.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
http://www.bloomberg.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-008765.PMC4550711.pdf
"All testing sessions will be performed at the same time of the day.Table 1 Trial registration data Data category Information Primary registry and trial identifying numberhttps://www.anzctr.org.au ACTRN12613000642785 Date of registration in primary registry7th June, 2013 Secondary identifying numbers None Source of monetary or materialsupportUniversity of South Australia Primary sponsor University of South Australia Contact person: JDB (jon.buckley@unisa.edu.au) Secondary sponsor NoneContact for public queries JTF (joel.fuller@mymail.unisa.edu.au)Contact for scientific queries JTF (joel.fuller@mymail.unisa.edu.au)Public title The effect of footwear on running performance and injury riskScientific title In distance runners, do lightweight running shoes, compared to standard running shoes, improve running performance and reduce risk of injury?",Non-OADS,/arxiv_data1/oa_pdf/6d/04/bmjopen-2015-008307.PMC4550712.pdf
"Canberra: Australian Government, 2010.Viewed 12th June 2015. http://www.ausport.gov.au/__data/assets/pdf_file/0018/436122/ERASS_Report_2010.PDF 17.",Non-OADS,/arxiv_data1/oa_pdf/6d/04/bmjopen-2015-008307.PMC4550712.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007941).,Non-OADS,/arxiv_data1/oa_pdf/f8/f3/bmjopen-2015-007941.PMC4550713.pdf
http://repair.lshtm.ac.uk; http://www.isrctn.com/ ISRCTN30083294 31.,Non-OADS,/arxiv_data1/oa_pdf/f8/f3/bmjopen-2015-007941.PMC4550713.pdf
https://clinicaltrials.gov/ct2/show/study/NCT01515072 32.,Non-OADS,/arxiv_data1/oa_pdf/f8/f3/bmjopen-2015-007941.PMC4550713.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008374).,Non-OADS,/arxiv_data1/oa_pdf/3b/e2/bmjopen-2015-008374.PMC4550714.pdf
Secondary regional variation ofhealth expenditure in Japan (in Japanese) 2012. http://www.mhlw.,Non-OADS,/arxiv_data1/oa_pdf/3b/e2/bmjopen-2015-008374.PMC4550714.pdf
"http://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken03/01.html Tsugawa Y, et al.BMJ Open 2015; 5:e008374.",Non-OADS,/arxiv_data1/oa_pdf/3b/e2/bmjopen-2015-008374.PMC4550714.pdf
http://www.e-stat.go.jp/SG1/estat/eStatTopPortalE.do 18.,Non-OADS,/arxiv_data1/oa_pdf/3b/e2/bmjopen-2015-008374.PMC4550714.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007461).,Non-OADS,/arxiv_data1/oa_pdf/4a/db/bmjopen-2014-007461.PMC4550716.pdf
Funding This project was conducted in the context of the pretest studies of the German National Cohort (http://www.nationale-kohorte.de).,Non-OADS,/arxiv_data1/oa_pdf/4a/db/bmjopen-2014-007461.PMC4550716.pdf
3. http://www.nationale-kohorte.de/index_en.html (accessed 20 Nov 2013).4.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/bmjopen-2014-007461.PMC4550716.pdf
"Munich: Federal Statistical Offices, 2011. https://ergebnisse.zensus2011.de/#dynTable (accessed 20Mar 15).",Non-OADS,/arxiv_data1/oa_pdf/4a/db/bmjopen-2014-007461.PMC4550716.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007525).,Non-OADS,/arxiv_data1/oa_pdf/38/e3/bmjopen-2014-007525.PMC4550718.pdf
"London: Department of Health, 2003. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance 16.",Non-OADS,/arxiv_data1/oa_pdf/38/e3/bmjopen-2014-007525.PMC4550718.pdf
"London:The Royal College of Psychiatrists, 2015 http://www.rcpsych.ac.uk/pdf/Substance%20misuse%20in%20Older%20People_an%20information%20guide.pdf 41.",Non-OADS,/arxiv_data1/oa_pdf/38/e3/bmjopen-2014-007525.PMC4550718.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008269).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2013. http://www.nao.org.uk/report/emergency-admissions-hospitals-managing-demand/ (accessed 17Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2013. http://www.aihw.gov.au/publication- detail/?id=60129543133 (accessed 15 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2009. http://www.health.govt.nz/system/files/documents/publications/quality-ed-jan09.pdf (accessed 10 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2010. http://www.datadictionary.,OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2010. http://www.nuffieldtrust.org.uk/media-centre/press-releases/unsustainable-rise-emergency-admissions-avoidable-and-no-longer-affordab 11.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2013. http://www.england.nhs.uk/wp-content/uploads/2013/05/ae-imp-plan.pdf (accessed 20 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
Washington DC; 2006. http://www.law.uh.edu/faculty/jmantel/health-regulatory-process/IOM-RewardingProviderPerformance.pdf (accessed 22 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2013. http://www.qualitywatch.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
The Cochrane Collaboration; 2011. http://handbook.cochrane.org/chapter_22/22_overviews_of_reviews.htm (accessed 27 Feb 2015).,OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
http://www.euro.who.int/__data/assets/pdf_file/0003/90426/E91922.pdf (accessed 20Feb 2015).,OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
"Washington, 1978. http://ota.fas.org/ reports/7805.pdf (accessed 1 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
2012. http://www.gradeworkinggroup.org/publications/JCE_series.htm 35.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/bmjopen-2015-008269.PMC4550719.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008632).,Non-OADS,/arxiv_data1/oa_pdf/ba/33/bmjopen-2015-008632.PMC4550721.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007540).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Tallahassee: Medical Informatics, College of Medicine, Florida State University, 2014.http://fsu.edu (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Oxford: Centre of Evidence-Based Medicine (CEBM), University of Oxford, 2009. http://www.cebm.net(access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"York: Centre for Reviews and Dissemination (CRD), University of York, 2009. http://www.york.ac.uk (access date 20 May2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Edinburgh: ScottishIntercollegiate Guidelines Network (SIGN), 2011. http://www.sign.ac.uk (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Oxford: Centre of Evidence-Based Medicine (CEBM), University of Oxford, 2014. http://www.cebm.net (accessdate 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"London: National Institute for Health and Care Excellence (NICE), 2013.http://www.nice.org.uk (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Chichester: The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org (access date 20 May 2015).",OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
http://community.cochrane.org (access date 20 May 2015).,OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
Leiden: European Society for Blood and Marrow Transplantation (EBMT).http://www.ebmt.org (access date 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Rockville: Agency for Healthcare Research and Quality (AHRQ), 2009. http://archive.ahrq.gov (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Stepney: Australian Safety and Efficacy Register of NewInterventional Procedures —Surgical (ASERNIP-S), Royal Australasian College of Surgeons (RACS), 2009. http://www.surgeons.org (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH), 2003. https://www.cadth.ca(access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
http://www.has-sante.fr (access date 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Cologne: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)[German Institute for Quality and Efficiency in Health Care], 2013.https://www.iqwig.de (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Hyattsville: National Center for Health Statistics (NCHS), Public Health Service, 2001. http://www.cdc.gov (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Bethesda: Office of Rare Diseases Research (ORDR), National Institutes of Health (NIH), 2014. http://rarediseases.info.nih.gov (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Silver Spring: U.S. Food and Drug Administration (FDA), 2009. http://www.fda.gov (access date 20 May2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
http://effectivehealthcare.ahrq.gov(access date 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
"Silver Spring: U.S. Food and Drug Administration (FDA), 2011.http://www.fda.gov (access date 20 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/2a/4e/bmjopen-2014-007540.PMC4550722.pdf
http://www.crisisgroup.org/en/publication-type/media-releases/2009/africa/jongleis-tribal-conflicts-countering-insecurity-in-south-sudan.aspx 16.,Non-OADS,/arxiv_data1/oa_pdf/cb/92/bmjopen-2014-007534.PMC4550724.pdf
"Department of Gender and Women ’s Health 20, Avenue Appia Geneva, Switzerland http://www.who.int/gender/other_health/en/genderdisasters.pdf 22.",Non-OADS,/arxiv_data1/oa_pdf/cb/92/bmjopen-2014-007534.PMC4550724.pdf
Priority Result; 2008. http://ssnbs.org/census-2008-priority-results/ 24.,OADS,/arxiv_data1/oa_pdf/cb/92/bmjopen-2014-007534.PMC4550724.pdf
2012. http://csis.org/ files/publication/121114_Downie_HealthSudan_Web.pdf 33.,Non-OADS,/arxiv_data1/oa_pdf/cb/92/bmjopen-2014-007534.PMC4550724.pdf
http://www.ruralpovertyportal.org/country/ home/tags/south_sudan 39.,Non-OADS,/arxiv_data1/oa_pdf/cb/92/bmjopen-2014-007534.PMC4550724.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007805).,Non-OADS,/arxiv_data1/oa_pdf/18/c6/bmjopen-2015-007805.PMC4550727.pdf
http://urn.fi/URN:NBN: fi-fe201204193320 (accessed 2 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/18/c6/bmjopen-2015-007805.PMC4550727.pdf
http://urn.fi/URN:NBN: fi-fe201204193452 (accessed 2 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/18/c6/bmjopen-2015-007805.PMC4550727.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008033).,Non-OADS,/arxiv_data1/oa_pdf/b8/94/bmjopen-2015-008033.PMC4550728.pdf
http://d.g.wanfangdata.com.cn/Thesis_Y2106080.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b8/94/bmjopen-2015-008033.PMC4550728.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008443).,Non-OADS,/arxiv_data1/oa_pdf/86/29/bmjopen-2015-008443.PMC4550729.pdf
http://www.stroke.org.uk/resource-sheet/state-nation-stroke-statistics(accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/86/29/bmjopen-2015-008443.PMC4550729.pdf
Online.https://www.rcplondon.ac.uk/projects/ sentinel-stroke-national-audit-programme (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/86/29/bmjopen-2015-008443.PMC4550729.pdf
http://www.ninds.,Non-OADS,/arxiv_data1/oa_pdf/86/29/bmjopen-2015-008443.PMC4550729.pdf
http://www.institute.nhs.uk/quality_and_service_improvement_tools/quality_and_service_improvement_tools/process_mapping_-_alternative_conventional_ methods.html (accessed 18 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/86/29/bmjopen-2015-008443.PMC4550729.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009021).,Non-OADS,/arxiv_data1/oa_pdf/67/9e/bmjopen-2015-009021.PMC4550731.pdf
Washington DC: 2012. http://www.2endaids.org/about.html (accessed 14 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/67/9e/bmjopen-2015-009021.PMC4550731.pdf
Cochrane Collaboration 2007. http://apps.who.int/rhl/reviews/CD003255.pdf (accessed 14 Apr 2014).,OADS,/arxiv_data1/oa_pdf/67/9e/bmjopen-2015-009021.PMC4550731.pdf
http://www.mtnstopshiv.org/node/2003 (accessed 24 Nov 2013).,OADS,/arxiv_data1/oa_pdf/67/9e/bmjopen-2015-009021.PMC4550731.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/64/6e/bmjopen-2015-008884.PMC4550732.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008316).,Non-OADS,/arxiv_data1/oa_pdf/8b/86/bmjopen-2015-008316.PMC4550736.pdf
"Current use and outcome of hematopoietic stem cell transplantaton: CIBMTR Summary Slides, 2013. http://www.cibmtr.org/referencecenter/slidesreports/summaryslides/pages/index.aspx (accessed Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/8b/86/bmjopen-2015-008316.PMC4550736.pdf
"The Cochrane Collaboration, 2014. https://tech.cochrane.org/revman(accessed Feb 2015).",OADS,/arxiv_data1/oa_pdf/8b/86/bmjopen-2015-008316.PMC4550736.pdf
"Author affiliations 1Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia 2Westmead Clinical School and The George Institute for Global Health, Westmead Hospital C24, Sydney, New South Wales, Australia 3Royal Perth Hospital, Perth, Western Australia, Australia 4Physiotherapy Unit, Medical Rehabilitation Services Department, UKM Medical Centre, Kuala Lumpur, Malaysia 5Singapore General Hospital, Singapore, Singapore 6School of Health Sciences, Flinders University, Repatriation General Hospital, Daw Park, South Australia, Australia 7Community and Long Term Conditions Directorate, Auckland District Health Board, Auckland City Hospital, Auckland, New Zealand 8Department of Physiotherapy, Singapore General Hospital, Singapore, Singapore 9Royal Melbourne Hospital, Parkville, Victoria, Australia 10Department of Physiotherapy, Austin Health, Austin Hospital, Heidelberg, Victoria, Australia 11Florey Institute of Neuroscience and Mental Health, and Faculty of Medicine, Nursing and Health Sciences, Monash University, Box Hill Hospital, Box Hill, Victoria, Australia 12Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia 13Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK 14School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia Twitter Follow Julie Bernhardt at @AVERTtrial Collaborators The AVERT Trialists ’Collaboration: Available at the Lancet http://dx.doi.org/10.1016/S0140-6736(15)60690-0.Contributors JB designed the trial, interpreted the data, and drafted and revised the paper.",Non-OADS,/arxiv_data1/oa_pdf/2f/df/bmjopen-2015-008378.PMC4550737.pdf
http://www.socialresearchmethods.net/kb/ 13.,Non-OADS,/arxiv_data1/oa_pdf/2f/df/bmjopen-2015-008378.PMC4550737.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008482).,Non-OADS,/arxiv_data1/oa_pdf/b2/33/bmjopen-2015-008482.PMC4550738.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009460).,Non-OADS,/arxiv_data1/oa_pdf/da/bc/bmjopen-2015-009460.PMC4550739.pdf
"The Cochrane Collaboration, 2011.http://www.cochrane-handbook.org 9.",Non-OADS,/arxiv_data1/oa_pdf/da/bc/bmjopen-2015-009460.PMC4550739.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008160).,Non-OADS,/arxiv_data1/oa_pdf/20/a3/bmjopen-2015-008160.PMC4550741.pdf
"Health Informatics New Zealand 11th Annual Health Informatics Conferenceand Exhibition ; Rotorua: HINZ, 2012. http://www.hinz.org.nz/ uploads/file/2012conference/Papers/P18_MacRae.pdf.",Non-OADS,/arxiv_data1/oa_pdf/20/a3/bmjopen-2015-008160.PMC4550741.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/f9/main.PMC4550764.pdf
150Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.07.009 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/50/f9/main.PMC4550764.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/f9/main.PMC4550764.pdf
"For CYBB , CYBA ,NCF1 and NCF2 many variants harboring deletions, frame shifts, missense, nonsense and splice site mutations have beenidenti ﬁed and are accessible at the immunode ﬁciency (ID) bases (http://structure.bmc.lu.se/idbase /).",Non-OADS,/arxiv_data1/oa_pdf/50/f9/main.PMC4550764.pdf
Guidelines for Developing National Programmes on OSH  (2013) http://www.ilo.org/wcmsp5/groups/public/—ed_ protect/—protrav/—safework/documents/publication/wcms_214166.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
"Pointers for a global safety culture at work, Geneva, 2003. http://www.ilo.org/wcmsp5/groups/public/—ed_protect/— protrav/—safework/documents/publication/wcms_142840.",Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
http://www.ilo.org/wcmsp5/groups/public/@ed_protect/@protrav/@safework/ documents/normativeinstrument/wcms_107831.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
http://www.ilo.org/wcmsp5/groups/public/@dgreports/@dcomm/documents/statement/ wcms_095910.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
"7) International Labour Organization P081—Protocol of 1995  to the Labour Inspection Convention, 1947 Protocol of  1995 to the Labour Inspection Convention, 1947 (Entry into  force: 09 Jun 1998) Adoption: Geneva, 82nd ILC session (22 Jun 1995) http://www.ilo.org/dyn/normlex/en/f?p=NORM LEXPUB:12100:0:NO:P12100_ILO_CODE:P081, ILO.",Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
http://www.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB:12100:0:NO:P12100_ILO_ CODE:C129.,Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
http://www.ilo.org/public/ english/region/afpro/cairo/downloads/wcms_107727.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/e0/indhealth-53-378.PMC4550803.pdf
MICA with more than 100 identified alleles [http://www.ebi.ac.uk/ipd/ imgt/hla/].,Non-OADS,/arxiv_data1/oa_pdf/42/9f/TORJ-9-60.PMC4550945.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/9f/TORJ-9-60.PMC4550945.pdf
"Retrieved August 7, 2013, from: http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/59/b6/ABR-4-157.PMC4550953.pdf
"Retrieved september13, 2013, from: http://www.musictherapy.org/.",Non-OADS,/arxiv_data1/oa_pdf/59/b6/ABR-4-157.PMC4550953.pdf
"Retrieved  August 14, 2013, from: http://www.icmpcescom2012.web.auth.gr/sites/ default/files/papers/1044_Proc.pdf.",OADS,/arxiv_data1/oa_pdf/59/b6/ABR-4-157.PMC4550953.pdf
"Retrieved August 26, 2013, from: http://www.soar.wichita.edu/bitstream/ handle/10057/439/d05001.pdf?sequence=3.",Non-OADS,/arxiv_data1/oa_pdf/59/b6/ABR-4-157.PMC4550953.pdf
"Unpublished Thesis, Georgia University; 2008 Retrieved  September 3, 2013, from: http://www.kuscholarworks.ku.edu/dspace/ bitstream/1808/.../1/umi‑ku‑2707_1.pdf.",Non-OADS,/arxiv_data1/oa_pdf/59/b6/ABR-4-157.PMC4550953.pdf
"[3,4]  MLST has identified international clonal complexes  (CCs) responsible for the dissemination of MBL- producing and MDR isolates of P. aeruginosa ,  particularly in European countries,[9,10] Japan,[11]  Singapore and Brazil (http://pubmlst.org/paeruginosa/).",Non-OADS,/arxiv_data1/oa_pdf/4c/ef/ABR-4-156.PMC4550956.pdf
The database at http://pubmlst.org/paeruginosa  was used to assign numbers to particular alleles and to  identify sequence types (STs).,OADS,/arxiv_data1/oa_pdf/4c/ef/ABR-4-156.PMC4550956.pdf
"Also, ST235, ST207, ST623, ST967, ST970 and ST972  were reported in Orumieh, Iran (http://pubmlst.org/ paeruginosa/).",OADS,/arxiv_data1/oa_pdf/4c/ef/ABR-4-156.PMC4550956.pdf
Available from: http://www.whatisseries.co.uk/ what‑is‑cost‑effectiveness/.,Non-OADS,/arxiv_data1/oa_pdf/c9/1c/IJO-63-496.PMC4550981.pdf
"have developed a glaucoma specific GQL‑15 scale, and defined Table 1: Demographic characteristics of glaucoma patients  and controls Glaucoma  (n=62) (%)Controls  (n=60) (%)P Age years (mean±SD) 55.6±9.6 54.9±6.7 0.72 Gender Male 33 (53.2) 32 (53.3) 0.91 Female 29 (46.8) 28 (46.7) Literacy Literate 40 (64.5) 38 (63.3) 0.18 Illiterate 22 (35.5) 22 (36.7) Literacy, as defined in census operations, is the ability to read and write with  understanding in any language (http://lawmin.nic.in/ncrwc/finalreport/v2b1‑5.",Non-OADS,/arxiv_data1/oa_pdf/77/5c/IJO-63-511.PMC4550984.pdf
Available  from: http://www.mdfoundation.com.au/LatestNews/ MDFoundationDeloitteAccessEconomicsReport2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/91/IJO-63-516.PMC4550985.pdf
"This is an Open Access article distributed under theterms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/29/civ428.PMC4551003.pdf
Novel alleles were subjected to Sanger sequencing at ID Genomics ( http://idgenomics.com ) and were submitted to the Institut Pasteur ’sK.,OADS,/arxiv_data1/oa_pdf/19/29/civ428.PMC4551003.pdf
Available at: http://www.fda.gov/downloads/AnimalVeterinary/ SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResist anceMonitoringSystem/UCM334834.pdf .,Non-OADS,/arxiv_data1/oa_pdf/19/29/civ428.PMC4551003.pdf
Available at: http://www.cdc.gov/ drugresistance/threat-report-2013 .,OADS,/arxiv_data1/oa_pdf/19/29/civ428.PMC4551003.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/f9/civ433.PMC4551006.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/23/civ449.PMC4551011.pdf
Supplementary Data Supplementary materials are available at Clinical Infectious Diseases online ( http://cid.oxford journals.org ).,Non-OADS,/arxiv_data1/oa_pdf/87/23/civ449.PMC4551011.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/5b/civ454.PMC4551012.pdf
Available from: http://www.icmje.org.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://www.culik.com/1190fall2012/Paper_1_ files/rennie.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://publishingresearchconsortium.com/ index.php/prc‑documents/prc‑research‑projects/35‑prc‑ summary ‑4‑ware‑final‑1/file [Last accessed on 2015 Jul 29].,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://www.publicationethics.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://www.web.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://f1000research.com/ posters/1094564 [Last accessed on 2015 Jul 29].,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from: http://www.publications.parliament.uk/pa/ cm201012/cmselect/cmsctech/……/856.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/IJA-59-465.PMC4551022.pdf
Available from:  http://dx.doi.org/10.1016/j.bjane.2013.10.008.,OADS,/arxiv_data1/oa_pdf/35/ea/IJA-59-488.PMC4551026.pdf
"Medical College, Kangra, TANDA (HP) Organising Chairman:  Dr. Sudarshan Kumar Name of the conference: 7th Central Zone Conference & 29th MP State  Conference 2015 Date:  3rd to 4th October 2015 Venue:  Motel Shiraz, MP Nagar, Bhopal Organising Secretary:  Dr. Surendra Raikwar Contact:  +91 94065 33300, +91 89591 13801 E-mail: mpisaconcentzone2015@gmail.com, drskraikwar@gmail.com,  centralzonempisacon2015@gmail.com Website: www.isampchapter.com Name of the conference: ISA JAC 25th East Zone Conference Date:  6th to 8th November 2015 Venue:  Hotel The Stadel, Kolkatta Organising Secretary:  Dr. Subhendu Sarkar Contact:  +91 98311 71162 E-mail: subhendusarkar757@gmail.com, sarkar_subhendu@yahoo.com Name of the conference: 7th Annual Conference of ICA Date:  13th to 15th November 2015 Venue:  Hotel Savera, Dr. Radhakrishnan Road, Chennai 600004 Organising Secretary:  Dr. K. Balakrishnan Contact:  +91 98410 29259  E-mail: ica2015@gmail.com (visit isaweb.in ISA > ICACON2015) Name of the conference: KISACON2015, 31st Annual Conference of Indian  Society of Anaesthesiologists, Karnataka State Chapter Date:  9th to 11th October 2015 Venue:  S N Medical College, Bagalkot  Organising Secretary:  Dr. Ramesh Koppal Contact:  +91 98455 04515 E-mail: rameshkoppaldr@gmail.com Website: www.kisacon2015.com Name of the conference: 48th Gujarat State Conference of Indian Society of  Anaesthesiologists 2015 (GISACON 2015) Date:  9th to 11th October 2015 Venue:  Shanku’s Water World Resort (Ahmedabad-Mehsana Highway) Organising Chairman:  Dr. R G Agrawal Organising Secretary:  Dr. H G Bhavsar Contact:  +91 98242 33694 E-mail: info@gisacon2015.com Website: www.gisacon2015.comName of the conference: ukisacon 2015 Uttrakhand State ISA Conference 2015 Date:  27th to 29th November 2015 Venue:  Max Hospital, Dehradun Organising Secretary:  Dr. Sanjeev Nivargi Contact:  +91 78959 00714 E-mail: sanjeev.nivargi@maxhealthcare.com Name of the conference: 28th Assam State Branch ISA Conference ABISACON 2015 Date:  3rd to 4th October 2015 Venue:  NEDFi Building, Guwahati Organising Secretary:  Dr. Jogendra Narayan Goswami Contact:  +91 98640 23709 E-mail: jogengo74@gmail.com Name of the conference: 6th National Airway Conference 2015 (NAC 2015) Date:  18th to 20th September 2015 Venue:  Workshop: Srinagar, Conference: Gulmarg (J&K) Organising Secretary:  Dr. Zulfiqar Ali Contact:  +91 94190 86761 E-mail: nacsrinagar2015@gmail.com Website: http://aidiaa.org/NAC2015/NAC_home.html Name of the conference: AORA 2015 5th National Conference of Academy of  Regional Anaesthesia of India Date:  25th to 27th September 2015 Venue:  J N Tata Auditorium, Near IISC, Bengalur Organising Secretary:  Dr. Kumar M V Contact:  +91 98450 25236 E-mail: aoraindia2015@gmail.com Website: http://www.aora2015.com Name of the conference: AOACON Date:  11th to 13th September 2015 Venue:  Hotel Marriot, Hyderabad Organising Secretary:  Dr. Sunil T Pandya Contact:  +91 98483 10000, +91 98487 42426 E-mail: aoahyderabad2015@gmail.com, suniltp05@gmail.com Website: http://www.prernaanaesthesia.com Name of the conference: 25th Joint Annual Conference of ISA East Zone & 36th  Annual State Conference of ISA West Bengal State Branch - ISAJAC 2015 Date:  6th to 8th November 2015 Venue:  Hotel The Stadel, Kolkata Organising Chairperson:  Dr. Sumanta Dasgupta, Mobile: 9002080513 Organising Secretary:  Dr. Subhrndu Sarkar Contact:  +91 98311 71162 E-mail: subhendusarkar757@gmail.com Website: www.isawb.in Name of the conference: 8th National Conference of Paediatric Anaesthesia 2016 Date:  28th to 30th January 2016 Venue:  Scudder Auditorium, Christian Medical College, Vellore Organising Chairperson:  Dr. Sajan Philip George Organising Secretary:  Dr. Ekta Rai Contact:  0416-228-2105 / 3556 E-mail: iapa8@cmcvellore.ac.in Website: www.ncpa2016.inAnnouncement",Non-OADS,/arxiv_data1/oa_pdf/b3/28/IJA-59-499.PMC4551028.pdf
A resident doctor who was not participating in the trial  prepared the randomization sequence using ‘research  randomizer’ software (http://www.randomizer.org/)  before starting the study.,Non-OADS,/arxiv_data1/oa_pdf/be/99/IJA-59-507.PMC4551030.pdf
Available  from: http://www.dX.doi.org/10.1155/2010/984981.,Non-OADS,/arxiv_data1/oa_pdf/02/11/IJA-59-525.PMC4551039.pdf
Available from: http://www.anzsbt.org.au/publications/ documents/ANZSBT_Guidelines_Administration _Blood_ Products_2ndEd_Dec_2011_Hyperlinks [Last accessed on 2015  Feb 05].,Non-OADS,/arxiv_data1/oa_pdf/ce/6c/IJA-59-527.PMC4551040.pdf
Available from: http://www.anzsbt.org.au/publications/ documents/ANZSBT_Guidelines_Administration _Blood_ Products_2ndEd_Dec_2011_Hyperlinks [Last accessed on 2015  Feb 05].,Non-OADS,/arxiv_data1/oa_pdf/51/39/IJA-59-528.PMC4551041.pdf
Available from:  https://www.acls‑algorithms.com/asystole.,OADS,/arxiv_data1/oa_pdf/51/39/IJA-59-528.PMC4551041.pdf
"After image acquisition by a flatbed scanner (Scanjet™  3800, HP), the yield of expressed recombinant protein  was determined by image analysis using ImageJ  software (v. 1.47, Rasband, W.S., ImageJ, U.S.  National Institutes of Health, Bethesda, MD, USA,  http://imagej.nih.gov/ij/, 1997–2012).",OADS,/arxiv_data1/oa_pdf/88/55/ABR-4-149.PMC4551058.pdf
"[Medline]   [CrossRef] 	 3)	 Nenonen 	N,	Hämäläinen 	P,	Takala	J,	Saarela	KL,	Lim	SL,	Lim	GK,	 Manickam	 K.	GLOBAL	ESTIMATES	 OF	OCCUPATIONAL 	ACCIDENTS	 AND	FATAL	WORK-RELATED 	DISEASES 	IN	2014	BASED	ON	2010	 AND	2011	DATA,	Report	to	the	ILO	http://goo.gl/UlZorD	 and	http://goo.gl/ tN7XDn	Tampere,	Singapore,	ILO	Geneva	2014.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
http://www.nature.com/bjc/journal/v107/n1s/index.html.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
Available	from:	 http://informahealthcare.com/doi/pdf/10.1080/02841860902913546.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
9)	 http://monographs.iarc.fr/ENG/Classification/index.php.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
11)	 CAREX 	Canadasee 	http://www.carexcanada.ca/en/occupational_approach/.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
"EU-OSHA 	Seminar,	Berlin	2012,	 https://osha.europa.eu/en/seminars/workshop-on-carcinogens-and-work-related-cancer/speech-venues/session-a-methods-to-assess-exposure-to- carcinogens-and-the-work-related-cancer-burden/the-burden-of-work- related-cancer-in-finland-and-two-exposure-information-systems-carex-and- finjem-including-estimates-on-occupational-exposure-to-carcinogens	and.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
irsst.qc.ca/media/documents/PubIRSST/RG-796.pdf 	and	http://www.irsst.,OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
19)	 WHO	http://www.who.int/ipcs/assessment/public_health/asbestos/en/.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
21)	 http://www.efbww.org/pdfs/Presentation%20Mr%20Takala.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
"Scand	J	Work	Environ	 Health	 27,	161–213http://www.sjweh.fi/show_abstract.php?abstract_id=605.",OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
Available	at	https://osha.europa.eu/en/publications/ reports/report-soar-work-related-cancer.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/indhealth-53-307.PMC4551060.pdf
"[CrossRef]  15) Japanese Ministry of Internal Affairs and Communications  Labour Force Survey, http://www.stat.go.jp/data/roudou/longtime/03roudou.htm#hyo_9.",OADS,/arxiv_data1/oa_pdf/c0/f3/indhealth-53-311.PMC4551061.pdf
38) Ministry of Internal Affairs and Communications The Population Census in 2010. http://www.e-stat.go.jp/SG1/ estat/List.do?bid=000001032402&cycode=0.,OADS,/arxiv_data1/oa_pdf/c0/f3/indhealth-53-311.PMC4551061.pdf
http://www.stat.go.jp/english/data/roudou/index.htm.,OADS,/arxiv_data1/oa_pdf/c0/f3/indhealth-53-311.PMC4551061.pdf
The Overview of the  Comprehensive Survey of the Living Conditions of People on  Health and Welfare in 2013. http://www.mhlw.go.jp/toukei/ saikin/hw/k-tyosa/k-tyosa13/.,Non-OADS,/arxiv_data1/oa_pdf/c0/f3/indhealth-53-311.PMC4551061.pdf
http://www.oecd.org/gender/data/balancingpaidworkunpaidworkandleisure.htm.,OADS,/arxiv_data1/oa_pdf/c0/f3/indhealth-53-311.PMC4551061.pdf
The final version was then posted on the Research Activity section of the INAIL website (http://www.ispesl.it/greenjobs/).,OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"2) ILO Defining “green”, issues and considerations 2011.  http://www.ilo.org/wcmsp5/groups/public/—dgreports/— inst/documents/publication/wcms_194180.pdf.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
September 2008. http://www.unep.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
April 2009. http://ec.europa.eu/energy/renewables/studies/doc/ renewables/2009_employ_res_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
European synthesis report  ILO 2010. http://www.cedefop.europa.eu/EN/Files/3057_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"12) Ellwood PA, Bradbrook S, Reynolds J, Duckworth MForesight of New and Emerging Risks to Occupational Safety and Health Associated with New Technologies by  2020: Phase 1—Key Drivers of Change EU-OSHA 2011.  https://osha.europa.eu/en/publications/reports/foresight-green-jobs-drivers-change-TERO11001ENN.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
ILO  Background Note to Towards a Green Economy: Pathways  to Sustainable Development and Poverty Eradication UNEP 2011. http://www.ilo.org/wcmsp5/groups/public/—ed_ emp/—emp_ent/documents/publication/wcms_152065.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
July 2011. http://www.eurofound.europa.eu/publications/htmlfiles/ef1114.htm.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
2011.  http://www.ilo.org/wcmsp5/groups/public/—dgreports/— dcomm/—publ/documents/publication/wcms_159585.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"24, 2012. http://www.cedefop.europa.eu/EN/Files/5524_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"24) EU-OSHA Green jobs and occupational safety and health:  Foresight of New and Emerging Risks to Occupational  Safety and Health Associated with New Technologies  by 2020—Summary, 2013. https://osha.europa.eu/en/publications/reports/summary-green-jobs-and- occupational-safety-and-health-foresight-on-new-and- emerging-risks-associated-with-new-technologies-by-2020.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"25) Ellwood PA, Bradbrook S, Reynolds J, Duckworth MForesight of New and Emerging Risks to Occupational Safety and Health Associated with New Technologies  by 2020: Phase 2—Key Technologies, EU-OSHA 2011.  https://osha.europa.eu/en/publications/reports/foresight-green-jobs-key-technologies.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"29) REN21 Renewables 2014 Global Status Report, 2014. http://www.ren21.net/portals/0/documents/resources/gsr/2014/gsr2014_full%20report_low%20res.pdf.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"Best Practices in Photovoltaics 2012, http://www.clca.columbia.edu/Clean&Green-Photovoltaics.pdf.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"March 2012, http://ec.europa.eu/public_opinion/flash/fl_342_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/41/e8/indhealth-53-332.PMC4551063.pdf
"http://www.mhlw.go.jp/toukei/ saikin/hw/k-tyosa/k-tyosa13/dl/04.pdf Accessed September 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/41/indhealth-53-368.PMC4551067.pdf
1–2 June 2009 25 This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/bf/main.PMC4551074.pdf
"Protein-protein interaction data We created a comprehensive, non-redundant datasetof human interacting protein pairs (PPIs) by com-bining experimentally derived datasets from fivemajor protein interaction databases, including DIP(Database of Interacting Proteins; http://dip.doe-mbi.ucla.edu), IntAct (http://www.ebi.ac.uk/intact),BIND (Biomolecular Interaction Network Database;http://www.bind.ca), HPRD (Human Protein Ref-erence Database; http://www.hprd.org) and MINT(Molecular Interaction Database; http://mint.bio.uniroma2.it/mint).",OADS,/arxiv_data1/oa_pdf/f3/bf/main.PMC4551074.pdf
The FASTA formatted protein sequences and PPI datasets foreach cancer used in this study can be downloaded athttp://bioinformatics.albany.edu/gpb/.,OADS,/arxiv_data1/oa_pdf/f3/bf/main.PMC4551074.pdf
Functional annotations for theselected interacting proteins were obtained from theGO database (http://www.geneontology.org).,OADS,/arxiv_data1/oa_pdf/f3/bf/main.PMC4551074.pdf
Creation of protein interaction net- works PPIs associated with differentially expressed can- cer genes were used to create networks with theapplication of Cytoscape program (v2.3.2) (http://www.cytoscape.org).,OADS,/arxiv_data1/oa_pdf/f3/bf/main.PMC4551074.pdf
"Osong Public Health Res Perspect 2015 6(3), 205 e210 http://dx.doi.org/10.1016/j.phrp.2015.02.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/0f/50/main.PMC4551138.pdf
"1These authors contributed equally to the study.Osong Public Health Res Perspect 2015 6(3), 184 e191 http://dx.doi.org/10.1016/j.phrp.2015.06.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/b4/e9/main.PMC4551139.pdf
"Osong Public Health Res Perspect 2015 6(3), 201 e204 http://dx.doi.org/10.1016/j.phrp.2015.02.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e1/04/main.PMC4551140.pdf
"For users and researchers throughout the world, microdata (in the form of SAS ﬁles) and analytic guidelines can be down-loaded from the KCHS website ( http://KCHS.cdc.go.kr/ ) in Korean.",OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4551141.pdf
"Osong Public Health Res Perspect 2015 6(3), 211 e217 http://dx.doi.org/10.1016/j.phrp.2015.05.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4551141.pdf
Available from: http://www.law.go.kr/lsInfoP.do?lsiSeq=48327#0000 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4551141.pdf
http://dx.doi.org/10.3961/jpmph.2010.43.2.174 [Korean].,Non-OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4551141.pdf
Available from: http://chs.cdc.go.kr/chs/index.do .,OADS,/arxiv_data1/oa_pdf/6c/3a/main.PMC4551141.pdf
"In this current issue of Osong Public Health and Research Perspectives , a study was to identify the This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0 ) which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/69/main.PMC4551144.pdf
"Osong Public Health Res Perspect 2015 6(3), 141 e142 http://dx.doi.org/10.1016/j.phrp.2015.06.004pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e5/69/main.PMC4551144.pdf
"Osong Public Health Res Perspect 2015 6(3), 170 e183 http://dx.doi.org/10.1016/j.phrp.2015.06.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4551150.pdf
"Osong Public Health Res Perspect 2015 6(3), 159 e163 http://dx.doi.org/10.1016/j.phrp.2015.04.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/d0/29/main.PMC4551153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/dd/mdv260.PMC4551154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/26/mdv281.PMC4551159.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/4c/mdv285.PMC4551162.pdf
"Osong Public Health Res Perspect 2015 6(3), 164 e169 http://dx.doi.org/10.1016/j.phrp.2015.05.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e1/25/main.PMC4551170.pdf
Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01064-15 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
"The pH sensor was calibrated in AVS TITRINORM buffers (VWR Chemicals, Denmark) having pH valuesof 4.0, 7.0, 8.0, and 9.0, traceable to standard reference material from NIST (http://www.nist.gov ).",OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
moved by using Seqclean ( https://sourceforge.net/projects/seqclean/ ).,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
"For characterizing the diversity of Desulfobulbaceae contained in the single ﬁlament data sets, trimmed Ion Torrent reads were mapped againstthe SILVA nonredundant 16S rRNA reference database, Release 119 usingBBmap 34.94 ( http://sourceforge.net/projects/bbmap/ ).",OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10 .1038/ismej.2013.239 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1038/nature11586 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10 .1038/nature08790 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1002/2014JG002665 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1002/2014JG002673 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
"http://dx.doi.org/10.1029 /2009JG001065 .8.Sato M, Mooney HM.",OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10 .1038/ismej.2014.41 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org /10.1016/j.gca.2014.12.014 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1128/aem.02682-14 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1038/ismej.2014.19 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1111/1758-2229 .12216 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.3389 /fmicb.2012.00072 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1021/es501037g .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Geophys Res Lett 30:2091. http://dx.doi.org/10.1029 /2003GL018096 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Anal Chem 68:4351– 4357. http://dx.doi.org/10.1021/ac960091b .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Limnol Oceanogr 34:474 – 478. http://dx.doi.org/10.4319/lo.1989.34.2.0474 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1007/978 -1-4757-0611-6_7 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Limnol Oceanogr 14:454. http://dx.doi.org/10.4319/lo .1969.14.3.0454 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.4319/lo .1982.27.3.0552 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.2307/2401670 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1111/j .1574-6941.2010.00878.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1016/S0580 -9517(01)30046-6 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Syst Appl Microbiol 22:434 – 444. http://dx.doi.org/10.1016/S0723 -2020(99)80053-8 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Bioinformatics 27:863– 864. http://dx.doi.org/10 .1093/bioinformatics/btr026 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
J Comput Biol 19:455– 477. http://dx.doi.org/10.1089 /cmb.2012.0021 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1093/bioinformatics/bts252 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1093/nar/gkh293 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
http://dx.doi.org/10.1093/nar/gks1219 .,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Nat Rev Microbiol 12:635– 645. http://dx.doi.org /10.1038/nrmicro3330 .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
Freshw Biol 46:431– 451. http://dx.doi.org/10 .1046/j.1365-2427.2001.00687.x .,OADS,/arxiv_data1/oa_pdf/8e/8a/zam6003.PMC4551263.pdf
contributed equally to this article.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01324-15 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1038/nbt0706-777 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10 .1021/ie801542g .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j.copbio .2009.05.003 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1002/bit .21100 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Biotechnol Biofuels 6:99. http://dx.doi.org /10.1186/1754-6834-6-99 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1128/AEM .07329-11 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Appl Environ Microbiol 75:6132– 6141. http://dx.doi.org/10.1128/AEM .01187-09 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Biotechnol Biofuels 6:131. http://dx.doi .org/10.1186/1754-6834-6-131 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Appl Environ Microbiol 77:5132– 5140. http://dx.doi.org/10.1128/AEM.05008-11 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Biotechnol Lett 32:661– 667. http://dx.doi.org/10 .1007/s10529-010-0209-9 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Appl Envi- ron Microbiol 75:4315– 4323. http://dx.doi.org/10.1128/AEM.00567-09 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1002/bit.10188 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
J Ind Micro- biol Biotechnol 38:431– 439. http://dx.doi.org/10.1007/s10295-010-0787-5 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j.gene .2009.06.018 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1002/(SICI)1097-0290(19991005) 65:1/H1102124::AID-BIT4 /H110223.0.CO;2-2 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1002/yea.1578 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Appl Microbiol Biotechnol 84:751– 61. http://dx.doi.org/10.1007 /s00253-009-2053-1 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Appl Microbiol Biotechnol 98:6511– 6521. http://dx.doi.org/10.1007/s00253-014-5802-8 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j.biortech.2007.09.031 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1002/jctb .1676 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Front Microbiol 5:402. http://dx.doi.org/10.3389/fmicb.2014.00402 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.3109 /07388551003757816 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/S0959-440X(02)00385-8 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j.jmb.2005.07.042 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
FEMS Yeast Res 10:385– 393. http://dx.doi.org/10.1111/j.1567-1364.2010.00623.x .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10 .1038/sj.jim.7000090 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Nat Prod Res 26:1922– 1925. http://dx.doi.org/10.1080/14786419.2011.643886 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Carbohydr Res 148: 71– 85. http://dx.doi.org/10.1016 /0008-6215(86)80038-6 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1271/bbb.60.909 .,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Phytochemis- try44:887– 889. http://dx.doi.org/10.1016/S0031-9422(96)00634-6 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j .soilbio.2011.03.016 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
Enzyme Microb Technol 16:826 – 834. http://dx.doi.org/10.1016 /0141-0229(94)90055-8 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016 /0168-1656(96)01552-0 .,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
http://dx.doi.org/10.1016/j .enzmictec.2003.04.001 .Pisithkul et al.,OADS,/arxiv_data1/oa_pdf/5c/5a/zam5761.PMC4551265.pdf
"This database and  other emerging data can be further mined either by mapping  additional features of chromatin, additional computational  re-analyses beyond the original studies, and/or a combination  of both approaches.Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> Received 29 June 2015 | Accepted 26 August 2015 | Published 28 August 2015© 2015 Molecular Vision 955Chromatin features, RNA polymerase II and the comparative  expression of lens genes encoding crystallins, transcription  factors, and autophagy mediators Jian Sun,1,2 Shira Rockowitz,2 Daniel Chauss,3 Ping Wang,4 Marc Kantorow,3 Deyou Zheng,2,4,5 Ales Cvekl1,2 1Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY; 2Department of Genetics,  Albert Einstein College of Medicine, Bronx, NY; 3Department of Biomedical Science, Florida Atlantic University, Boca Raton,  FL; 4Department of Neurology, Albert Einstein College of Medicine, Bronx, NY; 5Department of Neuroscience, Albert Einstein  College of Medicine, Bronx, NY Purpose:  Gene expression correlates with local chromatin structure.",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  956Numerous studies have shown that promoters and  enhancers are accessible to nuclease digestion in vivo.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  957(GEO accession number, GSM1841114) deposited within the  GSE66961 data set.",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  958levels [ 59,60].",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  959113 FAIRE-seq peaks were located within these super repres - sors.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  960expression correlate with an extremely high abundance of  pol II all across the individual transcriptional units.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  961transcription factors enriched in the lens epithelium and  lens fibers has not yet been conducted.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  962[18,74].",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  963group examined here (Figure 8B,C).",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  964effectors at the nascent autophagosome [ 108].,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  965levels, as its degradation is controlled by chaperone-mediated  autophagy [ 113] and transcriptional control of BNIP3 [ 114].",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  966(Figure 9A).,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  967Four sets of transcriptome data have been generated in  E13 embryonic chicken lens compartments [ 6].,OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  968an organelle-free zone, while in newborn mouse lenses, the  organelle-free zone is already established.",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  969ACKNOWLEDMENTS This work was supported by NIH grants R01 EY012200 (AC),  EY014237 (AC), EY013022 (MK), and R21 MH099452 (DZ),  and by unrestricted departmental grant from Research to  Prevent Blindness, Inc. to the Department of Ophthalmology  and Visual Sciences.",Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  97021.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  97147.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  972during erythroid maturation.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
Molecular Vision  2015; 21:955-973 <http://www.molvis.org/molvis/v 21/955> © 2015 Molecular Vision  97398.,Non-OADS,/arxiv_data1/oa_pdf/06/dc/mv-v21-955.PMC4551281.pdf
"Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> Received 22 June 2015 | Accepted 26 August 2015 | Published 28 August 2015© 2015 Molecular Vision 974Role of 5′TG3′-interacting factors (TGIFs) in Vorinostat (HDAC  inhibitor)-mediated corneal fibrosis inhibition Ajay Sharma,1,3 Nishant R. Sinha,3 Saad Siddiqui,3 Rajiv R. Mohan1,2,3 1Harry S. Truman Memorial Veteran Hospital, Columbia, MO; 2Mason Eye Institute, School of Medicine, Columbia, MO;  3Veterinary Medicine and Surgery, University of Missouri, Columbia, MO Purpose:  We have previously reported that vorinostat, an FDA-approved, clinically used histone deacetylase (HDAC)  inhibitor, attenuates corneal fibrosis in vivo in rabbits by blocking transforming growth factor β (TGFβ).",Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  975Previous studies from our laboratory have demonstrated that  vorinostat can inhibit TGFβ-mediated transdifferentiation  of cultured corneal fibroblasts to myofibroblasts and laser  surgery-induced corneal scarring in rabbits [ 15-17].,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
"Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  976(Bio-Rad Laboratories, Hercules, CA) was run at a universal  cycle (95 °C for 10 min, 40 cycles at 95 °C for 15 s, and 60 °C  for 60 s) in accordance with the manufacturer’s instructions,  using primers listed in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
"Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  977temperature, followed by primary antibody incubation for 90  min.",Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  978fibroblasts (–vorinostat).,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  979in myofibroblast formation.,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  980the exciting possibility of investigating the biologic functions  of these transcription factors in the corneal tissue.,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  981reduce corneal fibrosis primarily through the inhibition of  TGFβ effects [ 14-17].,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
"Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  982such as c-Ski, SnoN, Smad6, and Smad7 [ 18-20], and in that  case, the selective knockdown of only TGIFs will merely  partially reverse the antifibrotic effects of vorinostat.",Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  983differentiation.,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
Molecular Vision  2015; 21:974-984 <http://www.molvis.org/molvis/v 21/974> © 2015 Molecular Vision  98439.,Non-OADS,/arxiv_data1/oa_pdf/bd/1f/mv-v21-974.PMC4551282.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 377–387Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  377ORIGINAL ReseARcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S8937 5The patient–body relationship and the   “lived experience” of a facial burn injury:   a phenomenological inquiry of early   psychosocial adjustment Loyola M McLean1–3 Vanessa Rogers3–4 Rachel Kornhaber5–7 Marie-Therese Proctor8 Julia Kwiet3–4 Jeffrey streimer3–4 John Vandervord6 1Brain and Mind centre and Discipline  of Psychiatry, sydney Medical school,   University of sydney, sydney, N sW,   Australia; 2Westmead Psychotherapy  Program, Discipline of Psychiatry,   sydney Medical school, University  of sydney and Western sydney Local  Health District, Parramatta, N sW,   Australia; 3consultation-Liaison  Psychiatry, Royal North shore  Hospital, sydney, N sW, Australia;   4Discipline of Psychiatry, sydney  Medical school, University of sydney,   sydney, N sW, Australia; 5school of  Health sciences, Faculty of Health,   University of Tasmania, Alexandria,   NsW, Australia; 6severe Burns Injury  Unit, Royal North shore Hospital,   st Leonards, sydney, N sW, Australia;   7school of Nursing, University of  Adelaide, sA, Australia; 8Graduate  school of counselling, excelsia  college, sydney, N sW, Australia correspondence: Rachel Kornhaber   University of Tasmania, Locked Bag   5052, Alexandria, NsW, Australia   Tel +61 289 527 969  email r achel.kornhaber@utas.edu.a uBackground:  Throughout development and into adulthood, a person’ s face is the central  focus for interpersonal communication, providing an important insight into one’ s identity, age,  sociocultural background, and emotional state.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
"Available from http://www.psychology.sunysb.edu/attachment/ measures/content/aai_interview.pd f. Accessed April 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
"Available from: http://ehs.siu.edu/her/_common/documents/ dissertation/ dissertations_2/TAbrams.pd f. Accessed April 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/0d/jmdh-8-377.PMC4551300.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/ba/ijnrd-8-101.PMC4551301.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 101–109International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  101ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S8573 3generation of induced pluripotent stem cells  from renal tubular cells of a patient with alport  syndrome Wenbiao chen1,* Jianrong huang2,* Xiangqi Yu1 Xiaocong lin3 Y ong Dai1 1The clinical Medical Research  center, second clinical Medical  college of Jinan University, shenzhen  People’s hospital,  2Department of  hemodialysis, T he Third People’s  hospital of shenzhen, shenzhen,   guangdong,  3Institute of Biochemistry  and Molecular Biology, guangdong  Medical college, Zhanjiang, People’s  Republic of china *These authors contributed equally to  this work correspondence: Yong Dai   The clinical Medical Research center,  second clinical Medical college of Jinan  University, shenzhen People’s hospital,  shenzhen 518020, People’s Republic of  china   email daiyong2222@gmail.co mAbstract:  Alport syndrome (AS) is a hereditary disease that leads to kidney failure and is caused  by mutations in the COL4A3 , COL4A4 , and COL4A5  genes that lead to the absence of collagen  α3α4α5 (IV) networks in the mature kidney glomerular basement membrane.",Non-OADS,/arxiv_data1/oa_pdf/cd/ba/ijnrd-8-101.PMC4551301.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/cd/ba/ijnrd-8-101.PMC4551301.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/ba/ijnrd-8-101.PMC4551301.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1251.PMC4551305.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1251–1257Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1251ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9127 7Predictors of mortality in solid-organ transplant  recipients with infections caused by Acinetobacter  baumannii hua liu1 Qifa Ye2,3 Qiquan Wan2 Jiandang Zhou4 1Central sterile supply Department,   2Department of Transplant surgery,   Third Xiangya hospital, Central south  University, Changsha, 3Department  of Transplant surgery, Zhongnan  hospital, Wuhan University, Wuhan,   4Department of Clinical laboratory  of Microbiology, Third Xiangya  hospital, Central south University,   Changsha, People’s Republic of ChinaAbstract:  Acinetobacter baumannii  can cause a serious infection in solid-organ transplant (SOT)  recipients, and more data on A. baumannii  infection is needed.",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1251.PMC4551305.pdf
"It is an increasingly resilient opportunistic pathogen in critically ill or  immunocompromised patients, associated with soft-tissue infection, catheter-associated  bacteremia, ventilator-associated pneumonia, urinary tract infection, and peritonitis.11–13 Correspondence: Qiquan Wan Department of Transplant surgery,  Third Xiangya hospital, Central  south University, 138 Tongzipo Road,  Changsha, hunan 410013, People’s  Republic of China Tel +86 731 8861 8312 Fax +86 731 8861 8312 email 13548685542@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Liu et al Running head recto: A. baumannii  in solid-organ transplantation DOI: http://dx.doi.org/10.2147/TCRM.S91277",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1251.PMC4551305.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1251.PMC4551305.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1251.PMC4551305.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/28/ott-8-2209.PMC4551306.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2209–2214OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2209Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8960 6retrospective study of irinotecan/cisplatin  followed by etoposide/cisplatin or the reverse  sequence in extensive-stage small cell lung cancer Xiaoguang Xiao shujing Wang shu Xia Man Zou Yang li Yao Wei Qi Mei Yuan chen Department of Oncology, Tongji  hospital, Tongji Medical college  of huazhong University of  science and T echnology, Wuhan,   People’s republic of chinaBackground:  Much research has confirmed the favorable effect of irinotecan/cisplatin (IP)  and etoposide/cisplatin (EP) on extensive-stage small cell lung cancer (E-SCLC).",Non-OADS,/arxiv_data1/oa_pdf/91/28/ott-8-2209.PMC4551306.pdf
"Chemotherapy plays a key role in the treatment of extensive-stage SCLC (E-SCLC),  in that it not only alleviates symptoms but also prolongs survival in most patients.3,4  Etoposide and cisplatin (EP) is a classic chemotherapy regimen and is very widely  used.5,6 The traditional standard treatment for E-SCLC is etoposide and cisplatin, and  this combination alternating with a regimen of cyclophosphamide, doxorubicin, and correspondence: Yuan chen Department of Oncology, Tongji  hospital, Tongji Medical college of  huazhong University of science and  Technology, 1095 Jiefang road, Wuhan  430030, People’s republic of china Tel +86 027 8366 3407 email c henyuan008@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xiao et al Running head recto: Sequential use of EP and EC in extensive SCLC DOI: http://dx.doi.org/10.2147/OTT.S89606",Non-OADS,/arxiv_data1/oa_pdf/91/28/ott-8-2209.PMC4551306.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/91/28/ott-8-2209.PMC4551306.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/28/ott-8-2209.PMC4551306.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1527–1536Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1527Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6278 6Nystagmus in pediatric patients: interventions  and patient-focused perspectives Kimberly Penix1 Mark w Swanson1 Dawn K DeCarlo1,2 1School of Optometry, 2Department  of Ophthalmology, School of Medicine,   University of Alabama at Birmingham,   Birmingham, AL, USAAbstract:  Nystagmus refers to involuntary, typically conjugate, often rhythmic oscillations of  the eyes.",Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
"It is imperative to identify an underlying etiology if present, as the associated Correspondence: Dawn K DeCarlo UAB Callahan eye Hospital, Suite 405,  1720 University Boulevard, Birmingham,  AL 35233, USA Tel +1 205 325 8114 Fax +1 205 488 0746 email ddecarlo@uab.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Penix et al Running head recto: Nystagmus in pediatric patients DOI: http://dx.doi.org/10.2147/OPTH.S62786",Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
Notes:  Plotted using MATLAB programming provided open source by the Daroff- Dell’Osso Ocular Motility Laboratory ( http://www.omlab.org/software/software.,Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/d6/opth-9-1527.PMC4551307.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/31/ott-8-2215.PMC4551308.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2215–2225OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2215Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8653 6The influence of TLR4 agonist lipopolysaccharides  on hepatocellular carcinoma cells and the  feasibility of its application in treating liver cancer Junsheng gu ranran sun shen shen Zujiang Yu Department of Infectious Diseases,   The First Affiliated Hospital,   Zhengzhou University, Zhengzhou,   Henan, People’s Republic of ChinaObjective:  This study was designed to explore the influence of Toll-like receptor 4 (TLR4)  agonist lipopolysaccharides (LPS) on liver cancer cell and the feasibility to perform liver cancer  adjuvant therapy.",Non-OADS,/arxiv_data1/oa_pdf/1f/31/ott-8-2215.PMC4551308.pdf
"As no effective drug  or method is available, the curative effect of liver cancer is unsatisfying.2correspondence: Zujiang Yu Department of Infectious Diseases,  The First Affiliated Hospital, Zhengzhou  University, No 1 Jianshe East Road,  Zhengzhou, Henan 450052, People’s  Republic of China email yzj@ibhsedu.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Gu et al Running head recto: Influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells DOI: http://dx.doi.org/10.2147/OTT.S86536",Non-OADS,/arxiv_data1/oa_pdf/1f/31/ott-8-2215.PMC4551308.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1f/31/ott-8-2215.PMC4551308.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/31/ott-8-2215.PMC4551308.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/b7/fuv031.PMC4551310.pdf
The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan ).,OADS,/arxiv_data1/oa_pdf/22/b7/fuv031.PMC4551310.pdf
"An in- teractive, zoomable version of this figure is available online (http://dtree.ornl.gov/ebola ref9mer.html ).",Non-OADS,/arxiv_data1/oa_pdf/22/b7/fuv031.PMC4551310.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1a/84/2957.PMC4551311.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/03/1d/2963.PMC4551312.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/78/2971.PMC4551313.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/33/b1/2986.PMC4551314.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/3d/3001.PMC4551315.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b7/2b/3013.PMC4551316.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/64/06/3030.PMC4551317.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/f3/3047.PMC4551318.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cf/47/3061.PMC4551319.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/de/3071.PMC4551320.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/75/f9/3085.PMC4551321.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f5/1a/3104.PMC4551322.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c2/d5/3117.PMC4551323.pdf
Images were stitched andprocessed with ImageJ (http://imagej.nih.gov/ij/) software andwith the specific tracking plugin MTrackJ.,OADS,/arxiv_data1/oa_pdf/14/78/embj0034-2025.PMC4551350.pdf
GS-element mapping Genomic DNA flanking the P-element insertions in the GS(2)101M2 (GS(2)esg) line was recovered by inverse PCR (http://www.fruit- fly.org/ about/methods) and sequenced.,OADS,/arxiv_data1/oa_pdf/14/78/embj0034-2025.PMC4551350.pdf
"Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We thank Dr. S. Cohen, Dr. S. Hou, Dr.",Non-OADS,/arxiv_data1/oa_pdf/14/78/embj0034-2025.PMC4551350.pdf
Available at: http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/.,OADS,/arxiv_data1/oa_pdf/fd/2d/ajp-32-246.PMC4551416.pdf
"Osong Public Health Res Perspect 2015 6(3), 192 e200 http://dx.doi.org/10.1016/j.phrp.2015.06.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/main.PMC4551439.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/33/main.PMC4551467.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.04.011 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/33/main.PMC4551467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/33/main.PMC4551467.pdf
"S1 and S2, and Table S1 can be found with this ar- ticle online at http://dx.doi.org/10.1016/j.ebiom.2015.04.011 .",OADS,/arxiv_data1/oa_pdf/fd/33/main.PMC4551467.pdf
"http://dx.doi.org/10.1155/2013/972913 (Article ID 972913, 10 pages).",Non-OADS,/arxiv_data1/oa_pdf/fd/33/main.PMC4551467.pdf
Available at: http://www.npuap.org/resources/educational- and-clinical-resources/pressure-ulcer-categorystaging-illustrations/ .,Non-OADS,/arxiv_data1/oa_pdf/31/43/ofv112.PMC4551477.pdf
"[J Adv Prosthodont 2015;7:271-7] KEY WORDS: Anatomic contour zirconia crown; CAD-CAM; Lithium disilicate glass ceramic crown; Marginal  gap; Absolute marginal discrepancy; Marginal fit http://dx.doi.org/10.4047/jap.2015.7.4.271 http://jap.or.kr J Adv Prosthodont 2015;7:271-7 INTRODUCTION Zirconia has excellent aesthetic quality, biocompatibility,  and mechanical property.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/jap-7-271.PMC4551782.pdf
"82 62 530 5638: e-mail, mcnihil@jnu.ac.krReceived September 17, 2014 / Last Revision January 7, 2015 / Accepted  January 19, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/e9/jap-7-271.PMC4551782.pdf
ORCID Min-Kyung Ji  http://orcid.org/0000-0002-3525-644XSang-Won park  http://orcid.org/0000-0002-9376-9104 Kwi-Dug Yun  http://orcid.org/0000-0002-2965-3967Gye-Jeong Oh  http://orcid.org/0000-0001-5628-0505 Hyun-Pil Lim  http://orcid.org/0000-0001-5586-1404 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/ef/e9/jap-7-271.PMC4551782.pdf
"[J Adv Prosthodont  2015;7:278-87] KEY WORDS: Denture base; Color stability; Water sorption; Cytotoxicityhttp://dx.doi.org/10.4047/jap.2015.7.4.278 http://jap.or.kr J Adv Prosthodont 2015;7:278-87 INTRODUCTION As patient expectations about cosmetic dentistry have been increasing, dissatisfaction among patients with removable  partial dentures is also rising because of the unpleasant appearance of  metal frameworks, especially with regard to the exposure of  a metal clasp.",Non-OADS,/arxiv_data1/oa_pdf/ee/f0/jap-7-278.PMC4551783.pdf
"82 62 220 3825: e-mail, son0513@chosun.ac.krReceived November 14, 2014 / Last Revision February 23, 2015 /  Accepted March 20, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/f0/jap-7-278.PMC4551783.pdf
ORCID Dae-Eun Jang  http://orcid.org/0000-0002-0493-5052Ji-Young Lee  http://orcid.org/0000-0003-4615-4657Hyun-Seon Jang  http://orcid.org/0000-0003-1231-3816Jang-Jae Lee  http://orcid.org/0000-0001-8787-9940Mee-Kyoung Son  http://orcid.org/0000-0001-9225-1744 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/ee/f0/jap-7-278.PMC4551783.pdf
[J Adv Prosthodont 2015;7:288-93] KEY WORDS: Screw loosening; Reverse torque value; Retightening; Cyclic loading; Internal implanthttp://dx.doi.org/10.4047/jap.2015.7.4.288 http://jap.or.kr J Adv Prosthodont 2015;7:288-93 INTRODUCTION Screw clamping force via application of  torque is an essential  maintenance mechanism of implant prostheses.1 Unstable  screw joints induce complications such as screw loosening under continuous cyclic loading.,Non-OADS,/arxiv_data1/oa_pdf/f1/1b/jap-7-288.PMC4551784.pdf
"82 33 640 3153: e-mail, lila@gwnu.ac.kr Received December 15, 2014 / Last Revision May 19, 2015 / Accepted  June 4, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/1b/jap-7-288.PMC4551784.pdf
ORCID Woong-Rae Cho  http://orcid.org/0000-0003-0876-864XYoon-Hyuk Huh  http://orcid.org/0000-0003-4072-5199Chan-Jin Park  http://orcid.org/0000-0003-4734-214XLee-Ra Cho  http://orcid.org/0000-0003-3989-2870 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/f1/1b/jap-7-288.PMC4551784.pdf
"[J Adv Prosthodont 2015;7:294-302] KEY WORDS: Additive manufacturing; Subtractive manufacturing; Multi Jet Modeling; Micro-SLA; Marginal gap; Internal gaphttp://dx.doi.org/10.4047/jap.2015.7.4.294 http://jap.or.kr J Adv Prosthodont 2015;7:294-302 INTRODUCTION The dental industry has a long history in the development of  dental prostheses to recover a patient’s tooth function.1  As a substitute for teeth, a dental prosthesis must show sta- ble durability, aesthetic value, precise function, and conve - nient use, as well as biocompatibility in order to perform the desired function properly.",Non-OADS,/arxiv_data1/oa_pdf/e2/10/jap-7-294.PMC4551785.pdf
"82 2 3290 5665: e-mail, kuc2842@korea.ac.kr Received December 15, 2014 / Last Revision March 19, 2015 / Accepted   April 3, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/10/jap-7-294.PMC4551785.pdf
ORCID Jin-Young Park  http://orcid.org/0000-0002-8762-6908Hae-Young Kim  http://orcid.org/0000-0003-2043-2575Ji-Hwan Kim  http://orcid.org/0000-0003-3889-2289Jae-Hong Kim http://orcid.org/0000-0002-2679-8802Woong-Chul Kim  http://orcid.org/0000-0002-6730-4960 REFERENCES   1.,Non-OADS,/arxiv_data1/oa_pdf/e2/10/jap-7-294.PMC4551785.pdf
[J Adv Prosthodont 2015;7:303-11] KEY WORDS: Overdenture attachment; Resilient attachment; Surface wear; Retentionhttp://dx.doi.org/10.4047/jap.2015.7.4.303 http://jap.or.kr J Adv Prosthodont 2015;7:303-11 INTRODUCTION A complete denture has been the standard treatment strate - gy to restore functionality and aesthetics in edentulous  patients.,Non-OADS,/arxiv_data1/oa_pdf/51/37/jap-7-303.PMC4551786.pdf
"82 55 360 5130: e-mail, huhjb@pusan.ac.kr Received January 7, 2015 / Last Revision May 11, 2015 / Accepted May  12, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/37/jap-7-303.PMC4551786.pdf
ORCID Chang-Mo Jeong  http://orcid.org/0000-0001-5009-9799  Jung-Bo Huh  http://orcid.org/0000-0001-7578-1989 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/51/37/jap-7-303.PMC4551786.pdf
[J Adv Prosthodont 2015;7:312-6] KEY WORDS: Rapid prototyping; Selective Laser Sintering; Dental technique; Bond strength; Coefficient of  thermal expansionhttp://dx.doi.org/10.4047/jap.2015.7.4.312 http://jap.or.kr J Adv Prosthodont 2015;7:312-6 INTRODUCTION Recent advances in dental equipment allow restorations to be  fabricated using a variety of computer-aided technologies.,Non-OADS,/arxiv_data1/oa_pdf/51/2e/jap-7-312.PMC4551787.pdf
"82 2 940 2843: e-mail, kjh2804@korea.ac.krReceived February 11, 2015 / Last Revision May 11, 2015 / Accepted  May 13, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/2e/jap-7-312.PMC4551787.pdf
316ORCID Eun-Jeong Bae  http://orcid.org/0000-0002-3098-7673 Hae-Young Kim  http://orcid.org/0000-0003-2043-2575Woong-Chul Kim  http://orcid.org/0000-0002-6730-4960Ji-Hwan Kim  http://orcid.org/0000-0003-3889-2289 REFERENCES  1. van Noort R. The future of dental devices is digital.,Non-OADS,/arxiv_data1/oa_pdf/51/2e/jap-7-312.PMC4551787.pdf
[J Adv  Prosthodont 2015;7:317-22] KEY WORDS: Self-adhesive resin cements; Curing mode; Dentin surface pretreatment; Bond strengthhttp://dx.doi.org/10.4047/jap.2015.7.4.317 http://jap.or.kr J Adv Prosthodont 2015;7:317-22 INTRODUCTION The increasing patients’ and dentists’ interest in tooth-col- ored restorations has led to the invention of  many esthetic restoration materials and cements.,Non-OADS,/arxiv_data1/oa_pdf/68/35/jap-7-317.PMC4551788.pdf
"82 55 360 5221: e-mail, jeongkil@pusan.ac.kr Received January 27, 2015 / Last Revision March 20, 2015 / Accepted  April 13, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/35/jap-7-317.PMC4551788.pdf
ORCID Seung-Hyun Youm  http://orcid.org/0000-0003-3469-666XKyoung-Hwa Jung  http://orcid.org/0000-0002-8305-0016Sung-Ae Son  http://orcid.org/0000-0002-8421-4000 Jeong-Kil Park  http://orcid.org/0000-0001-6333-8138 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/68/35/jap-7-317.PMC4551788.pdf
"[J Adv Prosthodont 2015;7:323-8] KEY WORDS: SFI-Bar; Retention; Microleakage; Cyclic long-term loading; Chewing simulator; Implanthttp://dx.doi.org/10.4047/jap.2015.7.4.323 http://jap.or.kr J Adv Prosthodont 2015;7:323-8 INTRODUCTION In highly industrialized countries, the percentage of  edentu- lous people over 65 years of  age is projected to decrease considerably.",Non-OADS,/arxiv_data1/oa_pdf/8a/e9/jap-7-323.PMC4551789.pdf
"49 89 571 544: e-mail, cmehl@proth.uni-kiel.de Received February 16, 2015 / Last Revision June 8, 2015 / Accepted June  18, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/e9/jap-7-323.PMC4551789.pdf
ORCID Christian Johannes Mehl  http://orcid.org/0000-0001-7541-1021 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/8a/e9/jap-7-323.PMC4551789.pdf
"[J Adv  Prosthodont 2015;7:329-37] KEY WORDS: Clinical trial; Telescopic crown; Overdenture; Zirconia; Survival; Successhttp://dx.doi.org/10.4047/jap.2015.7.4.329 http://jap.or.kr J Adv Prosthodont 2015;7:329-37 INTRODUCTION Double crowns have not only been used to retain implant- supported overdentures (IODs) in the mandible and the maxilla with positive long-term prognoses and high implant and denture survival rates, but they were also applied as attachments for residual natural teeht.",Non-OADS,/arxiv_data1/oa_pdf/a7/fc/jap-7-329.PMC4551790.pdf
ORCID Sven Rinke  http://orcid.org/0000-0003-3804-6410Ralf  Buergers  http://orcid.org/0000-0002-6320-4348Dirk Ziebolz  http://orcid.org/0000-0002-9810-2368Matthias Roediger  http://orcid.org/0000-0002-8615-5147 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/a7/fc/jap-7-329.PMC4551790.pdf
"[J Adv Prosthodont 2015;7:338-42] KEY WORDS: Bar-retained overdentures; Implants; Marginal bone level; Radiographic; Peri-implantitishttp://dx.doi.org/10.4047/jap.2015.7.4.338 http://jap.or.kr J Adv Prosthodont 2015;7:338-42 INTRODUCTION Bar-retained implant overdentures (IODs) are a common  treatment option in implant prosthodontics, and the implants that support the prosthetic restorations exhibit high survival rates.",Non-OADS,/arxiv_data1/oa_pdf/9a/b1/jap-7-338.PMC4551791.pdf
"49 551 39 14034: e-mail, matthias.roediger@med.uni-goettingen.deReceived March 25, 2015 / Last Revision July 29, 2015 / Accepted August  5, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/b1/jap-7-338.PMC4551791.pdf
ORCID Sven Rinke  http://orcid.org/0000-0003-3804-6410Ralf  Buergers  http://orcid.org/0000-0002-6320-4348Matthias Roediger  http://orcid.org/0000-0002-8615-5147 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/9a/b1/jap-7-338.PMC4551791.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons AttributionNon-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), whichpermits noncommercial re-use,distribution, and reproduction inany medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/60/sjv004.PMC4551823.pdf
The basepair exemplars and mutual IDI values are available at http://ndbserver.rutgers.,OADS,/arxiv_data1/oa_pdf/70/3f/gkv651.PMC4551918.pdf
"These alignments are available for IL at the followingURL and at asimilar URL forHL: http://rna.bgsu.edu/data/jar3d/diagnostics/IL/1.13/ GroupToModelDiagnostic.html Acceptance and rejection regions for each motif group WecanalignagivensequencetoaparticularSCFG /MRF model and determine the alignment score, but how do we tell if the match is good enough to claim that the sequenceforms the 3D structure of the associated 3D motif group?",OADS,/arxiv_data1/oa_pdf/70/3f/gkv651.PMC4551918.pdf
The distribution of points from IL Rand in Figure 5shows that alignment score deficit and interior editdistancetogetheraremoreeffectiveinseparatingpoints from IL Rand from the other sequences than either one alone.GraphsanalogoustoFigure 5areavailableforallIL motif groups at http://rna.bgsu.edu/data/jar3d/diagnostics/ IL/1.13/ModelSpecificCutoffs.zip andatasimilarURLfor HL.,OADS,/arxiv_data1/oa_pdf/70/3f/gkv651.PMC4551918.pdf
AVAILABILITY Supplementary Section F explains the different JAR3D programfilesandhowtorunthem.TheJAR3Dexecutablefiles for scoring sequences against motif groups and for aligning sequences to a given motif group are available at http://rna.bgsu.edu/data/jar3d/models .,OADS,/arxiv_data1/oa_pdf/70/3f/gkv651.PMC4551918.pdf
The Matlab binary files from all releases of the RNA3DMotifAtlasstartingwithrelease1.0areavailableathttp://rna.bgsu.edu/data/jar3d/motifs/ These are neces- sarytobuildprobabilisticmodelsforMotifAtlasreleasesif one does notwant touse theprecomputedreleases.,OADS,/arxiv_data1/oa_pdf/70/3f/gkv651.PMC4551918.pdf
The figures were generated in Pymol (https://www.pymol.org/ ).,OADS,/arxiv_data1/oa_pdf/39/7a/gkv681.PMC4551924.pdf
Structural modeling of the MerR-DNA and Hg2+-MerR- DNA complexes The structural models of the meroperator DNA in com- plexes with either apo-MerR or Hg2+-MerR were con- structed using Discovery Studio 4.1 ( http://accelrys.com/ ).,OADS,/arxiv_data1/oa_pdf/39/7a/gkv681.PMC4551924.pdf
"The lengthening of H5 upon Hg 2+-binding is further accompanied by the straighten- ing of the helical axis, increasing the surface area of thedimer interface from 1794 to 2153 ˚A 2(calculated with the PISA server, http://www.ebi.ac.uk/pdbe/pisa/ ).",Non-OADS,/arxiv_data1/oa_pdf/39/7a/gkv681.PMC4551924.pdf
The Hg2+-ligating cysteine residues are markedcyan in the MerRsequence.The /H9251-helices and /H9252-strandssuggestedby the PredictProteinserver( https://www.predictprotein.org/ )ar e coloredred andgreeninthesequenceforcomparison.,Non-OADS,/arxiv_data1/oa_pdf/39/7a/gkv681.PMC4551924.pdf
"Segments of GAGcapable of inhibiting Ty1 his3-AImobility in trans To determine if additional Gag regions inhibited Ty1 his3- AImobility, phylogenetic comparisons between Gag pro- teins from different Pseudoviridae ( 19), predicted protein- folding patterns using XtalPred ( http://ffas.burnham.org/",OADS,/arxiv_data1/oa_pdf/a8/72/gkv695.PMC4551931.pdf
"At the bottom, XtalPred( http://ffas.burnham.org/XtalPred-cgi/xtal.pl )wasusedtopredictGagdisordered(yellow)and /H9251-helical(red)regions.Alsoshownisaninvariant tryptophanresidue(W184)foundinPseudoviridaeGagproteins( 19),thepositionofthenucleicacidchaperoneregion( 21),aC-terminaldisorderedregion (C-DR),andtheTy1protease(PR)cleavagesite(H401-N402).AnATGcodonwasaddedadjacenttoP173forexpressionoftheCTRandsCTR.",OADS,/arxiv_data1/oa_pdf/a8/72/gkv695.PMC4551931.pdf
TheRME source code and processing scripts for experimental datacanbedownloadedfromGitHub( https://github.com/lulab/ RME).,OADS,/arxiv_data1/oa_pdf/c8/99/gkv706.PMC4551937.pdf
Transcription factor search Thesearchforpossibletranscriptionfactorswasconducted usingtheMATCH(MatrixSearchforTranscriptionalFac-tor Binding Sites) database ( http://www.gene-regulation.,OADS,/arxiv_data1/oa_pdf/47/8b/gkv728.PMC4551943.pdf
"Among all of the knownRNAs,tRNAshavethemostmodifications[seeRNAmod- ification and tRNA databases: http://modomics.genesilico.",OADS,/arxiv_data1/oa_pdf/c1/62/gkv745.PMC4551947.pdf
"pl/(4);http://rna-mdb.cas.albany.edu/RNAmods/ (5);http: //trna.bioinf.uni-leipzig.de/ (6)],asmorethan100modifica- tionshavebeenidentifiedintRNAnucleosides( 4),withthe majority occurring in the main body and anticodon stem loop (ASL).",OADS,/arxiv_data1/oa_pdf/c1/62/gkv745.PMC4551947.pdf
All structure figures were generated using PyMOL ( http://www.pymol.org )a n d thefigureforthesecondarystructure-basedsequencealign-ment was made usingthe ENDscript server ( 51).,OADS,/arxiv_data1/oa_pdf/c1/62/gkv745.PMC4551947.pdf
"Among the 22characterized variants (http://www.lahey.org/studies), KPC-2and/H110023 occur most commonly (4), along with less common car- bapenemases that include OXA-48, NDM, and VIM (5).",Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
"Resistance genes were identiﬁed by BLAST against a database of resistance genes compiled from the Comprehensive Antibiotic Resistance Database(CARD), the Lahey Clinic (http://www.lahey.org/studies), and the Lacta-mase Engineering database (http://www.laced.uni-stuttgart.de) (42).",OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
"To identify all plasmid-associated contigs in an isolate, aBLAST search was conducted against the NCBI bacterial plasmid database( http://www.ncbi.nlm.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Trees were visual-ized in FigTree using the midpoint-branching tree-building option(http://tree.bio.ed.ac.uk/software/ﬁgtree/).,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Accession numbers for draft se- quence ﬁles (raw reads) are in Table S5 in the supplemental material.Reference plasmid sequences were downloaded from ftp://ftp.ncbi .nlm.nih.gov/genomes/Plasmids/ .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Reference transposon sequences used in this study are available at http://metagenomics.partners.org /PathogenGenomes/ .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.3201/ eid2007.121004 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Clin Microbiol Rev 20:440 – 458. http://dx.doi.org/10.1128/ CMR.00001-07 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/ 10.1016/S1473-3099(13)70190-7 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/ 10.1128/AAC.48.8.3203-3206.2004 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/JCM.43.6.2955-2958.2005 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Trends Microbiol 22:686 – 696. http://dx.doi.org/ 10.1016/j.tim.2014.09.003 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/ genomeA.01332-14 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1126/scitranslmed.3009845 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.04292-14 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Proc Natl Acad Sc iUSA 111: 4988 – 4993. http://dx.doi.org/ 10.1073/pnas.1321364111 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
Antimicrob Agents Chemother58:4961– 4965. http://dx.doi.org/10.1128/AAC.00125-14 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.46.5.1535-1539.2002 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/ AAC.01458-05 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.01069-13 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
J Antimicrob Chemother 63:659 – 667. http://dx.doi.org/10.1093/jac/dkp029 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/ AAC.44.3.561-567.2000 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2011.10.005 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.01648-12 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1093/jac/dks251 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.00167-07 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.00971-12 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/JCM.00349-15 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
J Clin Microbiol 51:680 – 683. http://dx.doi.org/10.1128/ JCM.02580-12 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
J Clin Microbiol 52:4003– 4009. http://dx.doi.org/10.1128/ JCM.01397-14 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1016/j.diagmicrobio.2015.01.003 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1093/jac/dku359 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1371/ journal.pone.0066358 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1101/gr.094615.109 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/mBio.00204-11 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
J Comput Biol 19:455– 477. http://dx.doi.org/10.1089/ cmb.2012.0021 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1093/bioinformatics/btt086 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/AAC.00419-13 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1038/nmeth.1923 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/ 10.1128/AAC.02412-14 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1186/gb-2009-10-3-r25 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1371/journal.pone.0011147 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
BMC Genomics 9:75. http://dx.doi.org/10.1186/ 1471-2164-9-75 .,OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1093/nar/gkt1226 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1128/JCM.06094-11 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1186/gb-2004-5-2-r12 .,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1093/molbev/msp077 .Genomically Informed Pathogen Surveillance July/August 2015 Volume 6 Issue 4 e01030-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/0f/54/mBio.01030-15.PMC4551976.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06870.x .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1016/j.tim.2014.12.006 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/ 10.1128/JB.01666-09 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
Biochemistry 52:4656 – 4666. http://dx.doi.org/ 10.1021/bi400617y .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1128/JB.01483-07 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2009.06769.x .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1007/ s00203-013-0922-6 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1002/mbo3.137 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
J Bacteriol 193:6629 – 6638. http://dx.doi.org/ 10.1128/JB.06006-11 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1074/jbc.M113.459305 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07668.x .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1111/j.1365-2958.2007.06005.x .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1371/journal.pgen.1004463 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1073/ pnas.95.10.5752 .Herrou et al.,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1128/MMBR.69.1.12-50.2005 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1016/ j.bbapap.2010.01.011 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1007/s10618-005-0001-y .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
J Bacteriol 189:4204 – 4216. http://dx.doi.org/10.1128/ JB.00175-07 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1016/ j.sbi.2015.01.006 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1016/j.bpj.2012.08.013 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1074/ jbc.M110.157164 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
Biochem Biophys Res Commun 290: 397– 402. http://dx.doi.org/ 10.1006/bbrc.2001.6152 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/ 10.1016/0378-1119(87)90127-2 .,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1093/nar/ gkm818 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1003084 .,Non-OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
Nat Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .Functional Domains of a Conserved Anti- /H9268Factor July/August 2015 Volume 6 Issue 4 e00910-15®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/a1/4b/mBio.00910-15.PMC4551977.pdf
http://dx.doi.org/10.1126/science.2475911 .Cowley et al.,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1146/annurev.med.58.071905.105316 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1172/JCI15217 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1159/000029503 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
State of the art: why do the lungs of patients with cystic ﬁbrosis become infected and why can’t they clear the infection?Respir Res 4:8. http://dx.doi.org/10.1186/1465-9921-4-8 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1016/0140-6736(93)92422-P .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1038/nrmicro2259 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1128/ CMR.15.2.194-222.2002 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1128/mBio.01012-14 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1172/JCI13870 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1371/journal.pone.0084353 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Bacteriol 189:8079 – 8087. http://dx.doi.org/10.1128/JB.01138-07 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1165/ rcmb.2012-0088OC .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1136/thorax.57.11.926 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Pediatr Pulmonol 44:866 – 872. http://dx.doi.org/10.1002/ ppul.21078 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2007.05772.x .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Mol Microbiol 92:399 – 412. http://dx.doi.org/10.1111/mmi.12566 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Dev Cell 3:593– 603. http://dx.doi.org/10.1016/S1534 -5807(02)00295-2 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1128/JB.01683-07 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1128/IAI.73.6.3764-3772.2005 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1038/ ismej.2010.88 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Expert Opin Ther Targets 16:859 – 873. http://dx.doi.org/ 10.1517/14728222.2012.708025 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1128/mBio.00956-13 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.4319/lom.2009.7.371 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Anal Chem 68:4351– 4357. http://dx.doi.org/10.1021/ac960091b .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.3354/ ame015201 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1016/ j.ijmm.2014.07.002 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Thorax 65:57– 62. http://dx.doi.org/10.1136/thx.2009.114512 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1172/JCI108553 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1016/j.jcf.2011.05.002 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1016/j.addr.2008.09.006 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Appl Chem22:417– 440. http://dx.doi.org/10.1002/jctb.5020220311 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1371/journal.pcbi.1002606 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1073/ pnas.1215867109 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Sci Rep 4:5821. http://dx.doi.org/10.1038/srep05821 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Front Mi-crobiol 4:124. http://dx.doi.org/10.3389/fmicb.2013.00124 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Breath Res 2:037011. http://dx.doi.org/10.1088/1752-7155/2/3/037011 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Breath Res 2:046004. http://dx.doi.org/10.1088/1752-7155/2/4/046004 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1021/es702290a .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1016/j.jcf.2012.07.009 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Microbiome 2:14. http://dx.doi.org/10.1186/ 2049-2618-2-14 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Microbiome 1:27. http://dx.doi.org/10.1186/2049-2618-1-27 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1007/BF00424897 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1111/j.1365-2672.2009.04457.x .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1146/annurev.mi.26.100172.001015 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Bacteriol http://dx.doi.org/10.1128/ JB.00059-15 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Bacteriol 186: 8407– 8423. http://dx.doi.org/10.1128/ JB.186.24.8407-8423.2004 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
J Med Microbiol 63:861– 869. http://dx.doi.org/10.1099/jmm.0.068130-0 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1016/j.mib.2013.06.013 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1111/j.1471 -4159.2010.06580.x .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1096/fj.06-6270fje .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
NitricOxide 41:38 – 47. http://dx.doi.org/10.1016/j.niox.2014.05.014 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1378/chest.128.5.3205 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.3892/ mmr.2012.904 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1586/17476348.2014.856267 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1093/biohorizons/hzt009 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Limnol Oceanogr 34:474 – 478. http://dx.doi.org/10.4319/lo.1989.34.2.0474 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1021/es980024u .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
Reactive transport in aquatic ecosystems: rapid model prototyping in the open source software R. Environ ModelSoftw 32:49 – 60. http://dx.doi.org/10.1016/j.envsoft.2011.08.011 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/ 10.1023/A:1026411118033 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1016/S0141-0229(02)00246-6 .,OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1097/00005176-198705000 -00013 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
http://dx.doi.org/10.1371/journal.pone.0016549 .,Non-OADS,/arxiv_data1/oa_pdf/34/a4/mBio.00767-15.PMC4551978.pdf
"Cellswere observed using a DeltaVision Core microscope (Image SolutionsLtd., Preston, United Kingdom), images were captured using a CoolSNAPcamera (Photometrics United Kingdom Ltd., London, United Kingdom),and image analysis was performed using ImageJ v1.45 ( http://rsbweb.ni- h.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1074/jbc.275.20.14882 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Mol Biol Cell 20:4856 – 4870. http://dx.doi.org/10.1091/mbc.E08 -11-1155 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/ 00221287-136-7-1421 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1172/JCI27114 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Curr Opin Microbiol 15:406 – 412. http://dx.doi.org/10.1016/j.mib.2012.04.005 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004050 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1146/ annurev.bi.51.070182.003555 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Drug Resist Updat 4:38 – 49. http://dx.doi.org/10.1054/ drup.2001.0185 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/ EC.3.4.955-965.2004 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
BioEssays 28:799 – 808. http://dx.doi.org/10.1002/bies.20441 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1016/B978-0-12-407678 -5.00004-0 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.3109/10408418709104445 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Yeast 10:851– 869. http://dx.doi.org/10.1002/yea.320100702 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Mol Microbiol 35:601– 611. http://dx.doi.org/10.1046/j.1365 -2958.2000.01729.x .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.3109/ 1040841X.2013.813904 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1002/ yea.1007 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.01944.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1074/jbc.M502162200 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1074/ jbc.M510360200 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1111/j.1567 -1364.2009.00541.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1080/ mmy.39.1.41.53 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1074/ jbc.272.28.17762 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2001.02347.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1002/yea.1473 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.00228-09 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1002/yea.1061 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
J Biol Chem 281:40399 – 40411. http://dx.doi.org/10.1074/jbc.M606361200 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1093/nar/gkn663 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.00085-13 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000040 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1074/mcp.M200062-MCP200 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/IAI.01092-12 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.00278-12 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1002/pmic.200390046 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/ AAC.49.6.2226-2236.2005 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/ MMBR.66.2.300-372.2002 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1038/nbt1114 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/00221287 -132-7-2023 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1007/ s002030000136 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1007/s00249-010-0612-0 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Mol Biol Cell 15:4179 – 4190. http://dx.doi.org/10.1091/mbc.E04-03-0181 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/ mic.0.28038-0 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1126/scisignal.2000056 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Micro- biology 144:411– 424. http://dx.doi.org/10.1099/00221287-144-2-411 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/mic.0.28616-0 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.00081-09 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1111/j.1462-5822.2012.01813.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
BMC Res Notes 5:258. http://dx.doi.org/10.1186/1756-0500-5-258 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/mic.0.27220-0 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2003.03495.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1128/IAI.72.12.7330-7333.2004 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2005.05037.x .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1099/mic.0.044206-0 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1002/pmic.201200228 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/ 10.1016/S0008-6215(00)00105-1 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1016/j.carres.2004.05.033 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Mol Biol Cell 18: 4603– 4614. http://dx.doi.org/10.1091/mbc.E07-06-0581 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1091/mbc.E12-06-0477 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1371/journal.pone.0045912 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Nanotechnol-ogy22:395102. http://dx.doi.org/10.1088/0957-4484/22/39/395102 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Yeast 27:673– 684. http://dx.doi.org/10.1002/yea.1801 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1038/nprot.2015.004 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Rev Sci Instrum 64:1868. http://dx.doi.org/10.1063/1.1143970 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1099/00221287-143-2 -297 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/ IAI.68.10.5953-5959.2000 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.4.2.298 -309.2005 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1016/ j.fgb.2005.05.006 .,OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
Microbiology 144:425– 432. http://dx.doi.org/10.1099/ 00221287-144-2-425 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1128/EC.3.5.1111 -1123.2004 .,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1371/journal.pgen.1000783 .Candida albicans Cell Wall Elasticity and Stress Resistance July/August 2015 Volume 6 Issue 4 e00986-15®mbio.asm.org 15,Non-OADS,/arxiv_data1/oa_pdf/fe/96/mBio.00986-15.PMC4551979.pdf
http://dx.doi.org/10.1093/ nar/gkt1352 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Curr Opin Biotechnol 17: 448 – 456. http://dx.doi.org/10.1016/j.copbio.2006.08.006 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1128/AEM.06865-11 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1128/JB.183.10.3065 -3075.2001 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1093/molbev/msi211 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1016/ j.tig.2012.11.001 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1371/journal.pgen.1002803 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
J Mol Biol 235: 472– 485. http://dx.doi.org/10.1006/jmbi.1994.1007 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
EMBO J 21: 4969 – 4977. http://dx.doi.org/10.1093/emboj/cdf490 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.04912.x .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1371/journal.pgen.1003541 .Adaptations to the Loss of CcrM in C. crescentus July/August 2015 Volume 6 Issue 4 e00952-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001749 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1111/mmi.12180 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1111/ mmi.12686 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/ 10.1128/MMBR.00024-06 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Microbiol Mol Biol Rev 69: 608 – 634. http://dx.doi.org/10.1128/MMBR.69.4.608-634.2005 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.4161/cib.24561 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Genes Dev 12:880 – 893. http://dx.doi.org/10.1101/gad.12.6.880 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1016/S0092-8674(00)80995-2 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
J Mol Biol 324: 443– 455. http://dx.doi.org/10.1016/S0022-2836(02)01042-2 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
J Bacteriol 189:8308 – 8320. http://dx.doi.org/ 10.1128/JB.00868-07 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1016/ S0065-2911(08)00001-5 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001979 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Proc Natl Acad Sc iUSA 98:4136 – 4141. http://dx.doi.org/ 10.1073/pnas.061029298 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1128/JB.01115-08 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1128/JB.01489-14 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Nat Rev Microbiol 6:613– 624. http://dx.doi.org/10.1038/nrmicro1932 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1371/journal.pone.0026028 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/ 10.1371/journal.pone.0012679 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1016/j.cell.2006.05.038 .,OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
Nature494:463– 467. http://dx.doi.org/10.1038/nature11879 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1101/sqb.2009.74.018 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/ 10.1038/nature08480 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1159/000099639 .,Non-OADS,/arxiv_data1/oa_pdf/d7/74/mBio.00952-15.PMC4551980.pdf
http://dx.doi.org/10.1111/j.1574-6976.2002.tb00620.x .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1016/0092-8674(84)90284-8 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/ 10.1128/JB.187.2.752-757.2005 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
Nature 406: 477– 483. http://dx.doi.org/10.1038/35020000 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/ 10.1016/S0092-8674(03)00611-1 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
J Bacteriol 188: 6419 – 6424. http://dx.doi.org/10.1128/JB.00565-06 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/ 10.1073/pnas.0605120103 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2007.05973.x .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1128/JB.00416-07 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1038/sj.emboj.7601747 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002189 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002472 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1371/journal.pgen.1000939 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
Proc NatlAcad Sc iUSA 108: 6199 – 6204. http://dx.doi.org/10.1073/ pnas.1013244108 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1128/ JB.187.21.7167-7175.2005 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
Nucleic Acids Res 40: 6026 – 6038. http://dx.doi.org/10.1093/nar/gks260 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1093/nar/ gku771 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
"http://dx.doi.org/ 10.1074/jbc.272.52.33312 .25.Datta HJ, Khatri GS, Bastia D .",OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1093/nar/21.22.5025 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/ 10.1073/pnas.1222538110 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1093/nar/16.11.5067 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/ 10.1007/BF00326535 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1006/plas.1995.1004 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
Mol Microbiol 66:428 – 439. http://dx.doi.org/10.1111/j.1365 -2958.2007.05930.x .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1073/ pnas.0803904105 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
EMBO J 17:4511– 4526. http://dx.doi.org/10.1093/emboj/ 17.15.4511 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1006/ jmbi.2000.4426 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
J Biol Chem 279:41058 – 41066. http://dx.doi.org/10.1074/jbc.M403151200 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
Mol Microbiol 54:836 – 849. http://dx.doi.org/10.1111/j.1365-2958.2004.04322.x .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1016/0022 -2836(87)90214-2 .Essential Features of V. cholerae oriCII July/August 2015 Volume 6 Issue 4 e00973-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1016/ j.jmb.2014.04.009 .,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
"http://dx.doi.org/10.1007/ BF00261159 .47.Polaczek P, Kwan K, Liberies DA, Campbell JL .",Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1038/nmeth.1318 .,Non-OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1038/nmeth.1923 .Gerding et al.,OADS,/arxiv_data1/oa_pdf/be/9c/mBio.00973-15.PMC4551981.pdf
http://dx.doi.org/10.1038/nrmicro2677 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/ 10.1016/S0022-5193(85)80169-7 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
Nat Commun 5:3842. http://dx.doi.org/10.1038/ncomms4842 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1111/j.1365-2958.2007.05782.x .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1111/ mmi.12059 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
Nat Rev Mi-crobiol 11:601– 614. http://dx.doi.org/10.1038/nrmicro3088 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1126/science.aaa1511 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1128/JB.186.11.3286-3295.2004 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/ 10.1016/j.bpj.2014.10.036 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1074/jbc.M111.258863 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1074/jbc.M111.336404 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1128/ JB.00734-07 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1016/ j.ultramic.2009.01.012 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1111/j.1365-2818.2009.03333.x .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
"http://dx.doi.org/10.1128/ JB.01474-10 .29.Loskill P, Pereira PM, Jung P, Bischoff M, Herrmann M, Pinho MG, Jacobs K .",OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1016/j.bpj.2014.07.029 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
Nat Commun 4:1496. http://dx.doi.org/10.1038/ ncomms2503 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1016/j.cell.2010.11.038 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
Mol Microbiol 88:664 – 672. http://dx.doi.org/10.1111/mmi.12203 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/ 10.1086/501471 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1128/ JB.184.19.5457-5467.2002 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1074/ jbc.M110.167312 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1038/305709a0 .,Non-OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1016/0378-1119(95)00652-4 .,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
http://dx.doi.org/10.1111/mmi.12813 .Wheeler et al.,OADS,/arxiv_data1/oa_pdf/21/10/mBio.00660-15.PMC4551982.pdf
Available from: http://www.mciindia.org/RulesandRegulations/ GraduateMedicalEducationRegulations1997.aspx.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/IJABMR-5-1.PMC4552054.pdf
Available from: http://www.faimer.org/education/regional.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/IJABMR-5-1.PMC4552054.pdf
Available  from: http://www.mciindia.org/InformationDesk/ForColleges/ FacultyDevelopmentProgrammes.aspx.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/IJABMR-5-1.PMC4552054.pdf
Available from:  http://www.facultyfocus.com/articles/teaching‑and‑learning/ keeping‑introverts‑in‑mind‑in‑your‑active‑learning‑classroom/.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/IJABMR-5-14.PMC4552056.pdf
Available from: http://www.mciindia.org/ RulesandRegulations/GraduateMedicalEducationRegulations1997.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a8/a4/IJABMR-5-21.PMC4552058.pdf
Available from: http://www.mciindia.org/RulesandRegulations/ GraduateMedicalEducationRegulations1997.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d7/d6/IJABMR-5-24.PMC4552059.pdf
Available from: http://www.faimer.org/education/fellows/ abstracts/04jamkar.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/d6/IJABMR-5-24.PMC4552059.pdf
Available from: http://www.facultyfocus.com/articles/ instructional‑design/a‑brain‑friendly ‑environment‑for‑learning/.,Non-OADS,/arxiv_data1/oa_pdf/6c/df/IJABMR-5-29.PMC4552060.pdf
Available from: http://www.science.,Non-OADS,/arxiv_data1/oa_pdf/8e/36/IJABMR-5-3.PMC4552061.pdf
Available from:  http://www.statstutor.ac.uk/resources/uploaded/sample‑size.pdf.,OADS,/arxiv_data1/oa_pdf/8e/36/IJABMR-5-3.PMC4552061.pdf
Available from: http://www.research.,Non-OADS,/arxiv_data1/oa_pdf/8e/36/IJABMR-5-3.PMC4552061.pdf
These forms can be downloaded from the  website https://www.abim.org/pdf/paper‑tools/mini‑cex.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/b2/IJABMR-5-32.PMC4552062.pdf
Available from: http://www.pravara.com/pdf/notice2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/04/IJABMR-5-50.PMC4552067.pdf
Available from:  http://www.mamatamedicalcollege.com/Medical%20Education.html.,Non-OADS,/arxiv_data1/oa_pdf/90/04/IJABMR-5-50.PMC4552067.pdf
Available from: http://www.businessballs.com/trainingevaluationtools.,Non-OADS,/arxiv_data1/oa_pdf/90/04/IJABMR-5-50.PMC4552067.pdf
Available  from: http://www.childtrends.org/wp‑content/uploads/2013/04/ child_trends‑2007_10_01_rb_whyprogeval.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/04/IJABMR-5-50.PMC4552067.pdf
Available from:  http://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf.,OADS,/arxiv_data1/oa_pdf/93/35/IJABMR-5-54.PMC4552068.pdf
Available from: http://www.who.int/gpsc/5may/ tools/WHO_IER_PSP_2009.02_eng.pdf [Last revised on 2009 Aug; Last  accessed on 2015 July].,OADS,/arxiv_data1/oa_pdf/93/35/IJABMR-5-54.PMC4552068.pdf
Available from: http://www.LSRC.ac.uk /2014/December/.,Non-OADS,/arxiv_data1/oa_pdf/ba/c0/IJABMR-5-58.PMC4552069.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page(https://uk.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/32/50/10.1177_2048004015601564.PMC4552180.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/47/3f/10.1177_2047981614558328.PMC4552181.pdf
"However, here too,  and in the extended ORIGIN analysis ( 9), there were limitations  for definitive interpretation as: (i) there is a rapid drop-off after  the median 6.2 year follow-up (arguably too short to evaluate the  full effect of exposure on cancer risk); (ii) there was interrupted  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,   provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/e4/bgv071.PMC4552242.pdf
"Indeed, germ-line deficiencies in DNA repair have been clearly shown to cause a number of hereditary cancer- prone diseases such as BRCA1- and BRCA2-associated breast  cancer, mismatch repair-associated hereditary non-polyposis  colorectal cancer, the nucleotide excision repair deficient  xeroderma pigmentosum, and MutYH-related attenuated  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,   provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/e2/bgv082.PMC4552243.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Correspondence:  George J.M.",Non-OADS,/arxiv_data1/oa_pdf/14/9a/emss-64747.PMC4552254.pdf
Age and sex incidence for  mortality were obtained from National UK Statistics ( http://www.cancerresearchuk.org/ cancer-info/cancerstats/mortality/ ).,OADS,/arxiv_data1/oa_pdf/14/9a/emss-64747.PMC4552254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/89/ndt-11-2185.PMC4552255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2185–2190Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2185OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8710 9Palliative whole-brain radiotherapy and health-   related quality of life for patients with brain   metastasis in cancer Ying gao1,* Fei gao2,* Jin-lu Ma1 Dong-li Zhao1 1Department of radiotherapy  Oncology, First affiliated hospital  of Xi’an Jiaotong University,   2Department of Neurology, First  affiliated hospital of Xi’an Medical  University, Xi’an, People’s republic  of china *These authors contributed equally  to this workObjective:  To assess the use of palliative whole-brain radiotherapy (WBRT) in the treatment  of brain metastases (BMs) and to evaluate the health-related quality of life (HRQOL) of these  patients.",Non-OADS,/arxiv_data1/oa_pdf/71/89/ndt-11-2185.PMC4552255.pdf
"However, correspondence: Ying gao Department of radiotherapy Oncology,  First Affiliated Hospital of Xi’an Jiaotong  University, 277 Yanta West road, Yanta,  Xi’an, shaanxi 710061, People’s republic  of china Tel +86 29 8532 4029 email togaoying@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gao et al Running head recto: WBRT and HRQOL for brain metastasis DOI: http://dx.doi.org/10.2147/NDT.S87109",Non-OADS,/arxiv_data1/oa_pdf/71/89/ndt-11-2185.PMC4552255.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/71/89/ndt-11-2185.PMC4552255.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/89/ndt-11-2185.PMC4552255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2191–2208Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2191Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7818 2Near-infrared photonic energy penetration: can  infrared phototherapy effectively reach the human  brain?,Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
DOI: http://dx.doi.org/10.2147/NDT.S78182 Point your SmartPhone at the code above.,Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
Or use: http://youtu.be/iZbP2IVekh 0video abstract,Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/3c/ndt-11-2191.PMC4552256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/1d/ijn-10-5249.PMC4552257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5249–5262International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5249OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8958 4T umor-targeting, ph-sensitive nanoparticles for  docetaxel delivery to drug-resistant cancer cells T uan hiep Tran1 Thiruganesh ramasamy1 Ju Yeon choi1 hanh Thuy Nguyen1 Thanh T ung Pham1 Jee-heon Jeong1 sae Kwang Ku2 han-gon choi3 chul soon Y ong1 Jong Oh Kim1 1college of Pharmacy, Yeungnam  University, Dae-Dong, 2college  of Korean Medicine, Daegu haany  University, gyeongsan, 3college  of Pharmacy, hanyang University,   hanyangdaehak-ro, sangnok-gu,   ansan,  south KoreaAbstract:  The attachment of polyethylene glycol (PEG) increases the circulation time of  drug-containing nanoparticles; however, this also negatively affects cellular uptake.",Non-OADS,/arxiv_data1/oa_pdf/2a/1d/ijn-10-5249.PMC4552257.pdf
"Therefore,  additional carrier functionalities are required to overcome the fundamental limitations  of PEGylated nanoparticle systems.6 Cationically charged nanoparticles interact with  the anionic plasma membranes of cells and are rapidly internalized;7 however, unlike correspondence: Jong Oh Kim college of Pharmacy, Yeungnam  University, 214-1, Dae-Dong,  gyeongsan 712-749, south Korea Tel +82 53 810 2813 Fax +82 53 810 4654 email jongohkim@yu.ac.k r  chul soon Yong college of Pharmacy, Yeungnam  University, 214-1, Dae-Dong, gyeongsan,  712-749, south Korea Tel +82 53 810 2812 Fax +82 53 810 4654 email csyong@yu.ac.krJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Tran et al Running head recto: Nanoparticles for DTX delivery to drug-resistant cancer cells DOI: http://dx.doi.org/10.2147/IJN.S89584",Non-OADS,/arxiv_data1/oa_pdf/2a/1d/ijn-10-5249.PMC4552257.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2a/1d/ijn-10-5249.PMC4552257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/1d/ijn-10-5249.PMC4552257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/2e/dddt-9-4847.PMC4552258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4847–4860Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4847Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8979 2effects of histamine and its antagonists on murine  T -cells and bone marrow-derived dendritic cells Xiufen hu1,* Mohammad ishraq Zafar2,* Feng gao2 1Department of Paediatrics,   T ongji hospital, 2Department of  endocrinology, Union hospital, T ongji  Medical college, huazhong University  of science and T echnology, Wuhan,   People’s republic of china *These authors contributed equally   to this workAbstract:  We determined the effects of histamine and its antagonists on the surface marker  expression of dendritic cells (DCs) and the influence of lipopolysaccharide (LPS), histamine,  and histamine receptor antagonists on DCs and T-cells.",Non-OADS,/arxiv_data1/oa_pdf/7c/2e/dddt-9-4847.PMC4552258.pdf
"T-cells, monocytes, and dendritic cells correspondence: Feng gao Department of endocrinology,  Union  hospital, Tongji Medical college,  huazhong University of science and  Technology, 1277 Jiefang avenue,  Wuhan 430022, People’s republic of china Tel +86 139 7152 5208 Fax +86 27 8535 6365 email gaofengwh@aliyun.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hu et al Running head recto: Effects of histamine and its antagonists on T-cells and dendritic cells DOI: http://dx.doi.org/10.2147/DDDT.S89792",Non-OADS,/arxiv_data1/oa_pdf/7c/2e/dddt-9-4847.PMC4552258.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7c/2e/dddt-9-4847.PMC4552258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/2e/dddt-9-4847.PMC4552258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/1c/cia-10-1377.PMC4552259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1377–1380Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1377Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S9023 3Significant association between parathyroid  hormone and uric acid level in men Kok-Y ong Chin1 Soelaiman Ima Nirwana1 Wan Zurinah Wan Ngah2 1Department of Pharmacology,   2Department of Biochemistry, Faculty  of Medicine, Universiti Kebangsaan  Malaysia Medical Centre, Kuala  Lumpur, MalaysiaBackground:  Previous reports of patients undergoing parathyroidectomy and of patients  receiving teriparatide as antiosteoporotic treatment have suggested a plausible relationship  between parathyroid hormone (PTH) and uric acid.",Non-OADS,/arxiv_data1/oa_pdf/07/1c/cia-10-1377.PMC4552259.pdf
"It adopted a purposive sampling technique, whereby subjects were solicited  via announcement with specific inclusion and exclusion criteria advertised via Correspondence: Soelaiman Ima Nirwana Department of Pharmacology, Faculty  of Medicine, Universiti Kebangsaan  Malaysia Medical Centre, Jalan Yaacob  Latif, 56000 Cheras, Kuala Lumpur,  Malaysia tel +60 3 9145 5002 Fax +60 3 9145 6633 email imasoel@ppukm.ukm.edu.m y Journal name: Clinical Interventions in Aging Article Designation: Short Report Y ear: 2015 Volume: 10 Running head verso: Chin et al Running head recto: Parathyroid hormone and uric acid in men DOI: http://dx.doi.org/10.2147/CIA.S90233",Non-OADS,/arxiv_data1/oa_pdf/07/1c/cia-10-1377.PMC4552259.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/07/1c/cia-10-1377.PMC4552259.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/07/1c/cia-10-1377.PMC4552259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/39/ndt-11-2177.PMC4552260.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2177–2183Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2177OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8738 1epidemiology and clinical presentation of stroke  in Upper egypt (desert area) hamdy N el Tallawy1 Wafaa M Farghaly1 reda Badry1 Nermin a hamdy2 ghaydaa a shehata1 Tarek a rageh1 Nabil a Metwally3 enas M hassan2 sayed s elsayed2 Mohamed a Yehia2 Wael T soliman2 1Department of Neurology and  Psychiatry, assiut University, assiut,   2Department of Neurology, el Minia  University, el-Minia city, 3Department  of Neurology, al-azhar University  (assuit Branch), assiut, egyptBackground:  Stroke is a common cause of morbidity and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a9/39/ndt-11-2177.PMC4552260.pdf
"Population and methods This door-to-door (every door) study was carried out on all inhabitants of Al Kharga  district, New Valley (n =62,583–13,915 families; 78 families refused to participate) and  Al Quseir city, Red Sea Governorate (n =33,285–7,590 families of whom 93 families correspondence: reda Badry Department of Neurology and Psychiatry,  assiut University, PO Box 71526,  assiut, egypt Tel +20 2 88 236 9541 email redaalbadry02@gmail.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: El Tallawy et al Running head recto: Epidemiology and clinical presentation of stroke in Upper Egypt DOI: http://dx.doi.org/10.2147/NDT.S87381",Non-OADS,/arxiv_data1/oa_pdf/a9/39/ndt-11-2177.PMC4552260.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a9/39/ndt-11-2177.PMC4552260.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/39/ndt-11-2177.PMC4552260.pdf
"Since the Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> Received 4 May 2015 | Accepted 27 August 2015 | Published 29 August 2015© 2015 Molecular Vision 985Association of gene polymorphism with serum levels of  inflammatory and angiogenic factors in Pakistani patients with  age-related macular degeneration Fareeha Ambreen,1 Muhammad Ismail,2 Irfan Zia Qureshi1 (All authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
"Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  986genes associated with AMD show a high degree of vari - ability and interference [ 5], it seems logical to investigate  these variations and determine the role of inflammatory  factors in the pathology of AMD.",Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
"Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  987Briefly, for IL-6, 100 µl of standard and serum samples were  added to the wells of a 96-well plate precoated with mono - clonal antibody.",Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  988Table  1.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  989The cuttable and uncuttable products are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
"Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  990Allele and genotype frequencies of IL-6:  Among SNPs of  IL-6, the frequency of the CC genotype for SNP rs1800795   (p<0.002; odds ratio [OR] = 0.4981; confidence interval [CI]  0.2422 – 1.0243) was significantly increased compared to other  genotypes.",Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  991allele frequency between control group and AMD patients  (p<0.8957; OR = 1.0279; CI 0.6829 – 1.5472).,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  992Table  5. g eno TyPe and allele  frequencies  in con Trol and amd PaTienTs for il-6 sn Ps.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  993Table  6. g eno TyPe and allele  frequencies  in con Trol and amd PaTienTs for il-8 sn Ps.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  994Table  7. g eno TyPe and allele  frequencies  in con Trol and amd PaTienTs for vegf sn Ps.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  995Table  8. g eno TyPe and allele  frequencies  in con Trol and amd PaTienTs for crP sn Ps.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
"Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  996and pathologic data that support the view that inflammatory  processes contribute to the initiation and progression of  AMD [ 2,3,26].",Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  997of the CRP gene.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  99813.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
Molecular Vision  2015; 21:985-999 <http://www.molvis.org/molvis/v 21/985> © 2015 Molecular Vision  99937.,Non-OADS,/arxiv_data1/oa_pdf/ed/90/mv-v21-985.PMC4552287.pdf
"1 and figs .S 2t oS 7 ) .F u r t h e r m o r e ,t h eh u m a n genome encodes a comparable number of tRNA genes for AAA and AAG codons (http://gtrnadb.ucsc.edu/Hsapi19/), and general codon usage is similar (0.44 versus 0.56, AAA versus AAG).",Non-OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
We note that the K137K synonymous change repre- sents a recurrent cancer mutatio nf o u n di nt h eC O S M I C( C a t a l o g u e of Somatic Mutations in Cancer) datab ase (http://cancer.sanger.ac.uk) (23)f o rt h e ZCRB1 gene (http://cancer.sange r.ac.uk/cosmic/mutation/ overview?id=109189).,Non-OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
"Similar results were obtained when we compared immunoprecipitations of overexpressed and HA-tagged wild-type MTDH gene and a K451K (1353G>A) variant, yet another cancer-associated mu- tation (http://cancer.sanger.ac.uk /cosmic/mutation/overview?id=150510; fig.",Non-OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
Gene Ontology analyses were done using Term Enrichment Service at http://amigo.geneontology.org/rte.,OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500154/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
"48, 625 –654 (2007); https://cshmonographs.org/inde x.php/monographs/article/view/3291.",Non-OADS,/arxiv_data1/oa_pdf/00/41/1500154.PMC4552401.pdf
201439837 | Received 5November 2014 | Revised 19May 2015 | Accepted 21May 2015 | Published online 25June 2015 EMBO Reports ( 2015 )16:1022 –1036 See also: V Albert & MN Hall (August 2015 ) Introduction C/EBP bis a transcriptional regulator with a broad tissue expression including liver and adipose tissue (http://www.genecards.org).,Non-OADS,/arxiv_data1/oa_pdf/a1/2b/embr0016-1022.PMC4552494.pdf
"To further support the direct regulatory role of C/EBP b in the examined gene regulation, we analysed the ENCODE data-base (http://genome.ucsc.edu/ENCODE/) for promoter occupationby chromatin immunoprecipitation sequencing (ChIP-Seq).",OADS,/arxiv_data1/oa_pdf/a1/2b/embr0016-1022.PMC4552494.pdf
"Ten minutes after injection, mice were sacrificed and tissue samples were collected and analysed in an immunoblotusing Akt- and phospho-Akt-specific antibodies (see below).HOMA2-IR was calculated using the HOMA2 Calculator v2.2.3 fromthe Diabetes Trials Unit, University of Oxford (http://www.dtu.ox.ac.uk/homa).",Non-OADS,/arxiv_data1/oa_pdf/a1/2b/embr0016-1022.PMC4552494.pdf
"Expanded View for this article is available online: http://embor.embopress.org Acknowledgements We thank Susanne Klaus and Susanne Keipert (DIfE, Potsdam) for help withbomb calorimetry; Kay Stötzer (Diagnostic Laboratory of the University HospitalJena) for the plasma and urine analysis; David Sabatini (Whitehead Institute,Cambridge) for providing the raptor and rictor shRNA plasmids; and JamesKirkland and Tamar Tchkonia (Mayo Clinic, Rochester) for advise on fatmetabolism and ageing.",Non-OADS,/arxiv_data1/oa_pdf/a1/2b/embr0016-1022.PMC4552494.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.005,Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"There is no online version, but the source code is available at http://panoct.sourceforge.net/ .",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Finally there is the P ANSEQ tool (pangenome sequence analysis program) [55], an online tool ( http://lfz.corefacility.ca/panseq/ ) that allows the user to proceed with three sorts of analyses: search for new regions, allowing the detection of unique zones; analysis of the core and the pangenome, giving information about the SNPs in the core or the distribution of accessory genes; and, ﬁnally, a selector of loci allowing us to ﬁnd those discriminating between selected genomes.",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
Supplementary data Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.nmni.2015.06.005 .,OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
http://dx.doi.org/10.1056/NEJMoa1106920 .,OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
Biosens Bioelectron 2012. http://dx.doi.org/10.1016/j.bios.2012.10.088 .,OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,7 2–85 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f9/11/main.PMC4552756.pdf
Available: http://www.eiu.com/site_info.asp?,Non-OADS,/arxiv_data1/oa_pdf/97/bb/520_2015_Article_2676.PMC4552769.pdf
"Alberta Health Services cancer guidelines, information for health professionals: Available: http://www.albertahealthservices.ca/ cancerguidelines.asp .",Non-OADS,/arxiv_data1/oa_pdf/97/bb/520_2015_Article_2676.PMC4552769.pdf
North American Association of Central Cancer Registries: Available: http://www.naaccr.org/Certification/WhoisCertified.aspx .,Non-OADS,/arxiv_data1/oa_pdf/97/bb/520_2015_Article_2676.PMC4552769.pdf
2013; Available at: https://secure.cihi.ca/free_ products/Cancer_Report_EN_web_April2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/97/bb/520_2015_Article_2676.PMC4552769.pdf
Available from: http://www.agora.nl/ZorgKiezen/Statistieken.aspx 24.,Non-OADS,/arxiv_data1/oa_pdf/a0/d0/520_2015_Article_2655.PMC4552770.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/a8/22/520_2015_Article_2654.PMC4552775.pdf
http://www.medicines.org.uk/emc/medicine/12843# PHARMACOKINETIC_PROPS .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/13318_2014_Article_204.PMC4552778.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.011,Non-OADS,/arxiv_data1/oa_pdf/89/05/main.PMC4552805.pdf
"Sequence BLAST analysis of the target genes set 1A, set 1B and ipaH matched with that of GenBank accession number CP004057, and the ialgene matched with that of GenBank accession number NC016833.We used the BLASTN program ( http://www.ncbi.nlm.nih.gov/ BLAST ) for database searching.",OADS,/arxiv_data1/oa_pdf/89/05/main.PMC4552805.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,9 7 –99 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/89/05/main.PMC4552805.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,9 7 –99 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/89/05/main.PMC4552805.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/fd/main.PMC4552806.pdf
"However, as the measured activity depends on proper trafﬁcking of AQP2-V71M to the plasma membrane, the determined activity might underestimate the remaining http://dx.doi.org/10.1016/j.fob.2015.07.003 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/fd/main.PMC4552806.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AQP, aquaporin; AVP, arginine vasopressin; AVPR2, V2 receptor; AQP ER, endoplasmic reticulum; GlpF, glycerol facilitator; GpA, glycophorin A; HM,half-membrane-spanning; NDI, nephrogenic diabetes insipidus ; TM, transmembrane; wt, wild-type ⇑Corresponding author at: Department of Pharmacy and Biochemistry, Johannes Gutenberg-University Mainz, Johann-Joachim-Becher-Weg 30, 55128 Mainz,Germany.",Non-OADS,/arxiv_data1/oa_pdf/c6/fd/main.PMC4552806.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.006,Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC4552807.pdf
Alignments were analyzed using the neighbour-joining statistical method with the Kimura two-parameter method in MEGA4 ( http://www.megasoftware.net ).,OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC4552807.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,9 4–96 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC4552807.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,9 4–96 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC4552807.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.06.009,Non-OADS,/arxiv_data1/oa_pdf/69/ad/main.PMC4552808.pdf
